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3. Abstract 
Myogenesis describes the formation of skeletal muscle fibers during embryogenesis and 
their regeneration of injury in the adult. The formation of myofibers includes the commitment 
of cell progenitors into the muscle lineage, their amplification and subsequent differentiation 
and fusion into multi-nucleated myotubes. The mammalian target of rapamycin (mTOR) 
assembles into two distinct complexes, termed complex 1 (mTORC1) and 2 (mTORC2), 
and controls cellular growth and metabolism, in response to nutrients and extracellular 
signals. The mTOR signaling pathway is crucial for homeostasis of mature skeletal muscle 
and mTOR deregulation in muscle results in progressive myopathies. Since myogenesis is 
determined by a complex regulatory network involving growth factors and external stimuli, I 
investigated the function of mTOR signaling in embryonic and adult myogenesis.  
 
This PhD thesis describes the role of mTORC1 and mTORC2 in embryonic and adult 
myogenesis using genetically modified mice. Depletion of raptor, an essential protein of 
mTORC1, in muscle progenitors caused the mice to die perinatally because of severe 
defects in muscle development. I observed that mTORC1 was highly active in embryonic 
muscle progenitors and precursors and became downregulated in differentiating and fusing 
myocytes, suggesting a predominant role in muscle cell commitment and proliferation. 
Accordingly, raptor-depleted myoblasts showed severe defects in proliferation, most 
probably caused by reduced rates of protein synthesis. Furthermore, loss of mTORC1 
reduced, but did not abolish differentiation of myoblasts. Thus, the myogenic process was 
still completed, but less efficiently, in the absence of mTORC1. To investigate the role of 
mTORC1 in adult myogenesis, depletion of raptor was induced in adult muscle stem cells, 
called satellite cells. mTORC1 depletion did not affect the quiescence of satellite cells but 
delayed their activation upon external stimuli. Furthermore, I established that satellite cells 
deficient for raptor proliferated and differentiated less efficiently, resulting in poor 
regeneration following muscle injury.  
 
Mice deficient for mTORC2 signaling in developing muscle were viable and showed 
no histological and functional alterations of skeletal muscle. Moreover, depletion of rictor in 
embryonic muscle progenitors did not affect the number of satellite cells and their myogenic 
function in adult skeletal muscle upon injury. In particular, rictor-depleted satellite cells did 
not differ from control cells in their proliferation, differentiation and fusion capacity. However, 
the number of satellite cells decreased following repeated muscle injuries in the absence of 
mTORC2. Furthermore, the number of quiescent satellite cells declined during physiological 
aging in mutant mice, causing an impairment in the regenerative capacity at progressed 
age.  
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In conclusion, I established that mTORC1, but not mTORC2 signaling is required for 
the formation of skeletal muscle during embryogenesis and for the regeneration of the tissue 
following severe muscle damage. I found that loss of mTORC1 reduces protein synthesis 
and thereby limits the proliferation and differentiation capacity of myoblasts during 
embryonic and adult myogenesis. In contrast, mTORC2 is dispensable for the myogenic 
function of myoblasts to proliferate, differentiate and fuse, but is required for the 
maintenance of the muscle stem cell pool during aging and after muscle injury. Overall, 
these results are of major importance as they extent our knowledge about the distinct roles 
of mTORC1 and mTORC2 in the myogenic process and the maintenance of the muscle 
stem cell pool. As mTOR is a central regulatory hub, integrating the metabolic status of a 
cell and translating those signals into proteostatic processes, my work has established that 
these mTOR-controlled functions are important in muscle precursors. These results may 
open new avenues regarding pathological conditions, such as aging or metabolic muscle 
disorders, which have also been related to mTOR deregulation.  
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4. Introduction 
Muscle is the most abundant tissue in the human body and is subdivided into skeletal, 
smooth and cardiac muscles. Skeletal muscle (simply referred to as muscle, in the 
following) corresponds to 40 % of the total body mass and is a type of striated muscle 
controlled by the somatic nervous system. The main function of muscle is to generate force 
necessary for locomotion and precise movements in the environment, and to control 
mechanical activity, including respiration and posture maintenance. Skeletal muscle is 
composed of differentiated, post-mitotic myofibers that consist of repetitions of actin and 
myosin filaments, which are responsible for its contractile properties. Since muscle is a 
metabolic organ that responds fast to its environment, muscle development, growth and 
regeneration occur throughout life of an organism. Myogenesis corresponds to the 
formation of skeletal muscle fibers during embryonic muscle development and during 
muscle regeneration in adult mice. Even though the mechanisms of myogenesis, including 
cell commitment, proliferation, differentiation and fusion, are similar at all developmental 
stages, the morphology and functionality of the generated muscles varies depending on the 
needs of the animal (Biressi et al., 2007). Since skeletal muscle is a highly plastic organ, its 
function is often compromised in pathological conditions, such as muscular dystrophies, 
which leads to an imbalance between muscle degeneration and regeneration and 
consequently in a decline in muscle homeostasis. During natural aging, muscles develop 
sarcopenia which is characterized by the loss in muscle mass and force (Evans and 
Campbell, 1993). Sarcopenia strongly affects muscle function and therefore results 
progressively in physical disability, a reduction in the quality of life and increases morbidity 
and mortality. Hence, it is of major importance to study and understand the pathways and 
mechanisms controlling skeletal muscle development, homeostasis and regeneration.  
 
4.1 Skeletal muscle development during embryogenesis 
All limb and trunk skeletal muscles originate, in vertebrates, from the paraxial mesoderm 
formed at early stages in the embryo (Comai and Tajbakhsh, 2014). The paraxial mesoderm 
gives rise by segmentation and epithelialization to somites which differentiate into 4 
independent compartments on either side of the neural tube (Figure 1) (Deries and 
Thorsteinsdottir, 2016): 1) the ventral sclerotome which differentiates into axial bones; 2) 
the syndetome that gives rise to tendons and connective tissue; 3) the dorsal 
dermomyotome containing muscle and brown fat progenitors, endothelial cells and cells 
contributing to the dorsal dermis; and 4) the myotome which originates from muscle 
progenitors delaminating from the dorsomedial part of the dermomyotome. While the 
dorsomedial, epaxial part of the myotome forms the back and intercostal muscles, the 
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ventrolateral, hypaxial myotome generates the diaphragm, limb and abdominal muscles. Of 
note, head and neck muscles derive from the cranial mesoderm which lacks any signs of 
segmentation (Comai and Tajbakhsh, 2014). 
 
 
 
Figure 1. At E10.5, the somites have formed four different compartments: the sclerotome, 
syndetome, dermomyotome and myotome (Deries and Thorsteinsdottir, 2016). 
 
 
Molecular regulation of embryonic myogenesis 
Myogenesis is regulated by a network of transcription factors expressed in a cell 
autonomous manner and through cell-cell communication. The first metameric structures 
formed in embryo are the somites which are specified by local oscillations of gene 
expression and by morphogen gradients, including Notch, Wnt, fibroblast growth factors 
(FGF) and retinoic acid (Bentzinger et al., 2012). Prior to segmentation, at embryonic day 
(E) 8, cells in the paraxial mesoderm start to express Pax3, which belongs to the Pax family 
of transcription factors characterized by their paired domain allowing sequence-specific 
binding to DNA (Buckingham and Relaix, 2007). Pax3 and Pax7 are two Pax members that 
regulate skeletal muscle development, while other Pax genes are important for the 
development of other tissues, e.g. central nervous system, skeleton, thymus and kidney. 
Pax3 remains transcribed in somites and is restricted around E10 to the dorsomedial and 
ventrolateral dermomyotome, while being replaced in the central part of the dermomoytome 
by Pax7 (Murphy and Kardon, 2011). Pax3 expression is essential for the formation of 
hypaxial muscle of the trunk and for the delamination and migration of muscle progenitors 
from the dermomyotome in order to form limb muscle (Relaix et al., 2004). In contrast, Pax7 
is dispensable for the formation of skeletal muscle since Pax3 is suggested to have a 
compensatory function during embryonic development (Hutcheson et al., 2009; Seale et al., 
2000). However, ablation of Pax7-expressing cells affects later stages of muscle 
development, causing smaller muscle marked by a reduced number of myofibers formed. 
Importantly, Pax3- and Pax7-expressing progenitor cells (Figure 2) in the dermomyotome 
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are not yet committed into the muscle lineage, as they are still capable of downregulating 
Pax3/7 expression and acquiring a non-myogenic fate (Ben-Yair and Kalcheim, 2005; Esner 
et al., 2006). Final determination and differentiation into the muscle lineage is controlled by 
a family of basic-helix-loop-helix (bHLH) transcription factors termed myogenic regulatory 
factors (MRFs), including Myf5, MyoD, Myogenin and Mrf4. Those factors have been 
identified on their common expression pattern and their ability to convert non-muscle cells, 
e.g. fibroblasts, into cells capable to fuse into myotubes (Braun et al., 1990; Braun et al., 
1989; Edmondson and Olson, 1989; Miner and Wold, 1990; Rhodes and Konieczny, 1989; 
Weintraub et al., 1991). While the basic domain of MRFs mediates DNA binding, the helix-
loop-helix sequences form heterodimers with E proteins that are necessary for the 
recognition of genomic E boxes present in muscle-specific promoters (Massari and Murre, 
2000). The skeletal muscle phenotype of Myf5- and MyoD-knockout mice was found to be 
normal (Braun et al., 1992; Rudnicki et al., 1992), suggesting that Myf5 and MyoD share 
redundant functions during myogenesis. Notwithstanding, Myf5:MyoD double-null mice 
completely lacked skeletal muscle tissue and MyoG expression (Rudnicki et al., 1993). 
Conditional cell ablation approaches, in which diphtheria toxin (DTA) expression was driven 
in Myf5- or MyoD-expressing cells, first suggested that Myf5 and MyoD independently 
regulate two functional cell lineages, which can compensate for each other to a large extent 
(Gensch et al., 2008; Haldar et al., 2008). However, a more recent report refutes this model, 
claiming that muscle formed in Myf5Cre-DTA embryos, described by Gensch et al. and 
Haldar et al., were generated by non-targeted, escaper cells (Comai et al., 2014). Comai et 
al. rather found that ablation of Myf5-expressing cells results in severe muscle loss (Comai 
et al., 2014). Consistently, MyoD(iCre) embryos, expressing DTA in MyoD-expressing cells, 
showed severe defects in myogenesis accompanied with a loss of Myf5-positive cells, 
indicating that most muscle progenitors express both transcription factors (Wood et al., 
2013). Myf5 and MyoD act as determination factors to commit progenitor cells into the 
Figure 2. Hierarchy of transcription factors controlling the specification and differentiation of 
myogenic cells 
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muscle lineage and induce their transition into muscle precursors, also called myoblasts 
(Figure 2) (Bentzinger et al., 2012). Mechanistically, Myf5 specifies and initiates skeletal 
muscle determination by modifying chromatin at its binding sites prior to MyoD expression, 
but does not yet recruit polymerase II (Conerly et al., 2016). Subsequent expression of 
MyoD, which binds to the same sites as Myf5 and recruits polymerase II, robustly induces 
gene transcription for further muscle specification (Conerly et al., 2016). Before entering the 
differentiation program, muscle precursors undergo extensive proliferation, expanding the 
population of cells, which will ultimately form post-mitotic, multi-nucleated myotubes 
(Buckingham et al., 2003). Differentiating myogenic cells are termed myocytes (Figure 2) 
and are characterized by their elongated shape, their high capacity to fuse together and the 
expression of MyoG (Chal and Pourquie, 2017). Myogenin-null mice die perinatally due to 
severe defects in embryonic muscle development, evidenced by the accumulation of 
undifferentiated muscle precursors (Hasty et al., 1993; Nabeshima et al., 1993). Hence, 
myogenin has a unique function in controlling differentiation and subsequent fusion of 
myocytes. The last member of the MRF family, Mrf4, is genetically linked to Myf5; in most 
Myf5:MyoD double-null embryos, Mrf4 expression is also affected (Kassar-Duchossoy et 
al., 2004). However, rescue of Mrf4 expression in Myf5:MyoD double-null embryos restored 
embryonic myogenesis only to some extent (Kassar-Duchossoy et al., 2004), thus indicating 
that Mrf4 alone is not sufficient to robustly drive skeletal muscle formation autonomously. 
Interestingly, Mrf4 is the only MRF factor that remains expressed in differentiated, multi-
nucleated myotubes (Hinterberger et al., 1991). Furthermore, it was suggested that Mrf4 is 
necessary for the downregulation of myogenin in postnatal skeletal muscle, therefore 
providing evidence for a role of Mrf4 in late stages of differentiation and in the maintenance 
of the differentiated state (Zhang et al., 1995).  
 
Embryonic and fetal wave of myogenesis 
During embryogenesis, the myogenic process occurs in successive waves and is therefore 
divided into embryonic and fetal myogenesis. In mice, embryonic myogenesis finishes 
around E14.5 with the generation of primary, embryonic myofibers as basic muscle pattern 
(Biressi et al., 2007). During the second wave of myogenesis, occurring between E14.5 and 
E17.5, secondary or fetal myofibers are generated and contribute to muscle growth and 
maturation by increasing the number of fibers and the size of primary fibers (Evans et al., 
1994). Peri- and postnatal development of skeletal muscle is driven by muscle progenitors 
that divide at a slow rate and fuse to adjacent myofibers and by the growth of existing 
myofibers (Biressi et al., 2007). The switch from embryonic to fetal myogenesis is regulated 
by the transcription factor Nfix (nuclear factor I x) whose expression is induced by Pax7 in 
fetal muscle (Messina et al., 2010). Nfix represses embryonic genes and induces the 
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expression of genes important for fetal myogenesis, including skeletal muscle-specific 
isoforms of enzymes. Interestingly, primary myofibers express Myh3, encoding the 
embryonic isoform of myosin heavy chain (MHC), and Myh7, encoding the slow isoform, 
and thereby acquire the identity of slow myofibers (type I fibers). In contrast, secondary 
myofibers become fast, type II fibers, by preferentially expressing Myh3 and Myh8 
(encoding the fast, perinatal isoform of MHC) (Biressi et al., 2007). Myh7 is one particular 
embryonic gene that is directly repressed by Nfix after the transition between embryonic 
and fetal myogenesis (Messina et al., 2010). 
 
4.2 Myogenesis in adult skeletal muscle 
During fetal myogenesis, a portion of Pax3- and Pax7-expressing muscle progenitors retain 
their uncommitted state and acquire the fate of skeletal muscle stem cells, also termed 
satellite cells (Kassar-Duchossoy et al., 2005). Even though satellite cells are considered 
as MRF-negative cells, most of them transiently expressed MyoD prenatally (Kanisicak et 
al., 2009). During late fetal myogenesis, Pax3/Pax7-positive progenitors colonize nascent 
myofibers and change their transcriptional program by downregulating Pax3 and inducing 
the expression of Myf5 (Kassar-Duchossoy et al., 2005; Relaix et al., 2005). 
Notwithstanding, Pax7 remains constantly and highly expressed in quiescent satellite cells, 
hence serving as a widely used specific cell marker. In adult skeletal muscle, satellite cells 
remain quiescent, adopt their specific localization underneath the basal lamina and exhibit 
a high nucleus-to-cytoplasm ratio (Dumont et al., 2015). The main function of satellite cells 
is to provide progeny in order to regenerate muscle fibers upon stimuli from their 
environment, such as muscle damage. Accordingly, satellite cells turn into an activated 
state which is accompanied by metabolic and transcriptional changes promoting their 
proliferation and differentiation. Activated satellite cells pass through the myogenic process, 
which shows similarities to embryonic muscle development. Thus, the process of skeletal 
muscle regeneration is also termed adult myogenesis. Additionally, adult myogenesis 
includes satellite cell self-renewal, which corresponds to the return of a portion of activated 
satellite cells back into quiescence to ensure further rounds of degeneration / regeneration. 
 
Molecular regulation of satellite cell quiescence 
Quiescent satellite cells tightly associate to myofibers through adhesion molecules, such as 
M-cadherin, Mcam, Megf10, integrin α4β1 and Vcam-1 (Brohl et al., 2012). Defects in 
adhesion or spontaneous activation of satellite cells promote their migration and cause them 
to localize to the myofibrillar interstitial space. The microenvironment surrounding satellite 
cells is termed the niche, which supports the self-renewal of the stem cell pool and prevents 
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their activation (Jones and Wagers, 2008; Scadden, 2006). The niche is a complex network 
including blood vessels, stromal cells, soluble factors, extracellular matrix, neural inputs and 
adhesion molecules. One important, extrinsic mediator of satellite cell quiescence is the 
Notch signaling: myofibers express the Notch ligand Delta 1 and satellite cells the Notch 
receptor and the co-receptor syndecan-3 facilitating Notch signaling transduction (Bjornson 
et al., 2012; Mourikis et al., 2012; Pisconti et al., 2010). Inhibition of Notch components or 
syndecan-3 causes the satellite cells to exit quiescence and to differentiate spontaneously, 
leading to self-renewal impairments (Dumont et al., 2015). Maintenance of the quiescent 
state of satellite cells also requires the inhibition of signaling pathways promoting their 
proliferation. In particular, FGF2 has been shown to induce satellite cell activation (Jones 
et al., 2001; Sheehan and Allen, 1999; Yablonka-Reuveni et al., 1999). Quiescent satellite 
cells display high expression of sprouty1, which counteracts FGF2 signaling and thereby 
actively maintains their quiescent state (Chakkalakal et al., 2012; Shea et al., 2010). 
Quiescent satellite cells strongly express cyclin dependent-kinase inhibitors, e.g. p21, p27 
and p57, while genes controlling DNA replication and cell cycle, such as cyclin A2, cyclin 
B1, cyclin E2 and survivin, are repressed (Cheung and Rando, 2013). The oncogene Dek 
also directly regulates myogenic progenitor proliferation: upon asymmetric cell division, Dek 
sequesters to the more committed, differentiated daughter cell (Cheung et al., 2012). 
Interestingly, Dek is post-transcriptionally suppressed by miR-489 in quiescent satellite cells 
in order to prevent activation. Additionally, quiescent satellite cells reduce their metabolism 
to a minimal level and mostly depend on fatty acid oxidation as an energy source. They 
undergo a metabolic switch during their transition to an activated state by using glycolysis 
to produce ATP rapidly (Ryall et al., 2015). Phosphorylation of the eukaryotic translation 
initiation factor 2A (eIF2α) in quiescent satellite cells leads to the repression of general 
mRNA translation, only allowing translation of specific mRNA selected dependent on their 
uORFs (Zismanov et al., 2016). Upon satellite cell activation, eiF2α is dephosphorylated, 
which induces protein synthesis required for their function in an activated state. In particular, 
Myf5 mRNA is sequestered in RNA granules in quiescent cells, but is translocated to 
polysomes and thus translated upon activation of the cells (Crist et al., 2012). Interestingly, 
it was proposed that two distinct phases of quiescence exist: one being more dormant and 
the other one being closer to activation, called “alerted state”, which is characterized by an 
increase in cell size and a faster cell cycle entry (Rodgers et al., 2014). This alerted state 
of satellite cell is initiated upon a systemic injury, which induces hepatocyte growth factor 
(HGF) binding to cMet and consequently activation of mTORC1.  
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The process of muscle regeneration 
Skeletal muscle regeneration is provoked in response to muscle damage either caused by 
direct trauma from extensive physical activity or induced by pathological conditions, such 
as neurological dysfunction or innate genetic defects. For successful restoration into a well-
innervated, fully vascularized and contractile skeletal muscle, the extracellular matrix is 
required as a template for the formation of myofibers (Charge and Rudnicki, 2004). Skeletal 
muscle regeneration includes an initial phase of muscle degeneration accompanied by an 
inflammatory response and followed by a secondary phase defined by the restoration of 
myofibers. Skeletal muscle degeneration is initiated by complete necrosis of muscle fibers. 
Already during the phase of muscle degeneration and the boost of pro-inflammatory 
cytokines, quiescent satellite cells get activated by various signals released from the 
extracellular matrix (e.g. FGF2, HGF and nitric oxide) and start to express MyoD (myoblast 
state) (Charge and Rudnicki, 2004; Dumont et al., 2015). Myoblasts exhibit the capacity to 
undergo proliferation, which is controlled by signaling pathways and multiple factors that 
either increase cell cycle progression or repress premature differentiation. Interestingly, the 
first ~30 – 40 % of divisions are asymmetric, while afterwards, symmetric divisions ensure 
expansion of the pool of muscle precursors, and the maintenance of mother cells with 
stemness features (Le Grand et al., 2009; Yennek et al., 2014). During asymmetric cell 
divisions, the daughter cell attached to the basal lamina keeps its stem cell fate and remains 
Myf5-negative. In contrast, in the more committed, apical daughter cell, Myf5 transcription 
is induced when Pax7 is methylated by the arginine methyltransferase Carm1 (Kawabe et 
al., 2012; Kuang et al., 2007; McKinnell et al., 2008). Interestingly, 10 % of Pax7-positive 
satellite cells have never expressed Myf5, suggesting that the satellite cell pool is 
heterogeneous and that some satellite cells have a higher propensity to contribute to the 
cell reservoir following activation (Kuang et al., 2007). Engraftment studies revealed that 
Myf5-negative satellite cells have a higher self-renewal potential (Kuang et al., 2007). 
Symmetric, planar division of Myf5-negative satellite cells is promoted by the planar cell 
polarity (PCP) pathway, which is considered as a non-canonical Wnt pathway, regulating 
cytoskeleton reorganization and gene expression (Le Grand et al., 2009). Satellite cell self-
renewal is not only determined by asymmetric and symmetric cell division, but involves also 
satellite cell intrinsic signaling pathways and multiple extrinsic factors from the niche, which 
affect their return into quiescence and the maintenance of a stem cell fate. In parallel, 
regulation of cell commitment during asymmetric cell division also relies on specific 
signaling pathways and polarity proteins. It was reported that the partitioning defective 
(PAR) complex, consisting of PAR-3 and PAR-6, and the atypical protein kinase C (aPKC) 
polarize to the more committed cell, where they activate p38α/β MAPK signaling and 
thereby induce the transcription of MyoD (Troy et al., 2012). After several rounds of cell 
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divisions, MyoD-expressing myoblasts permanently exit the cell cycle and enter the 
differentiation program by inducing the expression of cell cycle inhibitors (e.g. p21 and p57), 
and upregulating Myogenin and Mrf4 expression (Cornelison et al., 2000; Halevy et al., 
1995; Hollenberg et al., 1993). Similar to embryonic myogenesis, differentiating myoblasts 
in regenerating adult skeletal muscle undergo cell-cell fusion to form multi-nucleated 
myotubes that mature into specialized, innervated myofibers (Dumont et al., 2015). 
 
Efficient skeletal muscle regeneration not only depends on satellite cells, since non-
myogenic cells like immune cells and fibro-adipogenic progenitors (FAPs) also contribute 
to the restoration of myofibers following muscle damage. Skeletal muscle resident 
leukocytes, such as mast cells, macrophages and circulating monocytes, sense 
metabolites, DNA, RNA and other molecules released by permeable, damaged muscle 
fibers and thereby get activated and secrete additional cytokines. These factors, e.g. TNFα, 
tryptase and IL-6, promote satellite cell activation and proliferation, as well as the 
recruitment of additional, circulating leukocytes (Chen et al., 2007; Duchesne et al., 2011; 
Serrano et al., 2008). After a first invasion of granulocytes, which clear muscle debris by 
phagocytosis, M1 macrophages accumulate and induce a pro-inflammatory phase and 
myoblast proliferation by repressing early differentiation (Dumont et al., 2015). 
Subsequently, M2 macrophages, corresponding to an anti-inflammatory response, mediate 
myoblast differentiation and myofiber growth. Skeletal muscle resident FAPs are initially 
stimulated upon muscle injuries to amplify and provide pro-myogenic cues promoting the 
regenerating phase (Joe et al., 2010; Uezumi et al., 2010). Subsequently, the differentiation 
of FAPs is repressed by the presence of restored myofibers. However, in skeletal muscle 
undergoing chronic degeneration and regeneration, e.g. in muscular dystrophies, or 
exhibiting an impaired regenerative capacity, the dynamics of FAPs is not repressed, hence 
causing them to differentiate into fibroblasts and adipocytes, which is often observed as 
fatty degeneration (Joe et al., 2010; Mozzetta et al., 2013; Uezumi et al., 2010).  
 
Satellite cell function in aging 
During physiological aging, skeletal muscles get sarcopenic, which is characterized by an 
atrophy of type II (fast) myofibers, an heterogeneity in fiber size, an accumulation of 
collagen-rich and fatty tissue, and a reduced oxidative capacity (Sousa-Victor and Munoz-
Canoves, 2016). Sarcopenia is accompanied by a decline in the regenerative capacity of 
aged skeletal muscle (Brack and Munoz-Canoves, 2016). Even though over time satellite 
cells fuse and contribute to their adjacent myofibers in the absence of muscle damage, 
depletion of the satellite cell pool in young mice does not affect the maintenance of the 
cross-sectional area, therefore indicating that a deficiency in satellite cell homeostasis 
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during aging is not the main cause of sarcopenia (Fry et al., 2015; Keefe et al., 2015). The 
lower regenerative potential of aged skeletal muscle results partially from the decrease in 
satellite cell content during aging (Shefer et al., 2006; Sousa-Victor and Munoz-Canoves, 
2016). The decline in the myogenic potential of aged satellite cells also correlates with a 
lower proliferation and differentiation efficiency. Furthermore, it was established that 
satellite cells switch from their reversible quiescent state into senescence during geriatric 
age, corresponding to an age of more than 24 months in mice (Sousa-Victor et al., 2014). 
Derepression of p16INK4a (Cdkn2a) contributes to satellite cell senescence by causing the 
de-phosphorylation of the retinoblastoma protein (Rb) and the repression of E2F target 
genes, hence leading to an irreversible cell cycle exit and the loss of self-renewal. Loss of 
proteostasis resulted in oxidative stress and ROS production, which was unraveled as the 
key epigenetic regulator of p16INK4a in aging satellite cells. Moreover, in senescent satellite 
cells, foci with the phosphorylated form of the histone H2AX (pH2AX), a biomarker for DNA 
damage, accumulate (Sousa-Victor et al., 2014). Recently, it was discovered that the 
autophagy flux, responsible for the turnover of proteins and organelles, is dysfunctional in 
aged satellite cells (Garcia-Prat et al., 2016). Age-dependent changes in the satellite cell 
niche also contribute to the loss of stem cell quiescence and function during physiological 
aging. Aged skeletal muscle fibers express increased levels of FGF2, which correlates with 
a decreased expression of the FGF signaling inhibitor sprouty1 in satellite cells 
(Chakkalakal et al., 2012; Shea et al., 2010). Consequently, FGF2 signaling drives aged 
satellite cells to exit quiescence and enter the myogenic program without replenishing the 
stem cell pool. Mechanistically, FGF stimulation in the aged niche chronically activates 
p38α/β MAPK signaling via the FGF receptor-1 (FGFR1) expressed in resident satellite 
cells, which prevents their asymmetric cell division (Bernet et al., 2014). Hence, two 
committed daughter cells are generated and the self-renewal capacity of aged satellite cells 
abrogated. Overall, several cell-intrinsic alterations and external signals derived from the 
niche, determine changes in the fate and function of satellite cells during physiological 
aging.  
 
4.3 The mTOR signaling pathway 
The mammalian (or mechanistic) target of rapamycin (mTOR) is a serine/threonine protein 
kinase that controls cellular growth and metabolism, by integrating environmental cues 
including amino acids, growth factors and cellular energy such as ATP. Rapamycin, 
clinically termed sirolimus, is generated by the bacteria Streptomyces Hygroscopicus and 
was discovered because of its toxic, anti-proliferative effect in yeast. Rapamycin forms a 
gain-of-function complex with the 12-kDa peptidyl-prolyl-isomerase FK506-binding protein 
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(FKBP12), which binds to the mediators TOR1 and TOR2 (Cafferkey et al., 1993; Kunz et 
al., 1993). Later, mTOR was identified as the homolog protein in mammals (Brown et al., 
1994; Sabatini et al., 1994; Sabers et al., 1995). The catalytic subunit mTOR assembles 
into two structurally and functionally distinct complexes, termed mTOR complex 1 
(mTORC1) and mTOR complex 2 (mTORC2) (Figure 3). Both complexes include 
mammalian lethal with sec-13 protein 8 (mLST8), DEP domain containing mTOR-
interacting protein (DEPTOR) and Tti1/Tel2 complex (Laplante and Sabatini, 2012). 
mTORC1 additionally contains regulatory-associated protein of mTOR (raptor) and proline-
rich Akt substrate 40 kDa (PRAS40), whereas rapamycin-insensitive companion of mTOR 
(rictor), mammalian stress-activated map kinase-interacting protein 1 (mSin1) and protein 
observed with rictor 1 and 2 (protor1/2) are specific of mTORC2 (Laplante and Sabatini, 
2012). In mammals, rapamycin directly interacts and inhibits mTORC1, but not mTORC2 
(Brown et al., 1994; Sabatini et al., 1994). However, prolonged rapamycin treatment also 
disrupts and affects mTORC2 (Lamming et al., 2012).  
 
 
 
 
Figure 3. The mTORC1 signaling pathway 
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Upstream of mTORC1 
As a key sensor of the nutritive status of the cell, several upstream pathways control 
mTORC1 activation. Binding of growth factors, including insulin and insulin-like growth 
factors (IGF), to the receptor tyrosine kinase on the cell surface promotes the intracellular 
recruitment and tyrosine phosphorylation of the adapter protein insulin-receptor substrate 1 
(IRS1) and subsequent activation of the lipid kinase phosphatidylinositol-4,5-bisphosphate 
3-kinase (PI3K) (Figure 3) (Laplante and Sabatini, 2009). Consequently, the 
serine/threonine protein kinase B (PKB/Akt) is recruited to the membrane, where the 
phosphoinositide-dependent kinase 1 (PDK1) phosphorylates its activation loop (at the 
Threonine 308) (Alessi et al., 1997; Stokoe et al., 1997; Wick et al., 2000). Akt 
phosphorylates tuberous sclerosis complex 2 (TSC2), which disrupts the interaction with 
TSC1 (tuberous sclerosis complex 1) and leads to their dissociation from the lysosomal 
membrane (Inoki et al., 2002; Manning et al., 2002; Menon et al., 2014; Potter et al., 2002). 
The TSC complex functions as a GTPase-activating protein (GAP) for the small GTPase 
termed Ras homolog enriched in brain (Rheb) (Inoki et al., 2003a; Tee et al., 2003). GTP-
loaded Rheb stimulates the kinase activity of mTORC1 (Long et al., 2005) and thereby 
regulates mTORC1 downstream signaling in yet unknown mechanisms. Akt also activates 
mTORC1 independently from TSC1/2, by phosphorylating and inactivating PRAS40, which 
functions as an inhibitor through its binding to raptor (Sancak et al., 2007; Thedieck et al., 
2007; Vander Haar et al., 2007; Wang et al., 2007). Moreover, mTORC1 activation is also 
controlled by the availability of cytosolic and intra-lysosomal amino acids via distinct 
mechanisms (Figure 3). Lysosomal amino acids, in particular arginine, are sensed by 
SLC38A9, a lysosomal transmembrane protein involved in amino acid transport and 
integrated into the vacuolar H+-ATPase (v-ATPase), Ragulator and Rag GTPase complex 
(Jung et al., 2015; Rebsamen et al., 2015; Wang et al., 2015). V-ATPase, an ATP-driven 
proton pump controlling the acidification of the lysosomal lumen, directly interacts with the 
pentameric protein complex Ragulator that anchors Rag GTPases close to the lysosomal 
membrane (Shimobayashi and Hall, 2016). Amino acid stimulation weakens the interaction 
of the v-ATPase with Ragulator, consequently activating the heterodimeric protein Rag 
(Zoncu et al., 2011). The activated Rag complex, achieved by loading RagA/B with GTP 
and hydrolyzing RagC/D-GTP, recruits mTORC1 from the cytosol to the lysosomal 
membrane, where it encounters full activation by Rheb-GTP (Sancak et al., 2008). Another 
component in the amino acid-dependent activation of mTORC1 is the small regulatory 
polypeptide of amino acid response (SPAR), a polypeptide encoded by the conserved 
lncRNA LINC00961 acting upstream of the v-ATPase, Ragulator and Rag GTPase complex 
(Matsumoto et al., 2017). Lastly, mTORC1 reacts to stress conditions, e.g. low ATP levels 
or DNA damage, which are incompatible with cellular growth and metabolism (Figure 3). 
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Low energy levels upon starvation, resulting in a decreased ATP/AMP ratio, activate the 
stress responsive metabolic regulator AMP-activated protein kinase (AMPK); active AMPK 
inhibits mTORC1 signaling directly through the phosphorylation of raptor, as well as 
indirectly by phosphorylating and thereby activating TSC2 (Gwinn et al., 2008; Inoki et al., 
2003b; Shaw et al., 2004). 
 
Downstream of mTORC1 
mTORC1 functions as a central regulator of cell growth by controlling key players in protein 
translation and degradation (Figure 3). Active mTORC1 phosphorylates the p70S6 Kinase 
1 (S6K1, at the Threonine 389), which in turn activates several proteins involved in mRNA 
translation initiation, e.g. eIF4B, a protein associating with eIF4F and eIF4A and promoting 
ATP-dependent RNA unwinding before cap-dependent translation (Holz et al., 2005). 
Additionally, S6K1 promotes phosphorylation-dependent degradation of PDCD4, an 
inhibitor of eIF4A (Dorrello et al., 2006). The second major downstream substrate of 
mTORC1 is 4E-BP1, which represses 5’cap-dependent mRNA translation by sequestering 
eIF4E (Brunn et al., 1997; Gingras et al., 1999). Upon inhibitory phosphorylation by 
mTORC1, 4E-BP1 releases eIF4E allowing it to take part in the eIF4F complex and to direct 
ribosomes to the cap-structure of mRNAs. In addition to the role of mTORC1 in protein 
synthesis, mTORC1 negatively regulates protein catabolism, most notably autophagy. 
Autophagy is a cellular process degrading organelles and damaged proteins via the 
formation of autophagic vesicles (called autophagosomes), ultimately fusing with 
lysosomes. Autophagy is initiated upon activation of unc-51 like autophagy activating kinase 
1 (ULK1), which complexes with ATG13, FIP2000 and ATG101 and induces 
autophagosome formation (Ganley et al., 2009; Hara et al., 2008; Hosokawa et al., 2009). 
mTORC1 phosphorylates and inactivates ULK1 (at Serine 757), thereby blocking 
autophagy induction and reducing protein turnover (Castets et al., 2013; Kim et al., 2011). 
Lastly, mTORC1 is also implicated in de novo lipid synthesis via the sterol responsive 
element binding protein (SREBP) (Duvel et al., 2010), in nucleotide synthesis that are 
required for DNA replication, and in ribosome biogenesis in growing and proliferating cells 
(Saxton and Sabatini, 2017). 
 
Upstream of mTORC2 
In contrast to mTORC1, mTORC2 is insensitive to nutrients, but it functions as an effector 
of the insulin / growth factor and PI3K signaling, which promotes the association of 
mTORC2 with ribosomes to activate its kinase activity (Zinzalla et al., 2011). Another 
mechanism of mTORC2 activation involves the phosphorylation of mSin1, a specific 
component of mTORC2, by Akt, hence serving as a positive feedback loop between Akt 
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and mTORC2 (Yang et al., 2015). Surprisingly, mTORC2 signaling is also regulated by 
mTORC1, since mTORC1 was found to activate the growth factor receptor-bound protein 
10 (Grb10), an inhibitor of insulin / IGF-1 (Hsu et al., 2011; Yu et al., 2011). Additionally, 
S6K1, a direct mTORC1 target, phosphorylates and marks IRS1 for degradation, hence 
constituting a negative feedback loop reducing PI3K and mTORC2 signaling (Harrington et 
al., 2004; Shah et al., 2004).  
 
Downstream of mTORC2 
mTORC2 signaling plays a role in cellular metabolism and survival, by regulating several 
members of the protein kinase family. One such phosphorylation target of mTORC2 is the 
serine/threonine protein kinase 1 (SGK1, at the Serine 422), which regulates ion transport 
and cell survival (Garcia-Martinez and Alessi, 2008). mTORC2 has also been implicated in 
actin cytoskeleton organization via the phosphorylation of protein kinase C α (PKCα, at the 
Serine 657) (Jacinto et al., 2004; Sarbassov et al., 2004). The last well-described 
downstream target of mTORC2 is Akt, phosphorylated in the carboxyl-terminal hydrophobic 
motif (at the Serine 473). Upon phosphorylation by mTORC2, Akt is fully activated by 
phosphorylation in its activation loop (at the Threonine 308) by PDK1 (Sarbassov et al., 
2005). The mTORC2 / Akt axis regulates lipogenesis and glucose homeostasis in insulin-
stimulated tissues, e.g. liver and skeletal muscle (Hagiwara et al., 2012; Kumar et al., 2008; 
Yuan et al., 2012).  
 
4.4 mTOR signaling in skeletal muscle 
Skeletal muscle is metabolically highly active and quickly adapts its morphology in response 
to physiological conditions, but is often compromised upon a diseased state. To maintain 
skeletal muscle homeostasis, processes such as tissue regeneration and maintenance of 
muscle mass are of major importance. Since both processes require large amounts of 
nutrients and energy, mTOR is positioned as a central regulator of muscle health and 
function. Notably, skeletal muscle growth is based on hypertrophy, rather than an increase 
in number of fibers (Glass, 2005). Moreover, hypertrophy is induced upon mTORC1 
activation, but reversed into atrophy with rapamycin treatment (Bodine et al., 2001; Izumiya 
et al., 2008; Pallafacchina et al., 2002; Rommel et al., 2001). Mouse skeletal muscles 
expressing human TSC1, which stabilizes the TSC1/2 complex and consequently inhibits 
mTORC1, develop an atrophic phenotype (Wan et al., 2006). Similarly, muscle cells 
depleted for S6K show normal differentiation and fusion, but S6K-/- myotubes are atrophic 
and do not respond to IGF-I or nutrient stimulation (Ohanna et al., 2005). Even though 
expression of a constitutively active form of Akt, leading to short-term activation of 
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mTORC1, causes hypertrophy in muscle fibers (Bodine et al., 2001), sustained activation 
of mTORC1 in skeletal muscle, achieved by conditional knockout of TSC1 under the control 
of the human skeletal actin (HSA) promoter (TSCmKO), results in severe atrophy and in a 
late-onset myopathy (Castets et al., 2013). Mechanistically, sustained activation of 
mTORC1 inhibits autophagy induction through ULK1 inhibitory phosphorylation, resulting in 
the accumulation of damaged organelles. Furthermore, in TSCmKO muscle the rate of 
protein synthesis is strongly increased, thus provoking an unfolded protein response and 
ER-stress (Guridi et al., 2015). Interestingly, skeletal muscles deficient for mTORC1 
signaling (RAmKO) are atrophic and also show a degenerative phenotype, resulting in a 
progressive muscular dystrophy causing premature death of the mice (Bentzinger et al., 
2008; Romanino et al., 2011). In both TSCmKO and RAmKO mice, lean mass and muscle 
force are decreased, indicating that balanced mTORC1 signaling is necessary for 
homeostasis and function of adult skeletal muscle (Guridi et al., 2016). Notably, whole-body 
knockout of mTOR or Rptor affects viability in early stages of embryogenesis (Gangloff et 
al., 2004; Guertin et al., 2006; Murakami et al., 2004), confirming a central function of 
mTORC1 in cell, organ and body growth. Furthermore, it was demonstrated that shRNA-
mediated knockdown of Rptor or Rheb in C2C12 myoblasts enhances differentiation, by 
releasing the negative feedback of mTORC1 onto IRS1, and thereby increasing Akt 
signaling (Ge et al., 2011). Inversely, rapamycin treatment of rat and mouse myoblasts 
prevents differentiation in vitro (Conejo et al., 2001; Coolican et al., 1997; Cuenda and 
Cohen, 1999). Consistently, in vivo application of rapamycin inhibits differentiation of 
myoblasts during skeletal muscle regeneration following muscle injury in rodents (Ge et al., 
2009; Miyabara et al., 2010). Notably, mTORC1 downstream signaling is highly increased 
in regenerating compared to uninjured muscle (Matsumoto et al., 2017; Miyabara et al., 
2010; Rodgers et al., 2014). Moreover, it was proposed that mTORC1 remains inactive in 
quiescent satellite cells, but that the signaling is induced in the GAlert and activated states 
(Rodgers et al., 2014). Interestingly, SPAR, an upstream inhibitor of amino acid-induced 
mTORC1 signaling, is strongly down-regulated in skeletal muscle upon muscle injury and 
may thus contribute to mTORC1 activation in the tissue (Matsumoto et al., 2017). Several 
lines of evidence point to a potential role of mTORC1 in myogenesis: 1) in myoblasts 
proliferation and differentiation; 2) in the transition between quiescence and activation of 
satellite cells. The exact mechanisms how mTORC1 controls the formation of muscle fibers 
during development and regeneration of the tissue are yet to be identified.  
  
In contrast, the function of mTORC2 in adult skeletal muscle is less described. Mice 
depleted for rictor in differentiated, mature myofibers (RImKO – HSA promoter) are viable, 
have a normal life-span and show no alteration in skeletal muscle morphology (Bentzinger 
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et al., 2008). Nonetheless, whole-body metabolism of RImKO mice is perturbed due to 
defective insulin-stimulated glucose transport in skeletal muscle, which results in glucose 
intolerance of mutant mice (Kumar et al., 2008). Simultaneously, RImKO mice undergo a 
re-partitioning of lean to fat mass and exhibit increased abundance of intramyocellular 
triglycerides, providing fat as a preferred energy substrate (Kleinert et al., 2016). Although 
glucose and lipid metabolism is altered in the absence of mTORC2, the signaling is 
dispensable for the maintenance of adult skeletal muscle function. However, these studies 
addressed the consequences of mTORC2 depletion only in mature fibers (Leu et al., 2003; 
Schwander et al., 2003), but did not include the investigation on the role of mTORC2 in 
skeletal muscle formation and the function of satellite cells. Remarkably, whole-body 
knockout of Rictor in mice causes embryonic lethality at E11.5, thus indicating that 
mTORC2 signaling is crucial for embryogenesis (Guertin et al., 2006; Shiota et al., 2006). 
Inactivation of Rictor in the Myf5-lineage, i.e. in progenitors acquiring the fate of skeletal 
muscle or brown adipocytes, revealed that mTORC2 signaling is required for brown fat 
differentiation and growth (Hung et al., 2014). Moreover, loss of mTORC2 signaling shifts 
brown fat metabolism towards a more oxidative and less lipogenic state. Interestingly, Hung 
et al. provide evidence that mTORC2 is dispensable for embryonic muscle development, 
since mutant skeletal muscle did not show any alterations at young age. Nevertheless, long-
term consequences of mTORC2 inactivation in skeletal muscle and their resident stem cells 
remain to be studied in greater detail. In C2C12 myoblasts, shRNA-mediated knockdown 
of Rictor blocked terminal differentiation and fusion (Shu and Houghton, 2009). 
Mechanistically, mTORC2-induced phosphorylation of Akt (at the Serine 473) appears 
necessary for the downregulation of Rho-associated kinase 1 (ROCK1), which normally 
occurs during differentiation. Previously, ROCK1 has been implicated in actin cytoskeleton 
organization and was found to be active in proliferating myoblasts and downregulated 
during late differentiation and fusion (Nishiyama et al., 2004). Hence, detailed analysis of 
mTORC2 in the formation of muscle fibers, including proliferation, differentiation and fusion 
of myoblasts, and in satellite cell homeostasis needs further investigation.  
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5. Rationale and objectives of the thesis 
Several lines of evidence pointed to a potent role of mTORC1 and mTORC2 in embryonic 
and adult myogenesis, although the exact mechanisms have not yet been identified. The 
overall objective of my PhD work was to decipher the roles of mTOR signaling in the 
myogenic process, and the consequences of its deregulation in muscle development and 
regeneration. The first specific aim was to identify the functions of mTORC1 and mTORC2 
in embryonic myogenesis. For this purpose, I describe in detail the muscle phenotype of the 
two conditional knockout mouse models, generated in the lab, which were depleted for 
raptor or rictor in Myf5-expressing muscle progenitors, leading to inactivation of mTORC1 
(RAmyfKO) or mTORC2 (RImyfKO), respectively, from the onset of muscle development. 
More specifically, I focused on the consequences of mTORC1 or mTORC2 inactivation in 
myogenesis and tested the proliferation, differentiation and fusion capacity of muscle 
precursors, in vitro and in vivo. I also addressed whether inactivation of mTOR signaling 
affected the viability of muscle cells. The second specific aim of my PhD work was to 
determine whether mTORC1 and mTORC2 have similar functions in adult myogenesis, 
which involves satellite cells that are derived from fetal muscle progenitors and are essential 
for muscle regeneration upon injury. To investigate the function of mTORC1 in myogenesis 
of adult mice, we induced raptor depletion in Pax7-expressing satellite cells (RAscKO). I 
first addressed whether inactivation of mTORC1 or mTORC2 has an impact on the 
maintenance of the quiescent satellite cell pool. Secondly, I analyzed the myogenic capacity 
of RImyfKO and RAscKO satellite cells, by activating them either in culture conditions or by 
provoking muscle damage in vivo. Additionally, both experimental approaches allowed me 
to study their capacity to return into quiescence. Lastly, I investigated whether mTORC2-
deficient satellite cells and myofibers differ in the age-related changes. Hence, during my 
PhD work, I aimed to understand whether and how mTORC1 and mTORC2 signaling are 
involved in the dynamics and homeostasis of muscle progenitors and precursors and 
thereby in the formation and maintenance of muscle fibers during development and 
regeneration.  
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6. Results 
6.1 Manuscript 1: “Loss of mTORC1 in muscle progenitors reduces 
proliferation and differentiation and impairs, but does not abolish, 
myogenesis” 
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Abstract 
Myogenesis, corresponding to skeletal myofiber formation during embryogenesis and 
regeneration in the adult, is a highly complex process requiring growth factors and nutrients. 
The mammalian (or mechanistic) target of rapamycin (mTOR) functions as a central 
regulator of cell growth and metabolism in response to extracellular signals. mTOR 
assembles into two distinct complexes: mTOR complex 1 (mTORC1) and complex 2 
(mTORC2). Since mTORC1, but not mTORC2 is crucial for homeostasis of adult skeletal 
muscle, we aimed to understand the raptor-dependent role of mTORC1 in embryonic and 
adult myogenesis. We generated mice depleted for raptor, an essential protein of mTORC1, 
in embryonic muscle progenitors and adult muscle stem cells using Myf5-Cre and Pax7-
CreERT2 mice, respectively. mTORC1 inactivation in developing muscle causes perinatal 
lethality of the mice and impairs embryonic myogenesis. We determined that specifically 
mTORC1 affects proliferation and differentiation of muscle precursors, although raptor-
depleted cells contribute to myofiber formation. Removal of mTORC1 from muscle stem 
cells abolishes their myogenic function during regeneration of the adult tissue upon injury. 
Defects in adult myogenesis result from a delay of muscle stem cells to enter activation and 
from their limited capacity to proliferate and differentiate in the absence of mTORC1. Thus, 
we established that mTORC1 signaling is crucial for embryonic and adult myogenesis. 
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Introduction 
Skeletal muscle is the largest organ of the human body, accounting for approximately 40 % 
of the weight. Formation of skeletal muscle fibers, corresponding to the process of 
myogenesis, occurs in several steps and waves. Embryonic myogenesis is initiated in 
mesodermal progenitors, which reside in the dermomyotome and express the paired box 
protein-3 and -7 (Pax3 and Pax7). These cells become committed to the myogenic lineage 
by expressing myogenic regulatory factors (MRFs) Myf5, MyoD, Mrf4 or Myogenin. These 
myoblasts then become post-mitotic and fuse together in order to form multi-nucleated 
muscle fibers (Deries and Thorsteinsdottir, 2016). There are two waves of myogenesis, the 
embryonic wave that gives rise to primary myofibers, and the fetal wave (starting around 
E14.5 in mouse), which uses a distinct gene expression program, and results in secondary 
myofibers (Biressi et al., 2007a). Many of the steps and mechanisms of developmental 
myogenesis are also important upon injury-induced muscle regeneration, where quiescent 
Pax7-positive satellite cells become activated and give rise to myogenic cells that are 
capable of repairing the injured myofibers in a process termed adult myogenesis (Dumont 
et al., 2015). 
 
The mammalian (or mechanistic) target of rapamycin (mTOR) is a protein 
serine/threonine kinase that assembles into two structurally and functionally distinct multi-
protein complexes, mTOR complex 1 (mTORC1) and mTORC2 (Saxton and Sabatini, 
2017). High doses of the name-giving drug rapamycin block mTORC1 instantaneously by 
the direct binding of the FKBP12-rapamycin complex. In contrast, mTORC2 signaling is 
attenuated only after prolonged exposure to rapamycin (Sarbassov et al., 2006), arguing 
that rapamycin is not complex specific. In contrast, the different functions of mTORC1 and 
mTORC2 can be dissected by selective removal of their essential components raptor and 
rictor, respectively. Whole-body and cell- / tissue-specific knockouts for Rptor and Rictor, 
have shown that mTORC1 senses nutrients and growth factors and functions as a central 
regulator of cell growth by balancing protein synthesis and protein degradation, whereas 
mTORC2 can affect cytoskeletal remodeling and cell survival (Saxton and Sabatini, 2017). 
Interestingly, whole-body knockouts of Mtor, Rptor and Rictor in mice are embryonic lethal 
(Gangloff et al., 2004; Guertin et al., 2006; Murakami et al., 2004). Moreover, the phenotype 
caused by the tissue-specific ablations of Rptor or Rictor largely differ between tissues. For 
example, ablation of Rptor or Mtor in skeletal muscle causes a very similar phenotype 
dominated by muscle atrophy and a severe myopathy that results in early death of the mice 
(Bentzinger et al., 2008; Risson et al., 2009). In contrast, skeletal muscle-specific Rictor 
knockout mice do not have an overt phenotype, but their muscles show metabolic changes; 
in particular, a greater reliance on lipids and an increased lipid content (Kleinert et al., 2016). 
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In those experiments, the targeted genes were eliminated by driving Cre expression under 
the control of the human skeletal actin (HSA) promoter causing recombination in myonuclei 
but not in myoblasts or satellite cells (Leu et al., 2003).  
 
There is evidence that mTORC1 also affects myogenesis, although the data 
obtained from several studies using rapamycin (or rapalogs) are rather controversial. 
Rapamycin-mediated inhibition of mTORC1 abrogates proliferation of cultured C2C12 
myoblasts prior to differentiation (Conejo and Lorenzo, 2001), although rapamycin does not 
affect satellite cell proliferation in adult mice after freeze-injury in vivo (Miyabara et al., 
2010). Myoblasts deficient for the mTORC1 targets, S6 kinase 1 and S6 kinase 2, do not 
show any deficit in myoblast proliferation and fusion (Ohanna et al., 2005). There is also 
evidence that rapamycin abolishes myotube formation of C2C12 myoblasts (Coolican et al., 
1997; Cuenda and Cohen, 1999; Pollard et al., 2014). The rapamycin-inhibited role of 
mTOR in early differentiation is independent of its kinase domain and has been postulated 
to be based on mTOR-dependent regulation of IGF-II expression (Erbay and Chen, 2001; 
Erbay et al., 2003). However, fusion and maturation of myotubes requires the kinase activity 
of mTOR during differentiation in vitro and during muscle regeneration in vivo (Ge et al., 
2009; Park and Chen, 2005). The rapamycin-dependent inhibition of myotube formation is 
likely mediated through mTORC1 as loss of rictor in the Myf5-lineage does not affect 
embryonic myogenesis in vivo (Hung et al., 2014). However, knockdown of raptor enhances 
and raptor overexpression inhibits differentiation of cultured C2C12 myoblasts (Ge et al., 
2011; Pollard et al., 2014), suggesting a role of a raptor-independent mTOR complex in 
myoblast fusion.  
 
To resolve these open questions and to firmly determine the role of raptor-
dependent mTORC1 in myogenesis, we depleted raptor from muscle progenitors and adult 
satellite cells using Myf5-Cre (Tallquist et al., 2000) and Pax7-CreERT2 (Murphy et al., 
2011) mice, respectively. In developing muscle, mTORC1 depletion impairs embryonic 
myogenesis and results in perinatal lethality due to respiratory failure. We find that mTORC1 
signaling largely affects proliferation and differentiation of muscle precursors, although 
raptor-depleted cells do contribute to muscle fibers. Removal of mTORC1 from adult 
satellite cells causes a severe deficit in muscle regeneration upon injury. This defect is 
largely due to a strong delay of the satellite cells to transit from quiescence to activation and 
a deficit in cell proliferation and differentiation. Our data thus show that mTORC1 signaling 
is crucial for embryonic and adult myogenesis. 
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Results 
Depletion of raptor impairs muscle development 
Mice in which the mTORC1-essential component raptor is eliminated in myofibers, die 
between the age of four to six months because of a severe myopathy (Bentzinger et al., 
2008). In addition, whole-body knockouts for raptor die in utero (Guertin et al., 2006). As we 
were interested in the role of mTORC1 in myogenesis, we examined the activation state of 
mTORC1 in myogenic precursor cells and myotubes. We used embryonic day 11.5 (E11.5) 
pups and stained them for the phosphorylated form of S6, which is indicative of active 
mTORC1 (Saxton and Sabatini, 2017). The different cell types were identified by co-staining 
the cross-sections with specific antibodies against Pax7 for muscle progenitors, MyoD for 
myoblasts, myogenin for myocytes and embryonic myosin heavy chain (embMHC) for 
myotubes. While phospho-S6 staining was strong in Pax7+ and MyoD+ cells (Figure 1A, B), 
only a minority of myogenin+ and embMHC+ cells were also phospho-S6 positive (Figure 
1C, D). These data indicate high mTORC1 activity in the proliferative phase of embryonic 
myogenesis and low activity during cell fusion and fiber maturation (Figure 1E).  
 
To understand the role of mTORC1 in myogenesis, we generated mice that 
expressed Cre under the control of Myf5 (Tallquist et al., 2000) and carried floxed alleles 
for Rptor (Bentzinger et al., 2008). The Myf5 gene is expressed in progenitor cells of the 
somites starting at embryonic day 8 (E8) (Ott et al., 1991). Such mice, termed RAmyfKO 
(for raptor-Myf5-knockout; Myf5+/Cre; Rptorfl/fl), were born at the expected Mendelian ratio, 
appeared cyanotic (Figure 2A) and died immediately. RAmyfKO mice did not breathe and 
their lungs were not inflated (Figure S1A). The diaphragm muscle was thin (Figure S1A, B) 
and neuromuscular junctions did not form properly with motor nerves overshooting the sites 
of high acetylcholine receptor (AChR) density in mutant mice (Figure S1C). Moreover, many 
non-synaptic AChR clusters were visible in RAmyfKO mice. In contrast, mice depleted for 
rictor (Bentzinger et al., 2008) in Myf5-expressing progenitors (Tallquist et al., 2000), termed 
RImyfKO mice (for rictor-Myf5-knockout; Myf5+/Cre; Rictorfl/fl), were viable and showed a 
normal overall muscle histology at young age (Figure 2B), indicating that mTORC2 is not 
required for embryonic muscle development. Examination of embryos at different ages 
revealed that the body weight of RAmyfKO mice was reduced compared to controls (Ctrl; 
Myf5+/+; Rptorfl/fl) as early as E13.5 (Figure 2C). In contrast, embryos heterozygous for the 
targeted Rptor allele (Myf5+/Cre; Rptor+/fl - termed Het-RAmyfKO) were indistinguishable from 
Ctrl embryos and did not show any change in body weight (Figure S2A). The weight 
reduction of E18.5 RAmyfKO embryos was not based on an overall reduction in body size 
compared to Ctrl (Figure S2B). In particular, the length of the long bones was not altered 
(Figure S2C). The smaller size of the rib cage in RAmyfKO embryos, in turn, could be based 
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on the changes in myotomal development (Vinagre et al., 2010). Examination of skeletal 
muscles at E18.5 by H & E and by immunofluorescence staining revealed that their size 
was much smaller in RAmyfKO embryos, but the different muscle groups were still present 
(Figure 2D, E). The observation that muscle still formed in RAmyfKO embryos was 
supported by real-time PCR when mRNA was specifically isolated from muscle tissue of 
E18.5 embryos. Transcript levels of all the myogenic regulatory factors, with the exception 
of Myf5, were the same in RAmyfKO and Ctrl embryos (Figure 2F). The approximately 50 % 
reduction in Myf5 expression is based on the inactivation of one copy of the Myf5 gene in 
Myf5+/Cre mice (Figure S2D). Similar to the myogenic regulatory factors, expression levels 
of skeletal muscle markers, such as Myh3 (coding for embMHC) and Des (coding for 
desmin), were not altered in mutant embryos (Figure 2F). These results indicate that the 
muscles of RAmyfKO embryos successfully passed the myogenic process. As Myf5 is also 
expressed in brown adipose tissue, we also examined this tissue and found a strong 
reduction in RAmyfKO embryos (Figure S2E), indicating that raptor depletion in brown 
adipocytes results in a similar loss as in skeletal muscle. Non-targeted tissue, such as liver, 
did not show any change in the amount of raptor and of S6 phosphorylation, indicating that 
mTORC1 signaling in RAmyfKO liver was not affected (Figure S2F, Table S1). Besides the 
loss of skeletal muscle, we also observed an increased accumulation of fat droplets in the 
muscle tissue of E18.5 RAmyfKO embryos compared to Ctrl (Figure 2G). Thus, in summary, 
depletion of raptor, but not of rictor, during myogenesis results in loss of muscle tissue. 
However, muscles are formed in RAmyfKO embryos, albeit at much lower efficacy than in 
Ctrl. 
 
The observation that muscles can still form in RAmyfKO embryos could be explained 
in two ways: either mTORC1-deficient myoblasts are not viable and their loss is 
compensated by the expansion of non-targeted myoblasts or raptor-depleted myoblasts still 
contribute to the muscle lineage but at a significantly lower efficacy. To distinguish between 
those possibilities, we first examined the phosphorylation status of the mTORC1 target S6 
by immunofluorescence to test for successful recombination in the different cell populations. 
At E11.5, Pax7-positive cells in RAmyfKO mice were negative for the phosphorylated form 
of S6 (Figure S3A, S3E), indicative of the lack of mTORC1 activity. A very similar loss of 
phospho-S6 was found in MyoD-, myogenin-, and embMHC-positive cells (Figure S3B-E). 
As shown in Figure 1, Pax7- and MyoD-positive cells express high levels of phospho-S6 in 
Ctrl embryos at the same age. Thus, these experiments are evidence for the successful 
depletion of raptor in RAmyfKO muscle at this particular developmental stage. Next, we 
analyzed the size of Pax7- and embMHC-positive structures in Ctrl and RAmyfKO embryos 
as hints for the function of raptor in primary myogenesis. Transverse cross-sections were 
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prepared from the hindlimb region of E11.5 embryos. In E11.5 embryos, the area covered 
by Pax7-positive progenitors was similar between Ctrl and mutant embryos (Figure 3A), 
while there was a tendency of fewer embMHC-positive myotubes in RAmyfKO embryos 
(Figure 3B). This trend towards smaller areas covered by myogenic cells was confirmed in 
E13.5 embryos and affected both Pax7- and embMHC-positive cells (Figure 3C, D). 
Quantification of the size of the myotome (embMHC-positive cells) revealed a significant 
size difference of this structure at E13.5 in RAmyfKO compared to Ctrl embryos (Figure 
3E). As additional evidence for the relative contribution of myogenic cells to the entire 
embryo, quantitative real-time PCR on whole-body RNA extracts (normalized to the levels 
of β-actin mRNA) was performed (Figure 3F). Interestingly, at E11.5, Pax7 expression was 
not altered in mutant compared to Ctrl embryos, while markers for myogenic precursor cells 
and mature muscle fibers were lower. At E13.5, Pax7 expression was also lower in 
RAmyfKO embryos than in Ctrl (Figure 3F). The effect of mTORC1 inactivation on myogenic 
cells seemed not to be due to apoptosis as we could not detect any increase in the number 
of TUNEL-positive cells in E12.5 mutant mice compared to Ctrl (Figure 3G). Overall, these 
results indicate that mTORC1 contributes to primary myogenesis by affecting early stages 
of cell commitment, proliferation and differentiation. In addition, these results provide 
evidence that this effect becomes more pronounced at later stages of development. 
Strikingly, however, RAmyfKO embryos still contained differentiated primary myotubes 
(indicated by the presence of embMHC-positive regions). The finding that those structures 
were smaller than in Ctrl embryos indicate a slowing down of myogenesis. 
 
RAmyfKO embryos contain myogenic cells that escape Cre-mediated raptor 
depletion 
To address the question whether myogenic cells, that escaped recombination of the Rptor 
alleles, also contributed to the development of primary myotubes, we used an EGFP-
expressing reporter mouse to follow Cre-mediated recombination. In this mouse line, called 
mR26CSEGFP, the chick actin promoter drives expression of EGFP in the ROSA26 locus. 
Expression of EGFP in the absence of Cre is prevented by an upstream stop codon that is 
flanked by loxP sites. Successful recombination by Cre results in high levels of EGFP in the 
targeted cells (Tchorz et al., 2012). While hindlimb muscles of Ctrl embryos (Myf5+/+; 
Rptorfl/fl; mR26CSEGFP/+) did not express EGFP, all muscle fibers in Het-RAmyfKO embryos, 
carrying one floxed Rptor allele (Myf5Cre/+; Rptorfl/+; mR26CSEGFP/+), were positive for EGFP 
(Figure 4A). The intensity of the EGFP staining varied between different muscle fibers of 
Het-RAmyfKO muscle (Figure 4A; middle). Importantly, hindlimb muscle of RAmyfKO 
embryos with the Rptor gene floxed at both alleles (Myf5Cre/+; Rptorfl/fl; mR26CSEGFP/+) 
showed a mosaic expression of EGFP (Figure 4A; right). In contrast to Het-RAmyfKO 
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embryos, muscle of RAmyfKO embryos also contained fibers that were negative for EGFP, 
indicating that those fibers did not express the Cre recombinase at any time and thus 
continue to express raptor. Consistent with this, EGFP-negative muscle fibers were often 
also positive for phospho-S6, whereas EGFP-positive fibers were largely negative (Figure 
S4A). This result therefore suggests that cells that continue to express raptor, have a 
competitive advantage over cells in which mTORC1 is inactive. To quantify this effect, we 
isolated myogenic cells from the entire hindleg and foreleg of E18.5 embryos by FACS and 
determined the relative proportion of EGFP-positive and EGFP-negative cells (Figure S4B). 
As expected, Ctrl cells, which do not express Cre, were EGFP-negative, demonstrating that 
the floxed stop cassette for EGFP is not leaky (Figure 4B). In Ctrl EGFP+ muscles, that 
express Cre from the Myf5 locus (Myf5Cre/+; Rptor+/+; mRS26EGFP/+), more than 80 % of the 
cells also expressed EGFP. This value was very similar to cells isolated from Het-RAmyfKO 
embryos, demonstrating that haplo-insufficiency of raptor did not have any effect on 
myoblast generation. In stark contrast, however, only approximately 23 % of the myogenic 
cells isolated from RAmyfKO embryos were EGFP-positive, showing that loss of raptor 
results in a substantial increase of non-recombined myoblasts (Figure 4B). The freshly 
sorted cells were also genotyped using primers that specifically detect the targeted locus in 
Rptor gene (see scheme in Figure 4C). As control, we included embryos that were 
heterozygous for the floxed Rptor allele but were negative for Cre (Myf5+/+; Rptorfl/+; 
mR26CSEGFP/+). Genomic DNA from myoblasts isolated from those mice contained both, 
the floxed and the wild-type allele of Rptor (Figure 4D; Ctrl EGFP-; upper panel) and were 
negative for the recombined Rptor allele (Figure 4D; lower panel). The same result was 
obtained from EGFP-negative myoblasts of Het-RAmyfKO embryos (Figure 4D, Het-
RAmyfKO EGFP-). Importantly, EGFP-positive myoblasts from either Het-RAmyfKO mice 
(Het-RAmyfKO EGFP+) or RAmyfKO mice (RAmyfKO EGFP+) did not contain any floxed 
allele for Rptor (Figure 4D; upper panel), but were positive for the PCR product of the Rptor 
allele after recombination (Figure 4D; lower panel). In contrast, EGFP-negative myoblasts 
from RAmyfKO embryos were positive for the floxed Rptor allele (Figure 4D; RAmyfKO 
EGFP-; upper panel). The presence of the recombined Rptor allele in the RAmyfKO EGFP- 
myoblasts (lower panel) is probably due to contamination by EGFP-positive cells. In 
summary, these data show that expression of EGFP in the RAmyfKO embryos coincides 
with successful recombination of the floxed Rptor allele. Thus, the presence of EGFP-
positive RAmyfKO myoblasts and of EGFP-positive muscle fibers argues that the myogenic 
process can progress in the absence of raptor.  
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Loss of mTORC1 affects proliferation and differentiation of myoblasts 
As a next step, we aimed to directly address the function of mTORC1 in FACS-isolated 
myoblasts from E18.5 embryos with the different genotypes. Cells were additionally 
separated into EGFP-positive and EGFP-negative populations, were plated at the same 
density and cultured under growth conditions for 2 days. As mTORC1 is a key regulator of 
translation initiation, we measured the overall rate of protein synthesis using the surface 
sensing of translation (SUnSET) method (Goodman and Hornberger, 2013). Newly 
synthesized proteins were labeled with puromycin for 30 min and then stained with 
antibodies to puromycin (Figure 5A). As negative control, Ctrl cells were treated for 10 min 
with the protein synthesis inhibitor cycloheximide prior to the addition of puromycin. Control 
cells and EGFP-positive myoblasts from Het-RAmyfKO embryos incorporated puromycin to 
a similar extent, whereas puromycin incorporation was significantly lower in EGFP-positive 
myoblasts derived from RAmyfKO embryos (Figure 5A, B). Measurement of proliferation by 
a one-hour pulse with 5-bromo-2’-deoxyuridine (BrdU) revealed a highly significant 
impairment in EGFP-positive RAmyfKO myoblasts (Figure 5C, D). The efficacy to transit 
from proliferation to differentiation and the overall fusion capacity of RAmyfKO myoblasts 
was tested by switching from proliferation to differentiation medium. Fourteen hours after 
the medium change, the percentage of cells that still proliferated was low and it did not 
change between the genotypes (Figure 5E). However, fusion of RAmyfKO EGFP+ 
myoblasts was lower than in Ctrl EGFP- or Het-RAmyfKO EGFP+ cells after 72 hours (Figure 
5F). This difference was significant for the fusion index, but only slightly altered for the 
relative number of myonuclei per myotube (Figure 5G). To confirm that the function of 
mTOR in proliferation and differentiation of myoblasts is specific for mTORC1, we analyzed 
the myogenic potential of mTORC2-deficient primary myoblasts isolated from 2 – 3 week-
old RImyfKO mice. As expected, RImyfKO primary myoblasts lacked rictor expression and 
phosphorylation of Akt (at the Serine 473), a mTORC2 downstream substrate (Figure S5A, 
Table S2). Similar to mTORC2 inactivation in adult skeletal muscle (Bentzinger et al., 2008), 
we observed that total PKCα protein levels and its phosphorylated form (at the Serine 657) 
are reduced in RImyfKO myoblasts. In contrast, we confirmed that RImyfKO myoblasts 
exhibit normal mTORC1 signaling, shown by the phosphorylation of the S6 protein (at the 
Serine 235/236) (Figure S5A, Table S2). The proliferation capacity, measured by BrdU 
incorporation, of RImyfKO myoblasts was unchanged compared to Ctrl (Figure S5B, C). 
Similarly, the efficacy to transit from proliferation to differentiation was normal in mutant 
myoblasts (Figure S5D). Furthermore, after 48 hours of differentiation no difference in the 
fusion index and relative number of nuclei per myotube were detected between both 
genotypes (Figure S5E-G). These results show that mTORC1, but not mTORC2, is 
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important for proliferation and differentiation of myoblasts, consistent with the view that both 
of those processes require active protein synthesis (Pallafacchina et al., 2013).  
 
mTORC1 signaling in adult muscle stem cells  
Recent evidence showed that activation of satellite cells is paralleled by increased mTORC1 
signaling (Rodgers et al., 2014). In particular, activation of mTORC1 is necessary and 
sufficient for the transition of satellite cells from a quiescent to an “alert” state. However, it 
is not known whether mTORC1 function is still necessary in the quiescence state and how 
mTORC1 signaling would affect muscle regeneration. To address these questions and to 
overcome any possible compensatory mechanisms, we generated a new mouse model 
(Pax7Cre-ERT2/+; Rptorfl/fl; mR26CSEGFP/EGFP) that allowed selective depletion of raptor in 
satellite cells upon administration of tamoxifen (tmx) and monitoring of the cells by their 
expression of EGFP. These mice, called RAscKO, were analyzed 10 or 90 days after tmx 
injection (Figure 6A). Mice that were not injected with tamoxifen, did not express EGFP 
(Figure S6A), demonstrating that the mouse model was not leaky. In agreement with others 
(Murphy et al., 2011), tmx injection for 5 consecutive days resulted in the expression of 
EGFP in the vast majority of Pax7-positive satellite cells after 10 days (Figure 6B). 
Quantification by FACS showed that more than 84% of the satellite cells expressed EGFP 
(Figure S6B). Like in RAmyfKO myoblasts, PCR on genomic DNA isolated from the EGFP-
positive satellite cells showed successful recombination of the floxed Rptor alleles in 
RAscKO cells (Figure S6C). Examination of the number of satellite cells in tibialis anterior 
(TA) muscle 10 or 90 days after tmx injection, did not reveal any significant change in their 
number compared Ctrl mice (Figure 6C). These data indicate that mTORC1 activity is not 
essential to maintain the satellite pool under homeostatic conditions. 
 
Our finding that embryonic myogenesis is strongly impaired in RAmyfKO mice 
suggested that muscle regeneration in the adult may also be affected by inactivation of 
mTORC1 in satellite cells. To test this hypothesis, recombination of Rptor was induced by 
tmx injection and after 7 days, cardiotoxin was injected into the TA and extensor digitorum 
longus (EDL) muscles followed by 15 days recovery (see scheme in Figure 6D). Whereas 
the weights of the contralateral EDL and TA muscles were indistinguishable between 
RAscKO and Ctrl mice, the injured RAscKO muscle failed to regain a similar weight as 
regenerating Ctrl muscle (Figure 6E). Examination of muscles by H & E staining showed no 
difference between Ctrl and RAscKO mice in the contralateral leg (Figure 6F, left). However, 
a very obvious and dramatic difference between genotypes was observed in the injured 
legs (Figure 6F, right). While Ctrl muscle had fully regenerated, indicated by the presence 
of centronucleated myofibers, only few, small myofibers, containing centralized myonuclei, 
  Results – Manuscript 1 
Page | 35 
 
were present in regenerating RAscKO mice (Figure 6F). Consistent with poor regeneration, 
RAscKO muscle were rich in collagen (Sirius Red positive, Figure 6G, left), indicative of 
fibrosis, and showed accumulation of Oil Red O-positive lipids (Figure 6G, right). Thus, 
mTORC1 signaling in satellite cells is important for proper regeneration of muscle fibers. 
Nevertheless, the presence of centrally nucleated myofibers suggested that raptor-depleted 
satellite cells can contribute to regenerating muscle fibers. Indeed, all the regenerating, 
embMHC+ myofibers in cardiotoxin-treated muscle from RAscKO mice were also EGFP-
positive, whereas fibers in the contralateral, non-injured muscle were EGFP-negative 
(Figure 6H). Notably, almost all myofibers in regenerating Ctrl muscle downregulated 
embMHC expression 15 days post-injury (Figure 6H). These data indicate that raptor-
depleted satellite cells can fuse although their efficacy is greatly diminished. 
 
As noted, mice heterozygous for the floxed alleles of Rptor (Het-RAmyfKO) do not 
show any overt muscle phenotype. To test whether challenging of muscle would reveal a 
haplo-insufficiency, we conducted the same cardiotoxin experiment as described above in 
such Het-RAmyfKO mice. As expected, skeletal muscles of Het-RAmyfKO mice express 
only about half of the amount of raptor (Figure S7A, Table S3). As a consequence, phospho-
S6 and phospho-4E-BP1 tended to be reduced, indicating that mTORC1 activity is also 
reduced. Fifteen days after cardiotoxin injury, we could not detect any difference in muscle 
fiber regeneration between Ctrl and Het-RAmyfKO mice, shown by body and muscle weight 
(Figure S7B), and the overall histology of the regenerated muscle (Figure S7C). Moreover, 
the number of satellite cells in the injured and non-injured muscles was the same in Het-
RAmyfKO and Ctrl mice (Figure S7D, E). Thus, dampening of mTORC1 activity by 
approximately half does not affect successful muscle regeneration. 
 
Activation is delayed in raptor-depleted satellite cells 
To examine the proliferation and differentiation capacity of raptor-depleted satellite cells, 
we isolated single muscle fibers from EDL muscle of Ctrl and RAscKO mice, 90 days after 
tmx treatment. At time zero (T0), the number of Pax7-positive cells per muscle fiber was not 
significantly different in RAscKO mice from Ctrl (Figure 7A). In RAscKO mice, the Pax7-
positive cells also expressed EGFP (98.07 ± 0.50%; n = 5, 20-30 myofibers per animal), 
confirming that all EGFP-positive satellite cells were also negative for raptor. At T0, none of 
the Pax7-positive satellite cells also expressed MyoD (Figure 7A, E). After 24 hours of 
culture (T24h), satellite cells become activated, indicated by the expression of MyoD 
(Dumont et al., 2015). Indeed, in Ctrl mice, the majority of Pax7-positve cells were also 
MyoD-positive, whereas a larger proportion of cells from RAscKO mice were Pax7 positive, 
but MyoD-negative (Figure 7B, E), indicating a delay in activation. After 48 hours (T48h), 
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some satellite cells became Pax7-negative and MyoD-positive, indicating their 
differentiation in the myogenic lineage (Figure 7E). At 72 hours (T72h), fibers from Ctrl mice 
contained three different populations of myogenic cells, i.e. cells (Pax7+; MyoD-) that 
became quiescent satellite cells to replenish the pool, still activated satellite cells (Pax7+; 
MyoD+) and differentiating myoblasts (Pax7-; MyoD+). In contrast, fibers isolated from 
RAscKO mice largely contained activated satellite cells (Pax7+; MyoD+) and only a very 
small percentage of quiescent cells (Pax7+; MyoD-) and differentiating myoblasts (Pax7-; 
MyoD+) (Figure 7C, E). Importantly, the number of myogenic cells increased exponentially 
in fibers isolated from Ctrl mice, whereas the number of myogenic cells remained low in 
cultured fibers isolated from RAscKO mice (Figure 7D). In summary, these results show 
that activation of raptor-depleted satellite cells is delayed and that they proliferate much 
slower than Ctrl cells. The finding that transcription factors driving muscle differentiation are 
still induced in RAscKO satellite cells, is in agreement with our results that muscle fibers do 
form in RAscKO mice upon cardiotoxin injury. 
 
Isolation of satellite cells by FACS and subsequent cultivation revealed a significant 
slowing of proliferation in RAscKO cells (Figure S8A). In addition, RAscKO satellite cells 
formed fewer myotubes with often lower number of myonuclei when grown in differentiation 
medium for 4 days (Figure S8B), indicating an impairment in their fusion capacity. In 
summary, mTORC1 is not essential for the maintenance of Pax7+ cells in the quiescent 
state, but the signaling is crucial for proliferation, differentiation and fusion. Nevertheless, in 
spite of mTORC1 being inactive, our results indicate that raptor-depleted myoblasts and 
satellite cells make use of an alternative pathway to partially overcome the mTORC1 deficit.  
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Discussion 
mTORC1 signaling has been positioned as a central regulator of skeletal muscle 
homeostasis and growth at adult age. In most studies, HSA-Cre mice were used to drive 
Cre expression in differentiating myotubes and mature muscle fibers (Leu et al., 2003). 
Hence, to study the function of mTORC1 in muscle development, we generated mice 
depleted for raptor, the essential component of mTORC1, in Myf5-expressing cells 
(RAmyfKO). Myf5 is first detected at E8 in muscle progenitors and precursors in the 
dermomyotome. RAmyfKO embryos were perinatal lethal due to respiratory failure and 
exhibited strongly reduced skeletal muscle mass. In contrast, RImyfKO mice, characterized 
by the loss of mTORC2 signaling in Myf5+ muscle progenitors and precursors, were viable 
and did not show any alteration in muscle histology at young age. Hence, we provide 
evidence that mTORC1, but not mTORC2, is essential for embryonic muscle development. 
 
mTORC1, but not mTORC2, signaling is crucial for proliferation of myoblasts during 
myogenesis 
Consistent to the current view, we found that inactivation of mTORC1 reduced protein 
synthesis in proliferating embryonic myoblasts. Initiation of the translational machinery is 
controlled by S6K1 and 4E-BP1, which are the main downstream substrates of mTORC1 
(Saxton and Sabatini, 2017). Since protein synthesis is highly induced during the G1/S 
phase of the cell cycle (Cuyas et al., 2014), we analyzed whether loss of mTORC1 signaling 
in myogenic cells had an impact on their proliferation. Indeed, we provide evidence that 
mTORC1, according to the phosphorylation of the downstream S6 protein, was active in 
Pax7+ progenitor and MyoD+ precursor cells and the signaling decreased in Myogenin+ 
myocytes and embMHC+ myotubes, indicating that mTORC1 has a predominant function in 
proliferating cells during embryonic myogenesis. Concomitantly, we observed that the 
capacity of raptor-depleted myoblasts to proliferate was strongly reduced. Simultaneously, 
no increase in programmed cell death was detected upon the loss of mTORC1 in muscle 
progenitors and precursors. Consequently, the limited proliferation capacity of mTORC1-
deficient myoblasts resulted in a reduced number of cells passing the myogenic process. 
Consistent with our findings, a regulatory function of mTORC1 in proliferation has also been 
demonstrated in other cell types, e.g. in β-cells of the pancreas or in mouse embryonic 
fibroblasts (MEF) (Blandino-Rosano et al., 2017; Dowling et al., 2010). Interestingly, even 
though protein synthesis is low during the G2/M transition mTORC1 signaling remains 
hyperactive at this stage of the cell cycle (Bonneau and Sonenberg, 1987; Fan and 
Penman, 1970; Heesom et al., 2001). The increase in mTORC1 function during mitosis was 
shown to be mediated through the phosphorylation of raptor by the cyclin-dependent kinase 
1 (CDK1), which promotes IRES-dependent mRNA translation (Ramirez-Valle et al., 2010). 
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Thus, this suggests that mTORC1 signaling mediates its effect on proliferation through 
various mechanisms. However, we confirmed that the regulatory function of mTORC1 on 
proliferation is independent of mTORC2 signaling, since rictor-deficiency in myoblasts did 
not affect their proliferation capacity and their potential to form myotubes in vitro and in vivo. 
 
Raptor-depleted myoblasts contribute to the formation of myofibers 
Remarkably, in hindlimbs of E18.5 RAmyfKO embryos all muscles were formed and 
normally expressed the myogenic regulatory factors, even though they were clearly smaller. 
In spite of alterations in myofiber formation in E11.5 and E13.5 RAmyfKO embryos, raptor-
depleted myoblasts contributed to the myogenic process as confirmed by the introduction 
of an EGFP reporter in Myf5-Cre expressing cells. We detected EGFP+ myofibers, lacking 
S6 phosphorylation and thereby mTORC1 activity, in E18.5 RAmyfKO and regenerating 
RAscKO muscles. Consistently, mTORC1-deficient myoblasts isolated from RAmyfKO 
embryos or RAscKO mice formed multi-nucleated myotubes in vitro, even though their 
fusion efficiency was decreased. Previously, it was shown that mTOR, independent of its 
kinase activity, controls the early stages of differentiation (Erbay and Chen, 2001; Ge et al., 
2009). Additionally, several studies demonstrated that inhibition of mTORC1 signaling 
through rapamycin reduces the differentiation capacity of rat and mouse myoblasts in vitro 
and in vivo (Ge and Chen, 2012). Surprisingly, we provide evidence that in E11.5 Ctrl 
embryos mTORC1 signaling is absent in newly formed myofibers, suggesting that mTORC1 
is not required after the fusion process during the embryonic wave of myogenesis. During 
embryonic and fetal myogenesis, myofibers mainly increase in size through myonuclear 
addition, but they undergo a general maturation and hypertrophic phase after birth (White 
et al., 2010). Therefore, it could be that mTORC1 signaling plays different roles in myofibers 
depending on the developmental stage. In summary, we provide evidence that mTORC1 
signaling is not absolutely required for differentiation and fusion of muscle progenitors. 
Hence, inactivation of mTORC1 in muscle progenitors and precursors does not cause a 
complete blockage of the myogenic process. 
 
Loss of mTORC1 in developing muscle causes partial compensation by non-
recombined, raptor-expressing myoblasts 
Despite the presence of EGFP+, raptor-depleted myofibers, RAmyfKO muscles were also 
composed of EGFP-negative fibers, suggesting that those derived from EGFP-, non-Cre-
expressing cells and exhibited wild-type characteristics. It has been shown that Cre 
expression in the Myf5 locus is not faithful with the endogenous Myf5 expression, therefore 
leading to the generation of Myf5+, but non-targeted myogenic cells (Comai et al., 2014). 
Furthermore, it was demonstrated that ablation of Myf5-expressing cells in Myf5-Cre//DTA 
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embryos stimulates non-targeted escaper cells to compensate and contribute to muscle 
formation during embryonic development (Comai et al., 2014; Gensch et al., 2008; Haldar 
et al., 2008). Similarly, we observed an expansion of non-recombined, EGFP- myoblasts 
upon the loss of mTORC1 in the Myf5-lineage, indicative of a partial compensation for the 
counter-selection of EGFP+, raptor-depleted myoblasts. Strikingly, the EGFP expression in 
RAmyfKO muscle followed a heterogeneous patterning, leading to the hypothesis that 
EGFP+, raptor-depleted myofibers mainly derived from the primary, embryonic wave of 
myogenesis. In line, we determined that almost all muscle progenitors and precursors of 
E11.5 RAmyfKO embryos were indeed deficient for mTORC1 signaling. Subsequently, the 
compensatory phenotype of non-targeted cells likely stems from the secondary, fetal wave 
of myogenesis, leading to the formation of EGFP-, wild-type fibers. Interestingly, fast 
muscles, e.g. the EDL muscle of RAmKO mice, in which recombination of Rptor is induced 
in differentiating myofibers from E9.5 (Schwander et al., 2003), display signs of slow, Myh7-
expressing fibers (Bentzinger et al., 2008). Those myofibers either acquire a slow 
phenotype upon a fiber type switch at adult age or originate from changes in the transition 
between the embryonic and fetal wave of myogenesis as primary myofibers express only 
the slow (Myh7) and embryonic (Myh3) isoforms of myosin heavy chain, while secondary 
myofibers acquire the fate of fast fibers by upregulating Myh8 (Biressi et al., 2007b). In 
summary, defects upon inactivation of mTORC1 in progenitor and precursor cells lead to a 
partial compensation by non-targeted cells contributing to muscle formation in RAmyfKO 
hindlimbs. 
 
Restoration of myofibers following muscle injury requires mTORC1 
To increase recombination efficiency and recapitulate the function of mTORC1 in the 
myogenic process occurring during muscle regeneration of the adult tissue, we induced 
raptor depletion in Pax7-expressing cells (RAscKO). Satellite cells, characterized by their 
specific Pax7 expression, share similar characteristics to their embryonic counterpart during 
development as they originate from Pax3/7+, MRF- cells generated during fetal myogenesis 
(Kassar-Duchossoy et al., 2005). Abrogation of raptor, leading to inactivation of mTORC1, 
in Pax7-expressing cells did not affect the quiescent stem cell pool of RAscKO mice under 
homeostatic conditions, indicating that loss of mTORC1 signaling does not provoke 
apoptosis of satellite cells. Consistently, it was demonstrated that quiescent satellite cells 
in adult muscle exhibit low mTORC1 activity, however the signaling is induced upon an 
alerted stage (GAlert), characterized by a faster cell cycle entry upon a systemic injury 
(Rodgers et al., 2014). Furthermore, the transition into an activated state depends on the 
induction of general mRNA translation, which is necessary for the expression of Myf5 and 
MyoD, both promoting the myogenic process (Crist et al., 2012; Zismanov et al., 2016). 
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During muscle regeneration, activated satellite cells are marked by high mTORC1 (Rodgers 
et al., 2014), indicating that the signaling plays a predominant role in activated rather than 
quiescent satellite cells. Indeed, we observed that mTORC1-deficient satellite cells show a 
delay in the transition from quiescence into activation, since an increased proportion of 
RAscKO satellite cells lacked MyoD expression after 24 h in culture. Nevertheless, RAscKO 
satellite cells entered the activated state at later time points, proposing that the delay in 
MyoD expression was due to reduced rates of protein synthesis in the absence of mTORC1 
signaling. Despite the ability of raptor-depleted satellite cells to enter an activated state, 
their regenerative capacity was severely impaired in the absence of mTORC1. The 
regenerative failure of raptor-depleted satellite cells was most likely caused by their 
deficiency to proliferate in conditions of reduced rates of protein synthesis. Additionally, a 
decrease in the fusion efficiency of raptor-depleted satellite cells affected the restoration of 
myofibers, resulting only in small, embMHC+ myofibers formed in regenerating RAscKO 
muscle. Interestingly, large areas were infiltrated with collagens and lipids in injured 
RAscKO muscle, suggesting that fibroblast and adipocyte differentiation further suppressed 
the regeneration process. Fibroblasts and adipocytes infiltrating muscle undergoing chronic 
degeneration and regeneration, originate from fibro-adipogenic progenitors (FAPs), whose 
differentiation is repressed in healthy muscle by the presence of restored myofibers 
(Mozzetta et al., 2013; Uezumi et al., 2010). In summary, we provide evidence that loss of 
mTORC1 signaling in satellite cells does not prevent their transition from quiescence into 
activation, however severely impairs their capacity to regenerate skeletal muscle due to 
defects in proliferation and differentiation. 
 
Disruption of mTORC1 signaling in muscle fibers affects NMJ formation and 
maintenance 
The strong muscle weakness in RAmyfKO embryos was likely the cause for the respiratory 
failure and subsequent lethality at birth. However, it remains unclear whether the deficits in 
the formation of neuromuscular junctions (NMJ) contributed to the respiratory failure of 
RAmyfKO embryos. Similar to the innervation defects in the diaphragm of RAmyfKO 
embryos, RAmKO mice also show extrasynaptic AChR clusters in the diaphragm muscle 
(Bentzinger et al., 2008). Interestingly, deteriorations in skeletal muscle fibers, such as 
inhibition of autophagy, were found to impact on neuromuscular synaptic function and 
stability (Carnio et al., 2014). In skeletal muscle of RAmKO mice, autophagy is constantly 
induced and the flux with the subsequent degradation steps is decreased (Castets et al., 
2013). Therefore, it may well be that impairments in the autophagy flux provoke alterations 
in mTORC1-deficient myofibers and thereby cause changes in their neuromuscular 
synapses. Nevertheless, loss of autophagy in Myf5+ cells does not affect the viability of 
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mice, as well as embryonic muscle development, even though adult mice display an 
atrophic phenotype in skeletal muscle (Martinez-Lopez et al., 2013). Hence, possible 
alterations in the autophagy pathway upon mTORC1 inactivation in muscle progenitors and 
precursors of RAmyfKO and RAscKO mice may not be the main cause for the defects 
observed in myogenesis. 
 
In summary, our data demonstrate that coordinated mTORC1 signaling is crucial for 
the formation of skeletal muscle during embryogenesis and regeneration of the adult tissue. 
We provide evidence that mTORC1 activity is tightly controlled during the myogenic process 
and that loss of the signaling strongly affects proliferation and differentiation of muscle 
precursors. Given our observations, it is important to understand the activity and the 
function of mTORC1 in every step of the myogenic process, as the signaling is often 
deregulated in muscle pathologies and skeletal muscle aging. 
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Material and Methods 
Key Resources Table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit monoclonal anti-phospho-S6 
ribosomal protein (Ser235/236) 
Cell Signaling 
Technology 
Cat#4858S; 
RRID: 
AB_916156 
Rabbit polyclonal anti-phospho-S6 
ribosomal protein (Ser235/236) 
Cell Signaling 
Technology 
Cat#2211S; 
RRID: 
AB_331679 
Mouse monoclonal anti-Pax7 DSHB Cat#PAX7; 
RRID: 
AB_528428 
Rabbit polyclonal anti-MyoD1 (clone c-20) Santa Cruz Cat#sc-304; 
RRID: 
AB_631992 
Mouse monoclonal anti-MyoD1 (clone 5.8A) BD Bioscience Cat#554130; 
RRID: 
AB_395255 
Mouse monoclonal anti-Myogenin DSHB Cat#f5d; 
RRID: 
AB_2146602 
Mouse monoclonal anti-myosin (embryonic) DSHB Cat#F1.652; 
RRID: 
AB_528358 
Rabbit polyclonal anti-desmin  Abcam Cat#ab15200; 
RRID: 
AB_301744 
Rabbit polyclonal anti-laminin Abcam Cat#ab11575; 
RRID: 
AB_298179 
Chicken polyclonal anti-GFP Tag Thermo Fisher 
Scientific 
Cat#A10262; 
RRID: 
AB_2534023 
Rat monoclonal anti-BrdU [BU1/75 (ICR1)] Abcam Cat#ab6326; 
RRID: 
AB_305426 
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Mouse monoclonal anti-Puromycin (clone 
12D10) 
Millipore Cat#MABE343
; RRID: 
AB_2566826 
Rabbit polyclonal anti-Synaptophysin Dako Cat#A0010; 
RRID: 
AB_2315411 
Rabbit polyclonal anti-Neurofilament 200 Sigma Cat#N4142; 
RRID: 
AB_477272 
Rabbit monoclonal anti-Raptor Cell Signaling 
Technology 
Cat#2280S; 
RRID: 
AB_10694695 
Rabbit monoclonal anti-S6 ribosomal 
protein (clone 5G10) 
Cell Signaling 
Technology 
Cat#2217S; 
RRID: 
AB_331355 
Rabbit polyclonal anti-phospho-4E-BP1 
(Ser65) 
Cell Signaling 
Technology 
Cat#9451S; 
RRID: 
AB_330947 
Rabbit polyclonal anti-4E-BP1 Cell Signaling 
Technology 
Cat#9452S; 
RRID: 
AB_10693791 
Mouse monoclonal anti-α-Actinin Sigma Cat#A7732; 
RRID: 
AB_2221571 
Rabbit polyclonal anti-Pan-Actin Cell Signaling 
Technology 
Cat#4968S; 
RRID: 
AB_10695740 
Rabbit monoclonal anti-Rictor Cell Signaling 
Technology 
Cat#9476S; 
RRID: 
AB_10612959 
Rabbit polyclonal anti-phospho-PKCα 
(Ser657) 
Santa Cruz Cat#sc-12356; 
RRID: 
AB_2168557 
Rabbit polyclonal anti-PKCα Cell Signaling 
Technology 
Cat#2056S; 
RRID: 
AB_2284227 
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Rabbit monoclonal anti-phospho-Akt 
(Ser473) 
Cell Signaling 
Technology 
Cat#4058S; 
RRID: 
AB_331168 
Rabbit polyclonal anti-Akt Cell Signaling 
Technology 
Cat#9272S; 
RRID: 
AB_329827 
Mouse monoclonal anti-Integrin α-7 (clone 
3C12) 
MBL International 
Corporation 
Cat#K0046-3; 
RRID: 
AB_592046 
Rat monoclonal PE anti-CD11b eBioscience Cat#12-0112-
81; RRID: 
AB_465546 
Rat monoclonal PE anti-CD45 eBioscience Cat#12-0451-
81; RRID: 
AB_465667 
Rat monoclonal biotin anti-CD34 eBioscience Cat#13-0341-
81; RRID: 
AB_466424 
Rat monoclonal PE anti-Ly-6A/E BD Biosciences Cat#553108; 
RRID: 
AB_394629 
Mouse monoclonal PE anti-CD31 BD Biosciences Cat#555027; 
RRID: 
AB_395657 
   
Biological Samples 
Freshly-sorted muscle progenitor cells or 
muscle satellite cells 
This paper N/A 
Chemicals, Peptides, and Recombinant Proteins 
Alcian Blue Sigma 005500 
Alizarin Red Sigma A5533 
Cardiotoxin Latoxan L8102 
Puromycin Sigma P8833 
Cycloheximide Sigma C7698 
BrdU Sigma B5002 
Dispase II Roche 04942078001 
Collagenase B Roche 11088831001 
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Trypsin 2.5 %, no phenol red Fisher Scientific 15090046 
Tamoxifen Sigma T5648 
Oil Red O Sigma O0625 
Direct Red 80 Sigma 365548 
Penicillin-Streptomycin Thermo Fisher 
Scientific 
15140122 
Matrigel BD Biosciences 354234 
Chicken embryo extract (CEE) MP Biomedicals /  
US Biological Life 
Sciences 
92850145 /  
C3999 
Collagenase A Roche 10103586001 
FGF-basic (AA 10-155) recombinant human 
protein 
Thermo Fisher 
Scientific 
PHG0023 
RNase-free DNase Qiagen 79254 
PhosSTOP Roche 04 906 837 
001 
cOmplete Mini, EDTA-free Roche 11836170001 
Proteinase K Qiagen 19131 
α-Bungarotoxin Alexa-488 Thermo Fisher 
Scientific 
B13422 
APC-Cy7 Streptavidin BD Biosciences 5554063 
Cy3 Streptavidin Jackson Immuno 
Research Laboratories 
016-160-084 
Biotin-AffiniPure Goat anti-Mouse IgG1, Fcγ 
subclass 1 specific  
Jackson Immuno 
Research Laboratories 
115-065-205 
IgG-free, protease-free BSA Jackson Immuno 
Research Laboratories 
001-000-162 
   
Critical Commercial Assays 
In Situ Cell Death Detection Kit, Fluorescein Roche 11684795910 
Pierce BCA Protein Assay Kit Thermo Fisher 
Scientific 
23227 
RNeasy Mini Kit Qiagen 74104 
iScript cDNA Synthesis Kit Bio-Rad 170-8891 
Power SYBR Green PCR Master Mix Applied Biosystems 4367659 
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Experimental Models: Organisms/Strains 
Mouse: Pax7tm1(cre/ERT2)GAKA/J Jackson Laboratory JAX: 017763 
Mouse: Gt(ROSA)26Sortm8(CAG-EGFP)Npa (Tchorz et al., 2012) N/A 
Mouse: Myf5tm3(cre)Sor/J Jackson Laboratory JAX: 007845 
Mouse: Rptortm1Rueg (Bentzinger et al., 
2008) 
N/A  
   
Software and Algorithms 
FlowJo V10 FlowJo https://www.flo
wjo.com/ 
ImageJ-win64 National Institutes of 
Health 
https://imagej.
nih.gov/ij/down
load.html 
GraphPad Prism 7 Graph Pad https://www.gr
aphpad.com/ 
StepOne Software v2.3 Thermo Fisher 
Scientific 
https://www.th
ermofisher.co
m/ 
   
Other 
Cryostat CM1950 Leica N/A 
Microscope IX81 with camera XM10 and 
SC30 
Olympus N/A 
Stereomicroscope M60 with camera IC80 
HD 
Leica N/A 
Fluorescence microscope DM5000 B Leica N/A 
Microscope DMi8 with camera C11440  Leica / Hamamatsu N/A 
Confocal Microscope TCS SPE Leica N/A 
FACSAria IIIu (cell sorter) BD Bioscience N/A 
Step One Plus  Applied Biosystems N/A 
Fusion Fx7 Vilber Lourmat N/A 
  
Contact for Reagent and Resource Sharing 
Further information and requests for resources and reagents should be directed to and will 
be fulfilled by the Lead Contact, Markus A. Rüegg (markus-a.ruegg@unibas.ch). 
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Experimental Model and Subject Details 
Mouse Models 
RAmyfKO and RAscKO mice were generated by crossing Rptor-floxed mice (Bentzinger et 
al., 2008) with transgenic mice expressing Cre recombinase under the control of the Myf5 
promoter that were obtained from Jackson Laboratories (Tallquist et al., 2000) or mice 
expressing Cre in the Pax7 locus (Murphy et al., 2011), respectively. Both mouse models 
were additionally crossed with mR26CS-EGFP mice (Tchorz et al., 2012). RImyfKO mice 
were generated by crossing Rictor-floxed mice (Bentzinger et al., 2008) with Myf5-Cre mice 
(Tallquist et al., 2000). Genotyping and recombination PCR for the conditional Rptor or 
Rictor allele, Cre recombinase knock-in in the Myf5 or Pax7 locus and mR26-CS-EGFP 
transgene expression was performed as described (Bentzinger et al., 2008; Murphy et al., 
2011; Tallquist et al., 2000; Tchorz et al., 2012). To induce raptor depletion in Pax7-
expressing cells, intraperitoneal tamoxifen (2.5 mg/day) injections were administered in 
corn oil to 2 – 3 month-old mice for five consecutive days. For the analysis of adult mice, 
only male mice were used. All mice were maintained in a licensed animal facility with a fixed 
12 h dark-light cycle and allowed food and water ad libitum. All animal studies were 
performed under the guidelines and the law of the Swiss authorities and regularly controlled 
and approved by the veterinary office.  
 
Primary Cultures 
RAmyfKO primary muscle progenitors or RAscKO satellite cells were isolated by FACS and 
RImyfKO primary myoblasts as described previously (Rosenblatt et al., 1995). Primary 
myoblasts were maintained in Glutamax Dulbecco’s modified Eagle’s medium (DMEM 
Glutamax) supplemented with 10 % horse serum (HS), 20 % fetal bovine serum (FBS), 1 % 
chicken embryo extract (CEE), 1 % penicillin-streptomycin (pen/strep) and 0.5 ng/ml β-
fibroblast growth factor on Matrigel-coated cell culture dishes in 37 °C incubator with 5 % 
CO2. For induction of myogenic differentiation, an equal number of cells were plated at 
higher density and incubated with DMEM Glutamax with 4 % HS, 1 % CEE and 1 % 
penicillin / streptomycin one day after FACS isolation. To test the proliferation capacity of 
myoblasts, the same number of cells were incubated in proliferation medium for 48 h or in 
differentiation medium for 14 h and 7.67 ug/ml Bromodeoxyuridine (BrdU, Sigma) was 
added for 1 h. To analyze the rates of protein synthesis the cells were incubated with 1 µM 
puromycin (Sigma) with or without 100 ug/ul cycloheximide (Sigma) for 30 min. Cells were 
fixed with 4 % paraformaldehyde (PFA, Fluka Chemika), washed with PBS pH7.4, 0.1 M 
glycine and kept frozen for subsequent immunostaining. 
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Method Details 
Skeleton staining 
E18.5 embryos were skinned, macerated and stained with Alcian Blue (cartilage, Sigma) 
and Alizarin Red (ossified bones, Sigma). The detailed protocol was previously described 
(Schneider, 2013). The stained skeleton was imaged using the stereomicroscope M60 
(Leica) and the camera IC80 HD (Leica). 
 
Cardiotoxin injury 
2 – 3 month-old mice were anesthetized by intraperitoneal injection of Ketamine 
(111 mg/kg, Ketalar) and Xylzine (22 mg/kg, Rompun). The tibialis anterior (TA) and 
extensor digitorum longus (EDL) muscles of one left leg were injected with 150 µl of 6.7 µg 
Cardiotoxin (Latoxan) to induce complete muscle necrosis. The other leg was untreated 
and served as the contralateral control. The mice were treated with the analgesic 0.1 mg/kg 
Buprenorphine, twice a day for at least three days. The TA and EDL muscles were dissected 
15 days after injury for subsequent histology or immunofluorescent staining. 
 
Isolation of embryonic and adult muscle progenitors by FACS 
To obtain embryonic myogenic cells by FACS isolation the protocol was adapted from 
(Pasut et al., 2013). In brief, hindlimb and foreleg muscles of E18.5 embryos were dissected 
and minced. Digestion of the tissue was started by transferring the muscle pieces into PBS 
with Collagenase B (2.5 U/ml, Roche) and Dispase II (2.5 U/ml, Roche) at 37 °C for 40 min 
with repeated trituration using a FBS-coated pipette. Digestion was stopped by the addition 
of 2 volumes of 10 % FBS. The cell suspension was filtered with a 70 µm cell strainer 
(Corning) and centrifuged two times at 239 g for 5 min. Adult muscle stem cells were 
isolated from hindlimb and foreleg muscles of 3 month-old mice 10 days after tamoxifen 
treatment according to a protocol modified from (Garcia-Prat et al., 2016). The muscles 
were minced and digested in PBS with 0.16 % Collagenase B (Roche) and 0.125% Trypsin 
(Gibco) at 37 °C under rotating conditions. After 25 min, the supernatant was collected, 
enzyme-inactivated with 0.25 volume of FBS and filtered with a 70 µm cell strainer 
(Corning). The remaining muscle pieces were again digested at 37 °C under rotating 
conditions. This procedure was repeated 4 times until the entire muscle was digested. The 
collected cell suspension was centrifuged at 60 g for 10 min to remove big pieces, the pellet 
washed and re-centrifuged. All the supernatant was centrifuged at 500 g for 15 min to 
collect all the isolated cells. Single cells were incubated with the following antibodies: anti-
Integrin α-7 (MBL International Corporation), biotin anti-CD34 (eBioscience), PE anti-
CD11b (eBioscience), PE anti-CD45 (eBioscience), PE anti-Ly-6A/E (BD Biosciences), PE 
anti-CD31 (BD Biosciences), APC-Cy7 Streptavidin (BD Biosciences) and Alexa647 anti-
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mouse IgG1 (Molecular Probes). Additionally, DAPI was used as viability marker. 
Embryonic (Integrin α-7+/CD11b-/CD45-/Sca1-/CD31-) and adult (Integrin α-
7+/CD34+/CD11b-/CD45-/Sca1-/CD31-) myogenic cells were sorted by FACSAria IIIu cell 
sorter (BD Biosciences). Cells expressing EGFP were sorted based on their endogenous 
fluorescence.  
 
Single fiber isolation 
Single myofibers were isolated from the EDL muscle of 3 month-old mice 90 days after 
tamoxifen treatment by enzymatic digestion and trituration as previously described 
(Rosenblatt et al., 1995). In brief, the EDL was carefully dissected and digested in DMEM 
Glutamax (Gibco) supplemented with 1 mg/ml Collagenase A (Roche) and 1 % penicillin-
streptomycin (Thermo Fisher Scientific) for 1.5 h at 37 °C and 5 % CO2. Loose muscle 
bundles were transferred into DMEM Glutamax, 1 % pen/strep and triturated and cleaned 
into single myofibers. Fibers analyzed at T0 were immediately fixed with 4 % PFA. Fibers 
kept in culture for up to 72 h were transferred into DMEM Glutamax, 1 % pen/strep, 10 % 
HS, 1 % CEE and fixed with 4 % PFA at the time points indicated. Fibers were washed with 
PBS, permeabilized for 6 min with PBS, 0.5 % Triton-X100 and washed again. The fibers 
were then incubated in blocking solution (10 % HS, 10 % goat serum, 0.35 % Carrageenan 
– Sigma, PBS) for 30 min and primary antibodies were added overnight at 4 °C. Fibers were 
washed in PBS, 0.025 % Tween-20 (Sigma) and incubated with the secondary antibodies 
for 1.5 h. Following washing steps, the fibers were collected with a smoothened glass, horse 
serum-coated glass pipette and transferred on Non-Superfrost glass slides coated with 
84 % acetone, 16 % (3-aminopropyl)triethoxysilane (Sigma). The fibers were mounted with 
Vectashield Dapi mounting medium. Primary antibodies and the dilution factors used were 
listed below: anti-Pax7 (Pax7, supernatant, DSHB, 1:100), anti-MyoD1 clone c-20 (sc-304, 
Santa Cruz, 1:100). 
 
Histology  
Mouse embryos were isolated at the embryonic stage of interest and equilibrated in 30 % 
Sucrose/PBS overnight at 4 °C. Embryos were embedded and frozen in Tissue-Tek (Sakure 
Finetek) and serially sectioned into 12 µm sections on a cryostat (CM1950, Leica). Only 
sections from embryos that were frozen and cut in the same orientation, were compared. 
Muscles from adult mice were dissected and frozen in liquid nitrogen-cooled isopentane. 
Consecutive cryosections of 8 µm were prepared. Embryos or adult muscles expressing 
EGFP were fixed in 4 % paraformaldehyde (PFA) overnight or in 2 % PFA for 2 h, 
respectively, and were incubated in 20 % sucrose overnight prior to freezing. General 
histology on sections was performed using hematoxylin and eosin staining (Merck) followed 
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by sequential dehydration with 70 %, 90 %, 100 % ethanol and 100 % xylene. For oil red O 
staining, sections were fixed with 4 % PFA for 1 h and stained with Oil Red O (Sigma; 
5 mg/ml in 60 % triethyl-phosphate, Sigma) for 30 min. Then the sections were washed with 
running tap water and mounted in 10 % glycerol. Collagens were stained with a Picro-Sirius 
Red solution (Direct Red 80, Sigma; 1 mg/ml in 1.3 % aqueous solution of picric acid, 
Sigma) for 1 h followed by washing in 0.5 % acidic water for 30 min. The slides were 
mounted after dehydration in 100 % ethanol and after clearing in xylene.   
 
Immunostaining 
Cross-sections or cells were fixed with 4 % PFA for 6 min, washed in PBS pH7.4, 0.1 M 
glycine for neutralization and permeabilized with pre-cooled methanol for 6 min. Antigen 
retrieval was achieved by warming the sections in 0.01 M citric acid (Sigma) just below the 
boiling point. The samples were blocked in 3 % IgG-free BSA (Jackson Immuno Research 
Laboratories) supplemented with 0.05 mg/ml AffiniPure Mouse IgG, Fab Fragment 
(Jackson Immuno Research Laboratories). The primary antibodies with the according 
dilution listed below, were incubated overnight at 4 °C. The samples were washed with PBS 
and incubated with the corresponding secondary antibodies for 1.5 h at room temperature. 
After 3 times washing, the samples were mounted with Vectashield Dapi (Vector 
Laboratories). Immunostaining for EGFP and phospho-S6 ribosomal protein (Ser235/236) 
were performed without methanol treatment and antigen retrieval, instead 0.5 % Triton X-
100 (Sigma) was added to the blocking solution for permeabilization. Apoptotic nuclei were 
immunolabeled using the “In Situ Cell Death Detection Kit, Fluorescein” (Roche) according 
to manufacturer’s protocol. Whole-mount immunostaining of diaphragms from E17.5 
embryos was performed by fixing the tissue with 1 % PFA, 0.1 M sodium phosphate pH7.3 
at 4 °C. The diaphragms were rinsed in PBS and incubated in 0.1 M glycine pH7.3 for 
15 min. After washing, the tissue was permeabilized and blocked in 2 % BSA (Sigma), 4 % 
goat serum, 0.5 % Triton X-100 (Sigma), PBS. The primary antibody was incubated 
overnight in 2 % BSA, 4 % NGS, PBS. After washing 3 times for 1 h, the secondary antibody 
was incubated overnight. The washing was repeated and the samples sequentially post-
fixed in 1 % PFA, 100 % methanol and mounted in citifluor (Electron Microscopy Sciences). 
Primary antibodies and the dilution factors used were listed below: anti-phospho-S6 
ribosomal protein (Ser235/236) (4858S, CST, 1:100), anti-Pax7 (Pax7, supernatant, DSHB, 
1:50), anti-MyoD1 (554130, BD Bioscience, 1:500), anti-Myogenin (f5d, supernatant, 
DSHB, 1:50), anti-Myosin embryonic (F1.652, biosupe, DSHB, 1:1’200), anti-Desmin 
(ab15200, Abcam, 1:300), anti-Laminin (ab11575, Abcam, 1:300), anti-GFP (A10262, 
Thermo Fisher Scientific, 1:400), anti-BrdU (ab6326, Abcam, 1:300), anti-Puromycin 
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(MABE343, Millipore, 1:1’000), anti-Synaptophysin (A0010, Dako, 1:200), anti-
Neurofilament (N4142, Sigma, 1:8’000).   
 
Immunoblotting 
Quadriceps muscles from 3 month-old mice were frozen in liquid nitrogen and powdered on 
dry ice. Hindlimb and foreleg muscles from E18.5 embryos were minced and snap-frozen 
in liquid nitrogen. Proliferating primary myoblasts were collected after trypsination, washed 
in cold PBS and snap-frozen as pellet in liquid nitrogen. Samples were lysed in cold RIPA 
buffer (50 mM Tris-HCl pH8, 150 mM NaCl, 1 % NP-40, 0.5 % sodium deoxycholate, 0.1 % 
SDS, 1 % Triton X-100, 10 % glycerol, ddH2O) supplemented with phosphatase and 
protease inhibitor cocktail tablets (Roche), incubated on ice for 2 h and sonicated two times 
for 15 sec. Afterwards, the lysate was centrifuged at 16’000 g for 30 min at 4 °C. The cleared 
lysates were used to determine total protein amount using the Pierce BCA Protein Assay 
Kit (Thermo Fisher Scientific) according to manufacturer’s protocol. Proteins were 
separated on 4 – 12 % Bis-Tris Protein Gels (NuPage Novex, Thermo Fisher Scientific) and 
transferred to nitrocellulose membrane (Whatman). The membrane was blocked with 5 % 
BSA, 0.1 % Tween-20, TBS for 1 h at room temperature. The primary antibody diluted in 
the blocking solution was incubated overnight at 4 °C with continuous shaking. The 
membranes were washed three times for 15 min with TBST (0.05 % Tween-20, TBS) and 
incubated with the secondary horseradish peroxidase-conjugated antibody for 1.5 h at room 
temperature. After washing with TBST, proteins were visualized by chemiluminescence 
(KPL). Primary antibodies and dilution factors used were listed below: anti-Raptor (2280S, 
CST, 1:1’000), anti-phospho-S6 ribosomal protein (Ser235/236) (2211S, CST, 1:1’000), 
anti-S6 ribosomal protein (2217S, CST, 1:1’000), anti-phospho-4E-BP1 (Ser65) (9451S, 
CST, 1:1’000), anti-phospho-4E-BP1 (9452S, CST, 1:1’000), anti-Pan-Actin (4968S, CST, 
1:1’000), anti-α-Actinin (A7732, Sigma, 1:5’000), anti-Rictor (9476S, CST, 1:1’000), anti-
PKCα (2056S, CST, 1:1’000), anti-phospho-PKCα (Ser657) (sc-12356, Santa Cruz, 1:500), 
anti-Akt (9272S, CST, 1:1’000), anti-phospho-Akt (Ser473) (4058S, CST, 1:1’000). 
 
RNA extraction and qRT-PCR 
Total RNA were extracted from whole E11.5 and E13.5 embryos or from hindlimb and 
foreleg muscles of E18.5 embryos using the RNeasy Mini Kit (Qiagen) according to 
manufacturer’s protocol. RNA was transcribed into cDNA using the iScript cDNA Synthesis 
Kit (Bio-Rad). Selected genes were amplified and detected using the Power SYBR Green 
PCR Master Mix (Applied Biosystems) and the relative gene expression was determined 
with the Step One software and normalized to β-actin expression. All qPCR primers were 
listed in Table S3.  
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Quantification and Statistical Analysis 
All experiments were performed on a minimum of 3 independent biological samples 
indicated by the n-number (n). In all graphs, data are represented as the mean value and 
the respective standard error of the mean (SEM, error bars). Student’s t test was employed 
when two groups were compared to evaluate statistical significance. One or two-way 
ANOVA with Tukey’s multiple comparisons test was used in comparisons of more than two 
groups. P-values lower than 0.05 are considered statistically significant.  
 
Data and Software availability 
A list of software used in this study can be found in the Key Resources Table. 
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Figure 1. During embryonic myogenesis mTORC1 is active in proliferation, but the 
signaling is decreased during differentiation and fusion 
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(A - D) Immunostaining against phospho-S6 Ser235/236, indicative of mTORC1 activity, 
and Pax7 (A), MyoD (B), Myogenin (C), embMHC (D) on transverse cross-sections of Ctrl 
embryos at embryonic day (E) 11.5. Scale bar, 50 µm.   
(E) Quantification of the percentage of phospho-S6+ progenitor cells (Pax7+), precursor cells 
(MyoD+), myocytes (Myogenin+) and myotubes (embMHC+) (n = 3).  
Data represented as mean ± SEM. 
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Figure 2. Ablation of raptor severely impairs embryonic muscle development 
(A) Photograph of Ctrl (Myf5+/+; Rptorfl/fl) and RAmyfKO (Myf5+/Cre; Rptorfl/fl) pups at post-
natal day 0 (P0). 
(B) Hematoxylin and eosin (H&E) staining on TA muscle cross-sections of 2 month-old Ctrl 
(Myf5+/+; Rictorfl/fl) and RImyfKO (Myf5+/Cre; Rictorfl/fl) mice. Scale bar, 50 µm. 
(C) The body weight of Ctrl and RAmyfKO embryos was measured at embryonic day (E) 
13.5, 15.5 and E18.5 (n ≥ 7). 
(D) H&E coloration of transverse cross-sections through the whole embryo at E18.5. F, 
femur; Q, quadriceps muscle. Scale bar, 200 µm. 
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(E) Immunostaining for embryonic myosin heavy chain (embMHC; red) and desmin (green) 
on transverse cross-sections of E18.5 Ctrl and RAmyfKO quadriceps muscle. F, femur; Q, 
quadriceps muscle (delineated with a dotted line). Scale bar, 100 µm. 
(F) Relative mRNA levels of Pax7, Myf5, MyoD, MyoG, Myh3 and Des was measured by 
RT-qPCR in hindlimb RNA extracts of E18.5 embryos. Normalization to β-actin (n = 5). 
(G) Lipids were visualized by Oil Red O staining on hindlimb cross-sections of E18.5 Ctrl 
and RAmyfKO embryos. Fat droplets (red) accumulated between myofibers of RAmyfKO 
embryos. F, femur; T, tibia. Scale bar, 50 µm.  
Data represented as mean ± SEM. * p < 0.05, ** p < 0.01, Student’s t test.  
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Figure 3. Less myotubes are formed in the absence of raptor expression 
(A - D) Immunostaining against Pax7 (progenitor cells, red, A and C) or embMHC 
(myotubes, red, B and D) and laminin (green) on transverse cross-sections of E11.5 (A, B) 
or E13.5 (C, D) Ctrl and RAmyfKO embryos. Arrows point to Pax7+ progenitors in the 
dermomyotome and the hindlimbs and the dotted line labels the myotome containing 
embMHC+ myotubes. Scale bar, 100 µm. 
(E) The area of the myotome was measured by the embMHC staining on cross-sections of 
E11.5 and E13.5 embryos (n = 3-4). 
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(F) Relative mRNA levels of Pax7, MyoD, MyoG and Myh3 was measured by RT-qPCR of 
whole-embryo RNA extracts at E11.5 and E13.5. Normalization to β-actin (n = 5). 
(G) Immunostaining against Pax7 (red) and TUNEL (green) on transverse cross-sections 
of E12.5 Ctrl and RAmyfKO embryos. TUNEL+ nuclei (arrowhead) were detected in Ctrl and 
RAmyfKO embryos, but they did not co-localize with Pax7-expressing progenitors. Scale 
bar, 100 µm. 
Data represented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, Student’s t test. 
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Figure 4. Loss of mTORC1 in the Myf5-lineage causes partial compensation by non-
recombined, raptor-expressing myoblasts 
(A) Immunolabeling against laminin (red) and green fluorescent protein (EGFP, green) on 
hindlimb cross-sections of E18.5 embryos. The arrow point to EGFP- myofibers detected in 
RAmyfKO muscles. Scale bar, 50 µm. 
(B) Myogenic cells (Integrin α-7+ / CD45- / CD11b- / Sca1- / CD31-) were isolated from foreleg 
and hindlimb muscles of E18.5 embryos by FACS sorting and analyzed for their intrinsic 
EGFP expression. A representative FACS blot of myogenic cells isolated from Het-
RAmyfKO and RAmyfKO embryos, are displayed. The percentage of EGFP+ or EGFP- 
normalized to the total number of Integrin α-7+ myoblasts was quantified and compared 
between Ctrl (Myf5+/+; Rptorfl/fl; mR26CS+/EGFP), Ctrl EGFP+ (Myf5+/Cre; Rptor+/+; 
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mR26CS+/EGFP), Het-RAmyfKO (Myf5+/Cre; Rptor+/fl; mR26CS+/EGFP) and RAmyfKO (Myf5+/Cre; 
Rptorfl/fl; mR26CS+/EGFP) embryos (n = 4-8). 
(C) Schematic presentation of wild-type, floxed and recombined alleles of Rptor. Primers 
used for PCR are indicated as P1, P2 and P3. wt: wild-type allele of Rptor, flox: floxed allele 
containing loxP sites, rec: Rptor alleles after recombination by Cre. 
(D) PCR analysis was performed on FACS-isolated myogenic cells using primers to amplify 
a sequence from the wild-type (wt) or floxed (flox) Rptor allele (P1 – P2) or to detect a 
sequence from the recombined (rec) Rptor allele (P1 – P3). In Het-RAmyfKO EGFP+ and 
RAmyfKO EGFP+ cells the recombination product (204 bp) was detected and the band for 
the floxed sequence (228 bp) in Rptor was lost using primers P1 – P2 due to successful 
recombination (n = 3). 
Data represented as mean ± SEM. *** p < 0.001, two-way ANOVA with Sidak’s multiple 
comparisons test. 
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Figure 5. mTORC1 signaling is critical for proliferation, differentiation and fusion of 
embryonic myoblasts in vitro 
FACS-isolated Integrin α-7+ / Lin- myogenic cells from E18.5 embryos were plated at the 
same density for all genotypes and cultured in growth or differentiation media. 
(A) Directly after FACS-isolation the myogenic cells were cultured in growth media for 48 
hours (h) and incubated with puromycin only or in combination with cycloheximide (CHX) 
for 30 min. Puromycin incorporation, indicative of the rate of protein synthesis, was 
visualized by immunostaining against puromycin. Scale bar, 100 µm. 
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(B) Rates of protein synthesis was reported as the mean puromycin fluorescence intensity 
relative to Ctrl (n = 4). 
(C) Immunostaining against BrdU (red) and desmin (green) visualizes the myoblasts in the 
S-phase of the cell cycle during the 1 h pulse. Scale bar, 100 µm. 
(D and E) The percentage of BrdU+ / Desmin+ myoblasts after 48 h of proliferation (D, n = 3-
4) or after 14 h of differentiation (E, n = 4-5) was quantified. 
(F) Immunostaining against embMHC (red) and desmin (green) on myotubes after 3 days 
of differentiation. Scale bar, 100 µm. 
(G) The fusion index and size distribution were assessed after 3 days of differentiation 
(n = 3). 
Data represented as mean ± SEM. * p < 0.05, *** p < 0.001, one-way ANOVA with Tukey’s 
multiple comparisons test. 
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Figure 6. Raptor expression is essential for the restoration of muscle fibers following 
muscle injury 
(A) Experimental scheme for (B and C). Tamoxifen was administered for 5 consecutive days 
to 3 month-old mice and the muscles harvested 10 or 90 days after the treatment. For long-
term studies, tamoxifen injection was repeated every month. 
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(B) Immunostaining against Pax7 (red) and EGFP (green) on TA muscle cross-sections 
from 3 month-old Ctrl and RAscKO mice 10 days after tamoxifen treatment. Scale bar, 
10 µm. 
(C) Immunostaining against Pax7 (red) and laminin (green) on TA muscle cross-sections 
from 3 month-old mice 10 days after tamoxifen treatment. Arrowheads point to quiescent 
Pax7+ satellite cells lying underneath the basal lamina. The number of Pax7+ satellite cells 
in the TA muscle were counted and normalized to 100 myofibers 10 or 90 days after the 
tamoxifen treatment (n = 3-5). Scale bar, 100 µm and 10 µm at higher magnification. 
(D) Experimental scheme for (E - H). Cardiotoxin (Ctx) injury was applied to the TA and 
EDL muscle of 3 month-old mice 3 days after the tamoxifen treatment. Analysis of muscles 
was performed 15 days post-injury (Ctx, 15d). The contralateral muscle (CLM) was not 
injured.  
(E) The muscle weight of the uninjured and injured TA and EDL was measured 15 days 
after Ctx-injury (n = 3). 
(F) H&E coloration on CLM and Ctx, 15d TA cross-sections of Ctrl and RAscKO mice. 
Centralized nuclei are characteristics of regenerating fibers.  
(G) Sirius Red coloration (red, left panel) on regenerating TA muscles visualizes the 
collagens in the extracellular matrix between myofibers of Ctrl mice and additional 
accumulation in the fibrotic tissue of RAscKO mice. Oil red O staining (red, right panel) 
stains lipid droplets in the regenerating muscle of RAscKO mice. Scale bar, 50 µm. 
(H) Immunostaining against EGFP (green, left panel) or embryonic myosin heavy chain 
(embMHC, red, right panel) and laminin (white) on regenerating TA muscle of Ctrl and 
RAscKO mice 15 days post-injury. In regenerating Ctrl muscle only very few embMHC+ 
myofibers were detected. Almost all EGFP+ myofibers in regenerating RAscKO muscle 
were positive for embMHC. Scale bar, 50 µm and 10 µm at higher magnification. 
Data represented as mean ± SEM. ** p < 0.01, *** p < 0.001, Student’s t test. 
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Figure 7. Loss of mTORC1 delays activation of quiescent satellite cells 
Single myofibers were isolated from Ctrl and RAscKO EDL muscle 90 days after tamoxifen 
treatment and their associated satellite cells analyzed directly after isolation (T0) or after 
24, 48 or 72 h of culture (T24, T48, T72h). 
(A) Immunostaining against Pax7 (red), EGFP (green) and MyoD (grey) on quiescent 
satellite cells associated to isolated Ctrl and RAscKO myofibers at T0. The number of Pax7+ 
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cells normalized per fiber was counted (n = 4-5, 20-30 myofibers per animal). Scale bar, 
50 µm. 
(B and C) Immunostaining against Pax7 (red), EGFP (green), MyoD (grey) on satellite cells 
associated to myofibers after 24 h (B) or 72 h (C) of culture. At T24h, Ctrl satellite cells 
express MyoD in their activated state (B). At T72h, Ctrl satellite cells (C) have formed clones 
containing cells expressing Pax7 only (returning into quiescence, arrow) or cells expressing 
MyoD only (differentiating, asterix). Cells expressing both Pax7 and MyoD remain in an 
activated state (arrowhead). Scale bar, 50 µm. 
(D) The number of myogenic cells normalized per fiber was quantified at T0, T24h, T48h 
and T72h (n = 4-5, 20-30 myofibers per animal). 
(E) The number of Pax7- and / or MyoD-positive cells were quantified and normalized to the 
total number of myogenic cells on single isolated myofibers at T0, T24h, T48h and T72h 
(n = 4-5, 20-30 myofibers per animal). 
Data represented as mean ± SEM. ** p < 0.01, ** p < 0.01, *** p < 0.001, Student’s t test. 
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Supplemental data 
 
 
 
Supplementary Figure 1. RAmyfKO embryos die perinatally due to respiratory failure 
(A) H&E coloration on longitudinal cross-sections of newborn pups (P0) in the region of the 
lung, diaphragm (Dia) and liver. The alveolar spaces (Al) are smaller and the interstitial 
mesenchyme thicker in RAmyfKO lungs, indicating that their lungs were not inflated. Scale 
bar, 500 µm. 
(B and C) Whole-mount staining for synaptophysin / neurofilament (red) visualizes the 
phrenic nerve and fluorescently labeled α-bungarotoxin stains acetylcholine receptor 
clusters (AChR, green) on diaphragms of E17.5 embryos. In RAmyfKO diaphragms the 
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innervation zone is enlarged and disorganized (B, arrow), since motor neurons overshoot 
the innervation zone and many AChR clusters are not innervated (C, arrowhead). 
Fragmented postsynaptic AChR clusters in RAmyfKO diaphragms are indicated with a star. 
Scale bar, 500 µm (B) and 50 µm (C). 
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Supplementary Figure 2. 50 % reduction of raptor protein levels does not affect 
embryonic muscle development 
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(A) The body weight of Ctrl (Myf5+/+; Rptorfl/fl) and Het-RAmyfKO (Myf5+/Cre; Rptor+/fl) 
embryos was measured at E13.5, E15.5 and E18.5 (n = 4-12). 
(B and C) Alcian blue (cartilage) and alizarin red (ossified bones) staining of E18.5 embryos 
(B). T, tibia; F, femur; H, humerus; R, radius; U, ulna. Scale bar, 5 mm. The length of the 
respective bones was measured (n = 3-4) (C). 
(D) RT-qPCR analysis on E18.5 hindlimb muscle RNA extracts for the indicated genes. 
Normalization to β-actin (n = 5).  
(E) H&E coloration of transverse cross-sections through the upper part of E18.5 embryos. 
1, lung; 2, spinal cord; 3, trapezius muscle; 4, brown fat; 5, semispinalis muscles; 6, thymus. 
Scale bar, 1000 µm. 
(F) Western blot analysis on liver extracts of E18.5 Ctrl, Het-RAmyfKO and RAmyfKO 
embryos using antibodies against the proteins indicated. Equal amount of protein was 
loaded in each lane. Antibodies to Pan-actin was used as loading control (n = 3-4). 
Data represented as mean ± SEM. Student’s t test and one-way ANOVA with Tukey’s 
multiple comparisons test. 
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Supplementary Figure 3. mTORC1 activity is absent in muscle progenitors, 
precursors, myocytes and myotubes of E11.5 RAmyfKO embryos 
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(A - D) Immunostaining against phospho-S6 Ser235/236 and Pax7 (A), MyoD (B), Myogenin 
(C), embMHC (D) on transverse cross-sections of E11.5 RAmyfKO embryos. Scale bar, 
50 µm. 
(E) Quantification of the percentage of phospho-S6+ progenitors (Pax7+), precursors 
(MyoD+), myocytes (Myogenin+) and myotubes (embMHC+) (n = 3). 
Data represented as mean ± SEM. 
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Supplementary Figure 4. EGFP expression and mTORC1 activity in Het-RAmyfKO 
and RAmyfKO muscle fibers 
(A) Immunostaining for phospho-S6 Ser235/236 (red) and EGFP (green) on transverse 
cross-sections of E18.5 RAmyfKO hindlimbs. With higher magnification a representative 
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area of longitudinal myofibers are displayed to visualize the absence of co-localized 
phospho-S6 (arrowhead) and EGFP (star) staining in RAmyfKO muscle. Scale bar, 50 µm. 
(B) Myogenic cells were isolated from hindlimb and foreleg muscles of E18.5 Het-RAmyfKO 
embryos. Single cells were selected based on the side and forward scatter profiles (SSC / 
FSC). Dead cells were excluded using DAPI staining. The cells were purified by selecting 
Integrin α-7-high (APC, Ex633) and lineage-low (Sca1, CD45, CD31, CD11b; PE, Ex561). 
The myogenic cells were separated by two-way sorting according to their intrinsic EGFP 
expression. 
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Supplementary Figure 5. mTORC2 signaling is dispensable for proliferation and 
differentiation of myoblasts 
Primary myoblasts were isolated from the EDL muscle of 2 – 3 week-old Ctrl and RImyfKO 
mice and cultured in growth or differentiation media. 
(A) Western blot analysis on proliferating Ctrl and RImyfKO primary myoblasts using 
antibodies against the proteins indicated. Myoblasts isolated from RImyfKO muscle were 
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depleted for rictor and show decreased mTORC2 downstream signaling. Equal amount of 
protein was loaded in each lane. Antibodies to α-actinin were used as loading control 
(n = 3). 
(B) Immunostaining against BrdU (red) and Desmin (green) labels myoblasts in the S-phase 
during the 1 h BrdU pulse. Scale bar, 50 µm. 
(C and D) The percentage of BrdU+ / Desmin+ myoblasts after 48 h of proliferation (C) or 
12 h of differentiation (D) was quantified (n = 3). 
(E) Immunostaining against Desmin (green) on myotubes after 48 h of differentiation. Scale 
bar, 100 µm. 
(F) The fusion index and size distribution were assessed on 48 h differentiating Ctrl and 
RImyfKO myotubes (n = 3).  
Data represented as mean ± SEM. Student’s t test. 
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Supplementary Figure 6. EGFP labels raptor-depleted satellite cells of RAscKO mice 
(A) Immunostaining against Pax7 (red), EGFP (green) and laminin (white) on TA muscle 
cross-sections of Ctrl and RAscKO mice after vehicle or tamoxifen treatment. Scale bar, 
50 µm and 10 µm at higher magnification. 
(B) Representative FACS cytometry blots from hindlimb and foreleg muscles of 3 month-
old RAscKO mice 10 days after tamoxifen treatment. Cells were selected based on their 
lineage-low (Sca1, CD45, CD31, CD11b; PE, Ex561, not shown), Integrin α-7-high (APC, 
not shown), CD34-high (Alexa-647, Ex633) and EGFP-high signals. All satellite cells 
isolated from Ctrl (Pax7+/+; Rptorfl/fl; mR26CSEGFP/EGFP) and RAscKO (Pax7Cre-Ert2/+; Rptorfl/fl; 
mR26CSEGFP/EGFP) mice treated with / without tamoxifen, respectively, appeared as EGFP-
negative. 86.4 % of the satellite cells isolated from tamoxifen-treated RAscKO mice were 
EGFP-positive (n ≥ 2). 
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(C) PCR analysis was performed on FACS-isolated satellite cells using primers to 
distinguish between the wild-type (wt, 141 bp), floxed (flox, 228 bp) or recombined (rec, 
204 bp) Rptor allele. In Ctrl satellite cells the floxed allele was detected, while in RAscKO 
satellite cells the recombined Rptor allele was amplified (n = 3). 
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Supplementary Figure 7. 50 % reduction in raptor protein levels does not affect 
muscle regeneration at young age 
(A) Western blot analysis on contralateral (CLM), uninjured gastrocnemius muscle from 3 
month-old Ctrl (Myf5+/+; Rptorfl/fl) and Het-RAmyfKO (Myf5+/Cre; Rptor+/fl) mice using 
antibodies against the proteins indicated. Equal amount of protein was loaded in each lane. 
Antibodies to α-actinin were used as loading control (n = 5). 
(B) The body and muscle weight of 3 month-old Ctrl and Het-RAmyfKO mice was measured 
15 days after cardiotoxin- (Ctx) induced muscle damage. Restoration of the muscle weight 
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following injury compared to the uninjured, contralateral muscle (CLM) indicates that muscle 
regeneration was efficient in Het-RAmyfKO mice (n = 5). 
(C) H&E coloration on CLM and Ctx, 15d TA cross-sections of Ctrl and Het-RAmyfKO mice. 
Regenerating fibers are characterized by their centralized nuclei. Scale bar, 50 µm. 
(D) Immunostaining against Pax7 (red) and laminin (green) on cross-section of uninjured 
(CLM) or injured (Ctx, 15d) TA muscles to visualize quiescent Pax7+ satellite cells 
underneath the basal lamina. Scale bar, 100 µm and 20 µm at higher magnification. 
(E) Quantification of the number of Pax7+ satellite cells normalized to 100 myofibers in 
uninjured and injured TA muscles from Ctrl and Het-RAmyfKO mice (n = 4-5).  
Data represented as mean ± SEM. ## p < 0.01, represents statistical significance relative 
to the uninjured condition, Student’s t test. 
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Supplementary Figure 8. Raptor-depleted satellite cells exhibit proliferation and 
differentiation defects in vitro 
(A) Freshly sorted satellite cells were cultured in growth media for 48 h and BrdU-labeled 
1 h before fixation. Immunostaining against BrdU (red) and desmin (green) visualizes the 
myoblasts being in the S-phase of the cell cycle during the pulse (n = 3-4). Scale bar, 
100 µm. 
(B) Immunostaining against embMHC (red) and desmin (green) on myotubes after 4 days 
of differentiation. The fusion index was quantified after 4 days of differentiation (n = 3). Scale 
bar, 100 µm. 
Data represented as mean ± SEM. * p < 0.05, Student’s t test. 
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  E18.5 Liver 
  Ctrl Het-RAmyfKO RAmyfKO 
Raptor 100 ± 56 138 ± 52 155 ± 56 
phospho-S6  
Ser235/236 100 ± 23 106 ± 13 145 ± 26 
S6 100 ± 17 109 ± 13 124 ± 15 
 
Supplementary Table 1. Quantification of Western blot analysis in liver from E18.5 
Ctrl, Het-RAmyfKO and RAmyfKO embryos, related to Figure S2 
Protein levels were quantified in liver from E18.5 Ctrl, Het-RAmyfKO and RAmyfKO 
embryos. The total amount of protein was adjusted according to concentration. Data are 
represented as the average of grey values ± SEM, after background subtraction and 
normalization to Pan-Actin and to values from Ctrl mice (n = 3). One-way ANOVA with 
Tukey’s multiple comparisons test. 
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  Primary myoblasts 
  Ctrl RImyfKO 
Rictor 100 ± 11 10 ± 6 ** 
phospho-PKCα Ser657 100 ± 38 30 ± 6 
PKC 100 ± 28 38 ± 16 
phospho-Akt Ser473 100 ± 25 18 ± 4 * 
Akt 100 ± 32 66 ± 6 
phospho-S6 Ser235/236 100 ± 40 70 ± 6 
S6 100 ± 26 79 ± 11 
 
Supplementary Table 2. Quantification of Western blot analysis of primary myoblasts 
isolated from the EDL muscle of Ctrl and RImyfKO mice, related to Figure S5 
Protein levels were quantified in primary myoblasts isolated from the EDL muscle of 2-3 
week-old Ctrl and RImyfKO mice. The total amount of protein was adjusted according to 
concentration. Data are represented as the average of grey values ± SEM, after background 
subtraction and normalization to α-actinin and to values from Ctrl mice (n = 3). Student’s t 
test. 
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  Quadriceps muscle 
  Ctrl Het-RAmyfKO 
Raptor 100 ± 15 58 ± 9 * 
phoshpo-S6 Ser235/236 100 ± 23 61 ± 13 
S6 100 ± 6 106 ± 24 
phoshpo-4E-BP1 Ser65 100 ± 18 80 ± 15 
4E-BP1 100 ± 11 115 ± 34 
 
Supplementary Table 3. Quantification of Western blot analysis in quadriceps muscle 
from 3 month-old Ctrl and Het-RAmyfKO mice, related to Figure S7 
Protein levels were quantified in uninjured quadriceps muscle from 3 month-old Ctrl and 
Het-RAmyfKO mice. The total amount of protein was adjusted according to concentration. 
Data are represented as the average of grey values ± SEM, after background subtraction 
and normalization to α-actinin and to values from Ctrl mice (n = 5). * p < 0.05, Student’s t 
test. 
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 Forward primer Reverse primer 
Pax7 GAG GTG ACA GGA GGC AGA AG AGC TGC CAG CAA GAT GGT AT 
Myf5 AGG AAA AGA AGC CCT GAA GC GCA AAA AGA ACA GGC AGA GG 
MyoD CAT TCC AAC CCA CAG AAC CT TGC TGT CTC AAA GGA GCA GA 
MyoG ACT CCC TTA CGT CCA TCG TG CAG GAC AGC CCC ACT TAA AA 
Myh3 GCA CGA AGA AGC CAA GAT TC TCA GCT GCT CGA TCT CTT CA 
Des GAG GTT GTC AGC GAG GCT AC CTT CAG GAG GCA GTG AGG AC 
β-actin CAG CTT CTT TGC AGC TCC TT GCA GCG ATA TCG TCA TCC A  
 
Supplementary Table 4. Primers used for quantitative PCR analysis 
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Abstract 
Background: The mammalian target of rapamycin complex 2 (mTORC2), containing the 
essential protein rictor, regulates cellular metabolism and cytoskeletal organization by 
phosphorylating protein kinases, such as Akt, PKC and SGK. Inactivation of mTORC2 
signaling in adult skeletal muscle affects whole-body metabolism, but not muscle histology 
and function. However, it is not clear whether mTORC2 is required for the formation of 
myofibers during development and muscle regeneration.  
 
Methods: We developed a new mouse model depleted for rictor in the Myf5-lineage 
(RImyfKO) and characterized their muscle phenotype using histological, biochemical and 
molecular biological methods. The function of muscle stem cells was analyzed during 
cardiotoxin-induced muscle regeneration in vivo and in culture on isolated myofibers.  
 
Results: Skeletal muscle of young and aged RImyfKO mice appeared normal in size, 
composition and function in respect to their body weight. In young RImyfKO mice, quiescent 
muscle stem cells exhibited normal functional characteristics, such as proliferation, 
differentiation and fusion, following one severe muscle damage. However, upon multiple 
muscle injuries, RImyfKO muscle stem cells failed to replenish the stem cell pool. Moreover, 
the number of quiescent muscle stem cells in RImyfKO mice decreased during physiological 
aging, causing a decline in the regenerative capacity of mutant muscle at progressed age.  
 
Conclusions: Our study shows that mTORC2 signaling is dispensable for muscle 
development, but required for the homeostasis of muscle stem cells. Loss of mTORC2 does 
not affect the myogenic function of muscle stem cells, but impairs the replenishment of the 
pool after repeated injuries and during aging. These results point to an essential role of 
mTORC2 signaling in muscle stem cell maintenance and muscle physiology.  
 
Keywords: mTORC2, rictor, myogenesis, muscle development, muscle regeneration, 
satellite cells 
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Background 
During development, mesenchymal progenitors from somites, expressing the paired box 
protein 3 and 7 (Pax3 / Pax7), undergo a multi-step process, called myogenesis, that leads 
to the formation of skeletal muscle fibers. Myogenesis includes the commitment of the 
progenitors into the muscle lineage, their proliferation, differentiation and fusion, and is 
controlled by the sequential expression of myogenic basic-helix-loop-helix (bHLH) 
transcription factors Myf5, MyoD, Myogenin and Mrf4 [1]. Myogenesis is recapitulated in 
adult skeletal muscle during muscle regeneration following injury. Adult myogenesis 
depends on skeletal muscle stem cells, called satellite cells, that originate from progenitor 
cells expressing Pax7 and Myf5 during fetal embryogenesis [2].  
 
The mammalian (or mechanistic) target of rapamycin (mTOR) associates into two 
structurally and functionally different complexes called mTOR complex 1 (mTORC1) and 
mTOR complex 2 (mTORC2). mTORC1, containing the protein raptor, regulates cell growth 
by controlling the balance between protein synthesis and protein degradation [3]. In 
contrast, mTORC2, including the essential component rictor, regulates ion transport and 
cell survival by phosphorylating the serine/threonine protein kinase 1 (SGK1, at the Serine 
422) [4], as well as actin cytoskeleton organization via the phosphorylation of protein kinase 
C α (PKCα, at the Serine 657) [5, 6]. In the last years, mTORC2 has been shown to be a 
regulator of lipogenesis and glucose homeostasis in insulin-stimulated tissues, e.g. in liver, 
through its downstream substrate Akt, which is phosphorylated within its hydrophobic motif 
(Serine 473) [7-9]. Genetic inactivation of mTORC2 in adult skeletal muscle, using HSA-
Cre-induced depletion of rictor (RImKO mice), does not alter muscle organization and 
function [10], but impairs insulin-stimulated glucose transport and increases glycogen 
synthase activity in the tissue [11]. Moreover, whole-body metabolism of RImKO mice is 
perturbed due to a re-partitioning of lean to fat mass and an increase in intramyocellular 
triglycerides, which resulted in the preferred usage of fat as an energy substrate [12]. 
However, in those studies, mTORC2 was inactivated in differentiated, mature skeletal 
muscle, which did not address the role of mTORC2 signaling in the formation of the tissue 
and the function of satellite cells. Notwithstanding, germline depletion of rictor in mice 
resulted in embryonic lethality around E11.5 [13, 14], indicating that mTORC2 signaling is 
required for normal development. Inactivation of rictor in Myf5-expressing cells (i.e. 
progenitors in the dermomyotome giving rise to myoblasts and brown adipocytes) revealed 
an essential function of mTORC2 in brown adipocyte differentiation and growth: RImyfKO 
mice displayed a shift to a more oxidative and less lipogenic metabolism in the brown 
adipose tissue [15]. Even though these mutant mice developed normally and skeletal 
muscle mass was not altered at young age, long-term consequences of mTORC2 
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inactivation on muscle tissue homeostasis have not been studied in greater detail. In 
particular, whether its loss affects the satellite cell pool has not been investigated. Evidence 
for a specific role of mTORC2 in myogenesis originates from a study in C2C12 myoblasts, 
in which Rictor knock-down caused a blockage in their terminal differentiation [16]. During 
myoblast differentiation and fusion, Akt downregulates the Rho-associated kinase 
(ROCK1), involved in the regulation of the actin cytoskeleton, which was prevented in 
myogenic cells deficient for mTORC2.  
 
Here, we confirm that mTORC2 signaling is not required for the formation of skeletal 
muscle fibers during development and established that it is dispensable for muscle 
regeneration. Even though satellite cells are generated and functional in RImyfKO mice, the 
maintenance of the pool is impaired upon repeated injuries and natural aging, ultimately 
leading to a reduced satellite cell population in the absence of mTORC2. Hence, we unravel 
a determinant role of mTORC2 in satellite cell homeostasis and muscle physiology.   
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Methods 
Mice 
RImyfKO mice were obtained by crossing Rictor-floxed mice [10] with transgenic mice 
expressing Cre recombinase under the control of the Myf5 promoter (Jackson Laboratories 
[17]). Genotyping for conditional Rictor and the knock-in of Cre recombinase in the Myf5 
locus was performed as described previously [10, 17]. Females or males were used as 
indicated in the figure legend. No gender-specific differences were observed. In vitro force 
measurements of the extensor digitorum longus (EDL) and soleus (Sol) muscles were 
performed as described before [10]. All mice were maintained in standard conditions with a 
fixed 12 h dark-light cycle and free access to food and water. All animal studies were 
approved by the veterinary office of the Canton of Basel, in accordance to Swiss regulations.   
 
Muscle injury and regeneration 
5 or 14 month-old mice were anesthetized with Ketamine (111 mg/kg, Ketalar) and Xylazine 
(22 mg/kg, Rompun) by intraperitoneal injection. Tibialis anterior (TA) and EDL muscles 
were unilaterally injected with 6.7 µg cardiotoxin (Ctx; Latoxan) to provoke complete muscle 
degeneration. Mice were treated with 0.1 mg/kg Buprenorphine, twice a day for at least 
three days. The second muscle necrosis was induced 30 days after the first Ctx-injury. The 
injured, regenerating TA and EDL muscles, as well as the uninjured contralateral 
corresponding muscles, were harvested 15 days after the last injury.  
 
Single myofiber isolation and culture 
Single muscle fibers were isolated from the EDL muscle of 5 month-old mice by enzymatic 
digestion and trituration as previously described [18]. In brief, EDL was digested with 
1 mg/ml Collagenase A (Roche) in DMEM Glutamax (Gibco), 1 % penicillin-streptomycin 
(Thermo Fisher Scientific) for 1.5 h at 37 °C and triturated into single myofibers. Fibers were 
cultured in DMEM Glutamax supplemented with 1 % pen/strep, 10 % horse serum, 1 % 
chicken embryo extract and fixed with 4 % PFA at different time points. For immunostaining, 
fibers were permeabilized with PBS, 0.5 % Triton-X100, and blocked with PBS, 10 % horse 
serum, 10 % goat serum, 0.35 % Carrageenan (Sigma) for 30 min. Primary antibodies were 
added overnight at 4 °C. Fibers were washed with PBS, 0.025 % Tween-20, and incubated 
with secondary antibodies for 1.5 h. They were then mounted on slides coated with 84 % 
acetone, 16 % (3-aminopropyl)triethoxysilane (Sigma), with Vectashield Dapi (Vector).   
 
Histology and immunofluorescence staining 
Muscles were dissected and frozen in nitrogen-cooled isopentane. 8 µm consecutive 
cryosections were used for standard histological staining. Hematoxylin and eosin staining 
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(Merck) was performed followed by sequential dehydration with 70 %, 90 % and 100 % 
ethanol and 100 % xylene. Picrosirius red (1 mg/ml in 1.3 % aqueous solution of picric acid, 
Sigma) was applied for 1 h, followed by washing in 0.5 % acidic water for 30 min. After 
dehydration in 100 % ethanol the slides were cleared in xylene. For Oil red O staining, the 
sections were fixed with 4 % PFA for 1 h and stained with 5 mg/ml Oil red O, 60 % triethyl-
phosphate (Sigma) for 30 min. The sections were washed with water and mounted in 10 % 
glycerol. For immunohistochemistry, cryosections were fixed with 4 % PFA for 6 min, 
washed in PBS pH7.4, 0.1 M glycine and permeabilized with pre-cooled methanol for 6 min. 
Antigen retrieval was performed by warming the sections in 0.01 M citric acid. Sections were 
blocked in 3 % IgG-free BSA (Jackson Immuno Research Laboratories) supplemented with 
0.05 mg/ml AffiniPure Mouse IgG, Fab Fragment (Jackson Immuno Research 
Laboratories). Primary antibodies were incubated overnight at 4 °C. Sections were 
subsequently washed and incubated with the appropriate fluorescent secondary antibodies 
for 1.5 h at room temperature. After washing with PBS, the samples were mounted with 
Vectashield Dapi (Vector laboratories). For MHCIIa staining, PFA-fixation was not 
performed.  
 
Protein extraction and Western blot 
TA muscles were snap-frozen in liquid nitrogen and powdered on dry ice. Samples were 
lysed in cold RIPA buffer (50 mM Tris-HCl pH8, 150 mM NaCl, 1 % NP-40, 0.5 % sodium 
deoxycholate, 0.1 % SDS, 1 % Triton X-100, 10 % glycerol) supplemented with 
phosphatase and protease inhibitor cocktail tablets (Roche), incubated for 2 h, sonicated 
twice for 10 s, and centrifuged at 16’000 g for 30 min at 4 °C. Total protein amount from 
cleared lysates were determined according to manufacturer’s protocol (Pierce BCA Protein 
Assay Kit, Thermo Fisher Scientific). Equal amounts of protein were loaded and separated 
on 4-12 % Bis-Tris Protein Gels (NuPage Novex, Thermo Fisher Scientific).  
 
Antibodies 
Rabbit polyclonal antibodies are as follows: MyoD c-20 (sc-304) and phospho-PKCα 
(Ser657; sc-12356) from Santa Cruz; laminin (ab11575) from Abcam; Akt (9272), PKCα 
(2056), phospho-S6 ribosomal protein (Ser235/236; 2211), phospho-4E-BP1 (Ser65; 9451) 
and 4E-BP1 (9452) from Cell Signaling Technologies (CST). Rabbit monoclonal antibodies 
are as follows: Rictor (9476), phospho-Akt (Ser473; 4058) and S6 ribosomal protein (2217) 
from CST. Mouse monoclonal antibodies are as follows: Pax7 and myosin heavy chain 
(human fast fibers; A4.74) from Developmental Studies Hybridoma Bank (DSHB) and α-
actinin (sarcomeric; A7732) from Sigma. Rat monoclonal antibody against laminin α2 
(ab11576) was from Abcam. 
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Statistical analyses  
For muscle fiber size quantification, images were acquired using a Leica DM5000B 
fluorescence microscope with 10x objective, a digital camera (F-View; Olympus Soft 
Imaging Solutions GmbH) and the analySIS software (Soft Imaging System). The minimum 
distance of parallel tangents at opposing particle borders (minimal feret’s diameter) of 
muscle fibers from the entire TA / EDL muscle or random fields of the muscles, were 
measured with the analySIS software as described [19]. All experiments were performed 
on a minimum of 3 independent biological samples indicated by the n-number (n). In all 
graphs, data are represented as the mean value and the respective standard error of the 
mean (SEM, error bars). Student’s t test was employed to evaluate statistical significance 
and p-values lower than 0.05 are considered statistically significant.  
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Results 
Depletion of rictor in the Myf5-lineage is dispensable for skeletal muscle 
development 
To examine the function of mTORC2 in muscle progenitors, and their descendent satellite 
cells and adult myofibers, we generated conditional knockout mice depleted for rictor in 
Myf5-expressing cells (RImyfKO) by crossing Myf5-Cre mice [17] with mice carrying floxed 
alleles for Rictor [10] (Myf5+/Cre; Rictorfl/fl). Myf5 is expressed in progenitor cells of the 
somites from embryonic day (E) 8 [20] and determines cells differentiating into brown 
adipocytes or skeletal muscle cells [21]. RImyfKO mice were viable and born at the 
expected Mendelian ratio, but they could be distinguished from their littermate controls (Ctrl; 
Myf5+/+; Rictorfl/fl) by a reduction in their body weight (Figure 1A, 1B). Moreover, the 
reduction in body weight remained throughout life (Figure 1B). RImyfKO mice showed a 
normal distribution of fat and lean mass relative to their body weight (Figure 1C) and the 
mass of various hindlimb muscles, including the tibialis anterior (TA), extensor digitorum 
longus (EDL), soleus (Sol) and gastrocnemius (Gastro), normalized to the body weight was 
unchanged between Ctrl and mutant mice (Figure 1D). We confirmed that muscle extracts 
from RImyfKO mice were devoid of rictor and the mTORC2-specific phosphorylation of the 
downstream target Akt (Serine 473) was strongly decreased in mutant muscle (Figure 1E, 
Table 1). Total PKCα and its phosphorylated form (Serine 657) were both reduced in 
mTORC2-deficient muscle (Figure 1E, Table 1), similarly as already observed in RImKO 
mice [10]. In contrast, mTORC1-specific targets such as S6 ribosomal protein and 4E-BP1 
were not affected in RImyfKO mice, confirming that rictor depletion in Myf5-expressing cells 
only disrupts mTORC2, but not mTORC1, signaling (Figure 1E, Table 1). 
  
Since depletion of rictor in mature muscle fibers does not affect fiber size and 
cytoskeletal organization [10], we wondered whether mTORC2 inactivation in developing 
muscle would lead to muscle alterations in adult mice. By hematoxylin and eosin (H&E) 
staining, we observed no major histological difference in TA muscle from RImyfKO and Ctrl 
mice, at both 5- and 14-months of age (Figure 2A). Consistently, the fiber size distribution 
was unchanged in the EDL muscle of 14 month-old RImyfKO compared to Ctrl mice (Figure 
2B, C). Additionally, there was no difference concerning fiber type composition and fiber 
number between genotypes (Figure 2D, E), indicating that RImyfKO muscle do not develop 
structural changes with age. Furthermore, the specific twitch (sPt) and tetanic (sP0) forces 
of EDL and Sol muscles were similar in 14 month-old RImyfKO and Ctrl mice (Figure 2F), 
confirming that mTORC2 inactivation in developing muscle did not cause functional deficits 
of mature muscle. Thus, deletion of rictor in the Myf5-lineage affects whole-body growth, 
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but does not interfere with the formation of skeletal muscle during embryogenesis and does 
not lead to muscle alterations in the adult.      
 
mTORC2 signaling is dispensable for the myogenic function of satellite cells 
Since Myf5 is expressed in a subset of quiescent satellite cells in adult skeletal muscle [2, 
22, 23], we analyzed the satellite cell pool in RImyfKO muscle under homeostatic and 
challenging conditions. There was no significant difference in the number of Pax7+ cells in 
TA and EDL muscles from 5 month-old RImyfKO and Ctrl mice (Figure 3A, B). This result 
indicates that mTORC2 signaling is dispensable for the generation of the satellite cell 
population and its maintenance at young age. To directly challenge mTORC2-deficient 
satellite cells, we injected cardiotoxin (Ctx) into TA and EDL muscles to induce a complete 
degeneration of the tissue, followed by 15 days of recovery (1x Ctx, 15d). For some mice, 
muscles were re-injured 30 days after the first Ctx-injection and analyzed 15 days post-
injury (2x Ctx, 15d). The contralateral muscle remained uninjured. After one or two rounds 
of degeneration / regeneration, myofibers in Ctrl muscle were restored and exhibited 
centralized nuclei, a characteristic of regenerating fibers (Figure 3C). Similarly, an efficient 
regeneration was observed in muscle from 5 month-old RImyfKO mice; no accumulation of 
fibrosis, inflammation or adipogenic tissue was detected (Figure 3C). Consistently, the ratio 
between injured and uninjured TA and EDL muscle mass was not altered in RImyfKO mice, 
compared to Ctrl, after one or two Ctx-provoked muscle injures (Figure 3D). Furthermore, 
no difference in the fiber size distribution and in the total number of fibers was detected in 
RImyfKO muscle after the second muscle damage (Figure 3E-G), therefore providing strong 
evidence that the process of myofiber restoration was efficient in 5 month-old mice in the 
absence of mTORC2 signaling. As an efficient myofiber restoration lies on the activation of 
satellite cells, their proliferation and differentiation [24], we assumed that mTORC2 
inactivation did not affect any of these processes. In vitro analysis of primary myoblasts 
isolated from RImyfKO muscle confirmed that mTORC2 is dispensable for muscle cell 
proliferation, differentiation and fusion [25]. Lastly, we tested whether mTORC2 is involved 
in the replenishment of the satellite cell pool by analyzing the number of Pax7+ cells 
underneath the basal lamina after one or two injuries. Interestingly, the pool of Pax7+ cells 
tended to be reduced and was significantly decreased after one and two Ctx-induced 
injuries, respectively, in RImyfKO muscle compared to Ctrl (Figure 3H, I). This indicated 
that mTORC2 signaling is dispensable for the myogenic function of satellite cells, but 
necessary for the replenishment of the pool following multiple degeneration / regeneration.  
  
Interestingly, we observed an increased proportion of Pax7+ cells with an abnormal, 
interstitial localization in 5 month-old RImyfKO TA and EDL muscles (Figure 4A). To further 
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analyze the satellite cell pool in RImyfKO muscle, we isolated single muscle fibers of EDL 
muscle from 5 month-old mice and analyzed the attached satellite cells either immediately 
after isolation (t0) or after culturing the fibers for up to 72 hours (t24h, t48h, t72h; Figure 4B-
D). Interestingly, the number of Pax7+ cells at t0 in RImyfKO EDL fibers was reduced 
compared to Ctrl mice (t0; Figure 4B), supporting the observation of an increased proportion 
of interstitial satellite cells in vivo (Figure 4A). After 24 hours in culture (t24h), all Ctrl and 
RImyfKO satellite cells got activated as indicated by MyoD expression, which was absent 
at t0 (Figure 4C). Until 72 hours in culture, Pax7+/MyoD+ activated cells proliferated and 
formed clones, from which some cells returned into quiescence (characterized by MyoD 
downregulation; Pax7+/MyoD-), and some cells entered in differentiation (Pax7 
downregulation; Pax7-/MyoD+). At t48h, the proportion of Pax7-/MyoD+ cells was 
significantly increased in RImyfKO culture as compared to Ctrl, suggesting an anticipated 
commitment of the cells in the differentiation process. However, at t72h, the proportion of 
Pax7+/MyoD-, Pax7+/MyoD+, Pax7-/MyoD+ cells were similar in RImyfKO and Ctrl cultures 
(Figure 4C), indicating that mutant satellite cells do not show a defective capacity to return 
into quiescence. Furthermore, the increase in number of myogenic cells from t0 to t72h was 
comparable between both genotypes (Figure 4D), confirming that mTORC2 signaling is 
dispensable for proliferation of satellite cells. Altogether, these results suggest that 
mTORC2 signaling in satellite cells is dispensable for their myogenic function, but also for 
their self-renewal capacity.  
 
The satellite cell pool declines during aging in the absence of mTORC2 
Since at young age repeated degeneration / regeneration of skeletal muscle reduced the 
satellite cell pool in the absence of mTORC2 signaling, we wondered whether physiological 
aging would also alter their maintenance. Interestingly, the number of Pax7+ cells was 
reduced in TA and EDL muscles from 14 month-old RImyfKO mice, as compared to Ctrl 
(Figure 5A). To test the function of the remaining satellite cells in mutant muscle, we induced 
one injury by injecting cardiotoxin in TA and EDL muscles of 14 month-old mice and 
analyzed their regenerative capacity 15 days post-injury. By H&E staining, we observed 
that RImyfKO muscle showed a limited regenerative capacity, with smaller newly formed 
myofibers and an abnormal accumulation of lipid droplets, as compared to Ctrl (Figure 5B). 
Consistently, the ratio between the mass of injured and uninjured TA / EDL muscles from 
14 month-old RImyfKO mice tended to be reduced compared to Ctrl (Figure 5C) and the 
fiber size distribution in regenerating RImyfKO muscle was shifted towards smaller 
myofibers (Figure 5D, E). Of note, there was no increase in collagen-rich, fibrotic area in 
RImyfKO regenerating muscle (Figure 5F). Lipid infiltration in RImyfKO regenerating muscle 
was confirmed with Oil red O staining, with a significant increase in fat area (Figure 5F, G). 
  Results – Manuscript 2 
Page | 100 
 
Following muscle regeneration, the satellite cell pool remained smaller in RImyfKO mice 
compared to Ctrl (Figure 5H). Thus, mTORC2 signaling in satellite cells seems to be 
essential for the maintenance of the pool, and thereby for the regenerative capacity of 
muscle tissue, during aging. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Results – Manuscript 2 
Page | 101 
 
Discussion 
Our work dissects the role of mTORC2 in embryonic and adult muscle progenitors, by using 
mice depleted for rictor, the essential component of mTORC2, in the Myf5-lineage. In 
contrast to RImKO mice, depleted for rictor in adult skeletal muscle [10, 11], RImyfKO mice 
were lighter compared to littermate Ctrl. Hung et al. previously reported a difference in body 
weight in mice depleted for rictor in the Myf5-lineage, only between 6 and 15 weeks of age, 
and they argued that it may be caused by decreased adipose tissue mass and reduced 
growth [15]. Whole body growth is mediated by the family of insulin-like growth factors 
(IGFs), in which IGF-II is predominantly active during fetal development [26]. Igf2-/- mice and 
mice carrying a paternally derived mutated Igf2 gene were smaller and displayed a 40 % 
body weight reduction compared to littermate controls [27]. Recent reports revealed that in 
mouse embryonic fibroblasts (MEFs), IGF-II translation is controlled by mTORC2 through 
the phosphorylation of IGF-II mRNA-binding protein 1 (IMP1) [28]. Even though skeletal 
muscle is not the only source of circulating IGFs, it may well be that loss of mTORC2 in 
developing muscle affects whole body growth by reducing the amount of released IGF-II. 
Importantly, RImyfKO muscles developed normally in respect to their body weight and 
showed no major alterations in adult, indicating that mTORC2 signaling is not required for 
embryonic myogenesis and the maintenance of mature muscle.  
 
Myogenesis includes proliferation, differentiation and fusion of muscle progenitors / 
precursors in order to form multinucleated myotubes that mature into muscle fibers [24]. 
This process is involved during embryonic muscle development and recapitulated during 
injury-induced muscle regeneration. RImyfKO muscles were capable to undergo successful 
muscle regeneration following one or two subsequent muscle injuries at young age. In light 
of the efficient fiber restoration in RImyfKO mice at young age, we assumed that mTORC2 
signaling is not necessary for the myogenic function of adult muscle precursors to 
proliferate, differentiate and fuse. Consistently, primary myoblasts isolated from RImyfKO 
muscle efficiently proliferate, differentiate and fuse into multi-nucleated myotubes [25]. 
Furthermore, mTORC2-deficient satellite cells on single myofibers showed a similar 
capacity to proliferate and form clones in culture compared to Ctrl cells. These results 
contrast to a previous report with C2C12 myoblasts silenced for mTORC2 signaling (shRNA 
directed against Rictor), which suggested a potent role of mTORC2 in myoblast 
differentiation through Akt and ROCK1 [16]. Here, we provide evidence that mTORC2 
signaling is dispensable for proliferation, differentiation and fusion of embryonic and adult 
muscle precursors in vitro and in vivo.  
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In this study, we report that inhibition of mTORC2 in satellite cells alters their 
maintenance. The number of satellite cells was unaffected in muscle from young RImyfKO 
mice, but we observed an increased proportion of cells located in the interstitial space. This 
suggests that satellite cells lose their quiescence in the absence of mTORC2, as migration 
out of the niche is associated to the activation of the cells [29]. This may explain why 
following repeated injuries, the pool of RImyfKO satellite cells gradually declines. Satellite 
cells deficient for PTEN, an inhibitor of PI3K and Akt, were found to spontaneously activate 
and undergo premature differentiation [30]; Pten-/- satellite cells were unable to return into 
quiescence, which results in a depletion of the stem cell pool with age and in regenerative 
failure [30, 31]. Hence, RImyfKO and Pten-/- satellite cells, which are both characterized by 
a deregulation of Akt (decreased and increased phosphorylation at the site Serine 473, 
respectively), would also share phenotypic similarities. However, RImyfKO satellite cells did 
not show reduced capacity to return into quiescence in culture, suggesting that inactivation 
of mTORC2 signaling, and the subsequent Akt deregulation, did not impair their self-
renewal function. 
 
Interestingly, RImyfKO muscle not only lose satellite cells after repeated injuries but 
also in the absence of external stimuli during physiological aging. Likely as a consequence, 
the regenerative capacity of muscle from aged RImyfKO mice in response to one injury was 
reduced. Instead of an efficient fiber restoration, smaller myofibers accompanied with an 
accumulation of lipid droplets were formed. As an increased number of interstitial satellite 
cells were observed in RImyfKO muscle and a reduced number of Pax7+ cells remained 
associated to mutant fibers upon dissociation, the precipitated loss of satellite cells during 
aging may be caused by alterations of their niche or their interaction with myofibers. 
Adhesion molecules, such as M-cadherin, Mcam, Megf10 and integrin α4β1, mediate the 
interaction between satellite cells and myofibers and are involved in the colonization of the 
niche by the satellite cell (“homing”) [29]. Deregulation of the Notch signaling has been 
shown to cause instable adhesive interactions and homing deficits resulting in an interstitial 
localization of the stem cell [29]. Similarly, satellite cells deficient for syndecan-3, a 
transmembrane heparan sulfate proteoglycan, are prone to migrate away from their niche 
and fail to replenish the quiescent stem cell pool following injury [32-37]. Alterations of the 
homing capacity of mTORC2-deficient satellite cells may hence contribute to the defects 
observed. Alternatively, the loss of satellite cells in the absence of mTORC2 signaling may 
also be caused by an anticipated conversion into a pre-senescent state [38]. In course of 
natural aging, the number of satellite cells drops [39] and the regenerative potential of 
individual satellite cells declines [40-42], which have been related to several factors. 
Senescent satellite cells are marked by impaired autophagy, increased mitochondrial 
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dysfunction and oxidative stress [43]. Although Akt induction is sufficient to block FoxO3 
activation and autophagy [44], it was demonstrated that mTORC2 signaling does not control 
autophagy in skeletal muscle [45]. Moreover, also age-related alterations in signaling 
cascades and components of the satellite cell niche affect the homeostasis of their resident 
stem cell [46]. Since mTORC2-deficient satellite cells did not show any deficits in their 
myogenic function, it is unlikely that the phenotype appears cell-autonomously and may 
rather be caused by changes in the interaction between satellite cells and their niche.  
 
 
Conclusions 
Our study demonstrates that mTORC2 is dispensable for the formation and maintenance 
of skeletal muscle, and for the myogenic function of muscle stem cells. However, with age 
and after repeated injuries the number of muscle stem cells decreases and the regenerative 
capacity of the muscle diminishes in the absence of mTORC2. These observations highlight 
that mTORC2 signaling is essential for muscle stem cell homeostasis and provide evidence 
for mTORC2 targets required during aging and conditions of multiple rounds of 
degeneration / regeneration, as in muscular dystrophies.  
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Figure 1. Depletion of rictor in the Myf5-lineage affects whole-body growth   
a Photograph of Ctrl (Myf5+/+; Rictorfl/fl) and RImyfKO (Myf5+/Cre; Rictorfl/fl) mice at the age of 
5 months. b The body weight of Ctrl and RImyfKO male mice was measured at 5 and 14 
month of age (n = 6-8). c The fat mass and lean mass of 5 month-old, male Ctrl and 
RImyfKO mice was analyzed by EchoMRI (n = 4-6). d The mass of TA, EDL, Sol and Gastro 
muscles from 5 month-old RImyfKO males is unchanged compared to Ctrl littermates (n = 4-
6). e Western blot analysis of the proteins indicated in TA muscle from 5 month-old, male 
Ctrl and RImyfKO mice. Equal amount of protein was loaded in each lane. α-Actinin was 
used as loading control (n =5).  
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Data represent mean ± SEM. * p < 0.05, *** p < 0.001, Student’s t test.  
 
 
  TA muscle 
  Ctrl RImyfKO 
Rictor 100 ± 7 72 ± 4 * 
phospho-Akt Ser473 100 ± 12 18 ± 2 *** 
Akt 100 ± 7 76 ± 9 
phospho-PKCα Ser657 100 ± 22 31 ± 2 * 
PKC 100 ± 10 29 ± 2 *** 
phospho-S6 Ser235/236 100 ± 24 101 ± 27 
S6 100 ± 13 106 ± 16 
phospho-4E-BP1 Ser65 100 ± 24 98 ± 17 
4E-BP1 100 ± 10 81 ± 12 
   
Ratio phospho-Akt Ser473 / Akt 100 ± 13 25 ± 4 *** 
Ratio phospho-S6 Ser235/236 / S6 100 ± 25 93 ± 20 
Ratio phospho-4E-BP1 Ser65 / 4E-BP1 100 ± 31 117 ± 28 
 
Table 1. Quantification of Western blot analysis in TA muscle from 5 month-old, male 
RImyfKO and Ctrl mice, related to Figure 1 
Protein levels were quantified in TA muscle from 5 month-old, male RImyfKO and Ctrl mice. 
The total amount of protein was adjusted according to concentration. Data are represented 
as the average of grey values ± SEM, after background subtraction and normalization to α-
Actinin and to values from Ctrl mice (n = 5). * p < 0.05, *** p < 0.001, Student’s t test. 
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Figure 2. mTORC2 is not required for adult skeletal muscle homeostasis 
a Hematoxylin and eosin (H&E) coloration on TA cross-sections of 5 and 14 month-old Ctrl 
and RImyfKO mice. No alteration in muscle histology and fiber organization was detected 
in RImyfKO muscle. Scale bar, 50 µm. b Immunostaining against laminin (red) and myosin 
heavy chain IIa (MHCIIa, green) on EDL cross-section from 14 month-old, female Ctrl and 
RImyfKO mice. Type IIa fibers are labeled in bright green, type IIx in mild green and IIb 
fibers appear unstained. Scale bar, 100 µm and 20 µm at higher magnification. c – e Fiber 
size distribution (c), mean fiber size (d) and total number of fibers (e) was analyzed in the 
EDL muscle of 14 month-old Ctrl and RImyfKO mice (n = 3). f Specific twitch force and 
specific tetanic force of the EDL and Sol muscle from 14 month-old Ctrl and RImyfKO mice 
was measured (n = 4-7). 
Data represent mean ± SEM. Student’s t test. 
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Figure 3. Satellite cells of RImyfKO mice fail to replenish the pool after repeated 
injuries 
a Immunostaining against Pax7 (red) and laminin (green) on TA muscle cross-sections from 
5 month-old Ctrl and RImyfKO mice. Scale bar, 100 µm and 20 µm at higher magnification. 
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b The number of Pax7+ cells underneath the basal lamina was counted in TA and EDL 
muscles from 5 month-old, male Ctrl and RImyfKO mice and normalized to 100 myofibers 
(n = 4-5). c – i Cardiotoxin (Ctx) was injected into TA and EDL muscles of 5 month-old, 
male Ctrl and RImyfKO mice. Muscle analysis was performed 15 days post-injury (1x Ctx). 
Contralateral muscles were not injured. Some mice were re-injured 30 days after the first 
injury (2x Ctx). c H&E staining on 1x Ctx or 2x Ctx TA muscle cross-sections from Ctrl and 
RImyfKO mice. Centralized nuclei are characteristics of regenerating myofibers. Scale bar, 
100 µm and 10 µm at higher magnification. d The ratio between the mass of the injured and 
uninjured TA and EDL muscles was calculated after 1x Ctx or 2x Ctx (n = 3-4). A ratio of 1 
implies successful restoration of the injured muscle 15 days after the induction of muscle 
damage. e Immunostaining against laminin (green) on cross-sections of regenerating TA 
muscle following two Ctx-injuries. Scale bar, 100 µm and 50 µm at higher magnification. f – 
g The fiber size distribution (f) and total number of myofibers (g) was quantified in 2x Ctx 
TA muscle (n =3). h Immunostaining against Pax7 (red) and laminin (green) on regenerating 
TA and EDL muscle following 2x Ctx. Scale bar, 100 µm and 20 µm at higher magnification. 
i Quantification of the number of Pax7+ cells normalized to 100 myofibers fibers in the 
uninjured, 1x Ctx and 2x Ctx TA and EDL muscles (n = 3-7). 
Data represent mean ± SEM. * p > 0.05, Student’s t test. 
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Figure 4. mTORC2 signaling is dispensable for satellite cell quiescence and 
differentiation 
a Quantification of the number of interstitial Pax7+ cells normalized to 100 myofibers in the 
TA and EDL muscles of 5 month-old, male mice (n = 4-5). b Immunostaining against Pax7 
on freshly isolated myofibers from the EDL muscle of 5 month-old mice. Scale bar, 20 µm. 
Quantification of the number of Pax7+ cells associated on freshly isolated myofibers (t0) 
from the EDL muscle of 5 month-old male Ctrl and RImyfKO mice (n = 3-8, 10-30 myofibers 
per animal). c – d Single EDL myofibers were isolated from 5 month-old Ctrl and RImyfKO 
female mice and their associated satellite cells analyzed directly after isolation (t0) or after 
24, 48 or 72 h in culture (t24h, t48h, t72h). c The number of Pax7- and / or MyoD-positive 
cells was quantified and normalized to the total number of myogenic cells on single isolated 
myofibers at t0, t24h, t48h and t72h (n = 3, 10-30 myofibers per animal). d The total number 
of myogenic cells per myofiber was counted at t24h, t48h and t72h and normalized to t0 
(n = 3, 10-30 myofibers per animal). 
Data represent mean ± SEM. * p > 0.05, Student’s t test. 
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Figure 5. The satellite cell pool decreases with age in the absence of mTORC2 
a Immunostaining against Pax7 (red) and laminin (green) on TA and EDL muscle cross-
sections from 14 month-old, female Ctrl and RImyfKO mice. The number of Pax7+ cells 
underneath the basal lamina was counted and normalized to 100 myofibers (n = 3-5). Scale 
bar, 100 µm and 20 µm at higher magnification. b – h Ctx was injected into TA and EDL 
muscles of 14 month-old, male Ctrl and RImyfKO mice. Muscle analysis was performed 15 
days post-injury (1x Ctx). Contralateral muscles were not injured. b H&E coloration on TA 
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muscle cross-sections from 14 month-old Ctrl and RImyfKO mice 15 days after one Ctx-
injury. Centralized nuclei are a characteristic of regenerating myofibers. Arrowheads point 
to adipocytes generated in regenerating RImyfKO muscle. Scale bar, 100 µm and 50 µm at 
higher magnification. c The mass ratio between injured and uninjured TA and EDL muscles 
was calculated after 15 days of recovery (n = 5). d Immunostaining against laminin (red) on 
cross-sections of regenerating TA muscles following 1x Ctx. Scale bar, 100 µm and 50 µm 
at higher magnification. e The fiber size distribution was quantified in TA muscle 15 days 
after Ctx-injury (n = 3). f Picrosirius Red coloration (upper panel) on regenerating TA muscle 
stains collagens in the extracellular matrix between myofibers of Ctrl and RImyfKO mice. 
Oil red O staining (lower panel) visualizes lipid droplets in the regenerating muscle of 
RImyfKO mice. Scale bar, 100 µm and 50 µm at higher magnification. g Quantification of 
the adipocyte area normalized to the total muscle area after 1x Ctx (n = 5). h Quantification 
of the number of Pax7+ cells normalized to 100 myofibers in Ctx-injured TA and EDL 
muscles after 15 days recovery (n = 5). 
Data represent mean ± SEM. * p > 0.05, ** p > 0.01, Student’s t test. 
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7. Discussion 
The mTOR signaling pathway functions as a central hub controlling homeostasis and 
growth of adult skeletal muscle. Before my thesis, several reports pointed to an important 
role of the signaling in muscle fiber formation during embryogenesis and muscle 
regeneration. Because most of these studies were conducted in vitro and / or using 
pharmacological inhibitors, in-depth analysis of the role of mTOR signaling in vivo needed 
to be done to sort-out the different views. Therefore, we generated conditional knockout 
mice depleted for raptor or rictor under the control of the Myf5 promoter, in order to 
inactivate mTORC1 or mTORC2, respectively, in muscle progenitors and precursors 
(RAmyfKO and RImyfKO). Additionally, we generated a tamoxifen-inducible mouse model 
deficient for raptor in Pax7-expressing cells, resulting in the loss of mTORC1 in muscle stem 
cells (RAscKO). My PhD work provides strong evidence that loss of mTORC1, but not 
mTORC2, in muscle progenitors impairs, but does not abolish, embryonic and adult 
myogenesis. Furthermore, I established that mTORC2 signaling regulates the maintenance 
of the satellite cell pool. 
 
7.1 Inactivation of mTORC1, but not mTORC2, in developing muscle 
affects viability of mice 
RAmyfKO embryos died perinatally due to respiratory failure, while RImyfKO mice were 
viable and were born at the expected Mendelian ratio. Interestingly, both mouse models 
exhibited reduced body weight compared to their wild-type littermates. The skeleton, in 
particular the long bones of hindlimbs and forelegs, of RAmyfKO embryos was unchanged 
in size, indicating that whole-body growth was normal in the absence of mTORC1 in 
developing muscle. Muscle mass in RAmyfKO embryos was reduced, which most likely 
contributed to the decrease in the overall body weight. In contrast, RImyfKO mice appeared 
smaller in size, although whole-body growth of mutant mice was not analyzed in further 
details. As RImKO mice, depleted for rictor in adult muscle tissue, did not show growth 
retardation (Bentzinger et al., 2008), I concluded that loss of mTORC2 in developing, but 
not mature, muscle affects body size. Fetal growth is controlled by the family of insulin-like 
growth factors (IGFs), including IGF-I and IGF-II. Interestingly, Igf-1-/- and Igf-2-/- mice exhibit 
a growth deficiency of about 60 % compared to wild-type mice (DeChiara et al., 1990; Liu 
et al., 1993), confirming their specific role in fetal growth. IGF-II is abundant during fetal 
development, while its serum concentrations drop in the first days after birth (Agrogiannis 
et al., 2014). Inversely, IGF-I concentrations increase during postnatal development, 
primarily produced by the liver. Notably, in mouse embryonic fibroblasts (MEFs), IGF-II 
translation is controlled by mTORC2, via the phosphorylation of the Igf2 mRNA-binding 
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protein 1 (IMP1) at the Serine 181 (Dai et al., 2013). Binding of phosphorylated IMP1 to the 
Igf2 untranslated region leads to ribosomal entry and subsequent Igf2 translation. In light of 
this, in depth characterization of circulating and muscle-specific IGFs, in particular of IGF-II, 
in RImyfKO embryos and adult mice will give further insights on the mechanisms linking 
mTORC2 deficiency in developing muscle to altered growth.  
 
Surprisingly, skeleton analyses revealed that the thoracic cage of RAmyfKO 
embryos is smaller compared to littermate heterozygous and control embryos. Previously, 
it was demonstrated that mice lacking Myf5 show severe rib defects, causing death of the 
mutant mice immediately after birth (Braun et al., 1992). Similarly, ablation of Myf5-
expressing cells, achieved by the insertion of a DTA transgene in the Myf5 locus, caused 
malformations of the ribs and vertebrae (Gensch et al., 2008). Thus, one can hypothesize 
that altered development of the myotome, as observed upon mTORC1 inactivation in Myf5-
expressing cells, may affect the adjacent sclerotome forming the rib cage. However, it was 
suggested that the rib phenotype in Myf5-mutant mice is independent from the formation of 
the myotome, and rather depends on cis effects on a yet unknown gene (Kaul et al., 2000). 
Moreover, it was demonstrated that, at the thoracic level, Hox genes regulate Myf5 and 
Mrf4 myotomal expression, promoting rib specification through FGF and platelet-derived 
growth factor (PDGF) signaling, although the exact regulatory mechanisms are not yet 
known (Vinagre et al., 2010). Lastly, it is unlikely that 50 % reduction of Myf5, resulting from 
the knock-in of the Cre cDNA into one allele, affected rib cage development in RAmyfKO 
embryos, since Het-RAmyfKO embryos, which also have the Cre transgene integrated at 
the Myf5 locus, did not show a rib phenotype. These observations highlight the importance 
of considering the formation of surrounding tissue in the study of muscle development, as 
the generation of embryonic muscle structures tightly depends on cell-cell interactions and 
secreted factors. 
 
7.2 mTORC1 is crucial for the myogenic function of embryonic and adult 
muscle progenitors 
Proliferation, differentiation and fusion of myoblasts is restricted in the absence of 
mTORC1 signaling 
Myogenesis corresponds to the process leading to the formation of muscle fibers that 
occurs during embryonic muscle development and during muscle regeneration at the adult 
age. Interestingly, RAmyfKO, but not RImyfKO, embryos exhibited strongly reduced skeletal 
muscle mass relative to their whole-body size, suggesting that mTORC1, but not mTORC2 
signaling is crucial for embryonic muscle development. Nevertheless, in RAmyfKO 
embryos, all muscles were formed and they normally expressed myogenic regulatory 
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factors at E18.5. Furthermore, a proportion of myofibers in RAmyfKO muscle expressed 
EGFP, indicative of mTORC1 inactivation, hence providing evidence that myofiber 
formation still occurred in the absence of mTORC1. These observations indicated that 
mTORC1 is not absolutely required for the myogenic process, but that inactivation of the 
signaling severely impacts on the myogenic efficiency and consequently the viability of the 
mice.  
 
The myogenic process consists of major, sequential steps including the commitment 
of muscle progenitors, their proliferation, differentiation and subsequent fusion into multi-
nucleated myotubes. Embryonic and adult muscle progenitors from RAmyfKO and RAscKO 
mice, respectively, showed severe defects in proliferation and a reduced efficiency to 
differentiate and fuse (Figure 4). Notwithstanding, no increase in programmed cell death 
was observed in mTORC1-deficient muscle progenitors and precursors. Consistent with our 
findings, mTORC1 has been previously implicated in proliferation of other cell types, such 
as β-cells of the pancreas and MEF cells (Blandino-Rosano et al., 2017; Dowling et al., 
2010). Interestingly, it was proposed that mTORC1 controls proliferation through 4E-BP, 
while cell growth regulation is mediated by the S6K1 branch (Dowling et al., 2010; Ohanna 
et al., 2005). In parallel, I demonstrated that RImyfKO precursors efficiently proliferated in 
vitro and in vivo, indicating that mTORC2 signaling does not play a determinant role in 
muscle cell proliferation (Figure 4). Similarly, the differentiation and fusion capacity of 
muscle precursors was normal in the absence of mTORC2 in tissue culture and during 
muscle regeneration in vivo. These results contrasted with previous reports suggesting that 
differentiation of myoblasts is controlled by both mTORC1 and mTORC2 pathways, 
although contradictory results were obtained from the different studies. Inhibition of 
mTORC1 by the application of rapamycin blocked myogenic differentiation and fusion of rat 
and mouse myoblasts (Conejo et al., 2001; Coolican et al., 1997; Cuenda and Cohen, 
1999). Inversely, shRNA-mediated knockdown of Rptor, leading to inhibition of mTORC1, 
in C2C12 myoblasts resulted in increased differentiation due to the release of feedback 
inhibition of S6K1 on IRS1, hence leading to further activation of the PI3K / Akt pathway 
(Ge et al., 2011). Similarly, it was reported that inhibition of mTORC2, achieved by shRNA-
mediated silencing of Rictor, in C2C12 myoblasts prevented myotube formation in an Akt 
and ROCK1-dependent way, suggesting a potent role of mTORC2 in myoblast 
differentiation (Shu and Houghton, 2009). Recently, mTORC2 has also been implicated in 
C2C12 differentiation by phosphorylating SGK1 (at the Serine 422) (Chen et al., 2017). 
Hence, while previous studies, performed in vitro or using pharmacological inhibition of the 
signaling, have highlighted potential functions of mTORC1 and mTORC2 in the myogenic 
process, I provided strong evidence by using genetic approaches that mTORC1, but not 
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mTORC2, is required for the myogenic function of muscle cells, and thereby for the 
development of muscle tissue during embryogenesis.  
 
 
 
 
Figure 4. mTORC1, but not mTORC2, controls proliferation and differentiation of myoblasts during 
embryonic and adult myogenesis. mTORC2 signaling is crucial for the maintenance of quiescent 
satellite cells. 
 
 
Does mTORC1 control proliferation and differentiation of myoblasts by affecting 
protein synthesis? 
One potential mechanism of how mTORC1 controls proliferation is via its downstream 
substrates S6K1 and 4E-BP1, which regulate translation initiation (Brunn et al., 1997; 
Gingras et al., 1999; Holz et al., 2005). I confirmed that raptor-depleted myoblasts exhibited 
reduced rates of protein synthesis, which may likely be the limiting factor for their 
proliferation and differentiation in the absence of mTORC1. Surprisingly, in Het-RAmyfKO 
myoblasts, which express only 50 % of the raptor levels, mTORC1 downstream signaling, 
i.e. phosphorylation of the 40S ribosomal S6 protein (S6) and of 4E-BP1, was not 
significantly altered. Consequently, the rates of protein synthesis of Het-RAmyfKO 
myoblasts was comparable to control, suggesting that 50 % raptor protein is sufficient to 
maintain mTORC1 signaling and to efficiently drive translation initiation. Similarly, 
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haploinsufficiency of eIF4E is still compatible with normal mouse development and general 
induction of protein synthesis (Truitt et al., 2015). Therefore, it seems that regulators of 
protein synthesis are abundant in excess, although the dose requirements and the 
translational landscape of genome-wide mRNAs during embryonic muscle development 
need further investigation. Additionally, it would be interesting to analyze through which 
downstream substrate mTORC1 controls protein synthesis and the myogenic process. 
Thus, the use of specific pharmacological inhibitors or shRNAs targeting S6K1 or 4E-BP1 
in satellite cells may unravel through which branch mTORC1 controls the different steps in 
myogenesis.  
 
mTORC1, but not mTORC2, is necessary for myofiber restoration following muscle 
injury 
Myofiber formation, as a result of the myogenic process, is recapitulated during muscle 
regeneration of the adult tissue upon damage, and is thus considered as adult myogenesis. 
Young RImyfKO mice were capable to restore myofibers following one or two subsequent 
muscle injuries, indicating that mTORC2-deficient satellite cells efficiently proliferate, 
differentiate and fuse to generate new myofibers. In contrast, regenerating RAscKO muscle, 
depleted for raptor in satellite cells, failed to restore myofibers after one cardiotoxin-injury 
and only few, small embryonic MHC-positive myofibers were formed in the mutant muscle. 
Thus, similar to embryonic muscle development, adult myogenesis is severely impaired in 
RAscKO, but not in RImyfKO mice, indicating that mTORC1, but not mTORC2 signaling is 
required for the myogenic function of satellite cells following muscle injury. Consistently, in 
vivo application of rapamycin, inhibiting mTORC1 signaling, impaired the regenerative 
capacity of skeletal muscle (Ge et al., 2009; Miyabara et al., 2010): rapamycin delayed 
myofiber restoration but also limited the extend of myofiber cross-sectional area recovery 
one month after injury-induced muscle degeneration (Ge et al., 2009). Nevertheless, the 
regenerative failure in RAscKO muscle was more prominent compared to regenerating 
muscles treated with rapamycin, consistent with the idea that genetic inactivation of 
mTORC1 in satellite cells provokes a stronger phenotype than pharmacological inhibition 
of the signaling, which does not specifically target satellite cells in the muscle tissue. 
Remarkably, fat and fibrotic tissue accumulated in regenerating RAscKO muscle, indicating 
that FAPs differentiated into fibroblasts and adipocytes upon the regenerative failure of 
mTORC1-deficient satellite cells. FAPs are the source of fibrosis and adipogenesis in 
dystrophic muscles undergoing chronic degeneration / regeneration, e.g. in Duchenne 
muscular dystrophy, which further limits the potential of the remaining satellite cells in the 
regenerative process (Cordani et al., 2014; Mozzetta et al., 2013). One can hypothesize 
that FAP differentiation in regenerating RAscKO muscle contributed to the abrogation of the 
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myogenic capacity of raptor-depleted satellite cells. It would be, therefore, of interest to 
study the role of mTORC1 signaling for the interaction and communication of satellite cells 
with other cells, in particular FAPs, residing in the stem cell niche. To this purpose, co-
culture of raptor-depleted satellite cells in the presence of non-targeted FAPs may give 
further insights on whether FAPs further limit their myogenic capacity, including 
proliferation, differentiation and fusion. Additionally, satellite cells cultured with conditioned 
medium from FAP cells may unravel whether the interaction is driven by direct cell-cell 
contact or secreted factors. Lastly, since cardiotoxin-induced muscle injury induces 
complete necrosis of myofibers, it will be interesting to study the myogenic capacity of 
mTORC1-deficient satellite cells in more physiological conditions as in muscular dystrophy 
(by breeding RAscKO mice with mdx mice, a mouse model for Duchenne muscular 
dystrophy), or upon acute exercise-induced muscle damages (by submitting RAscKO mice 
to downhill treadmill exercise). This may give further insights into the regenerative capacity 
of mTORC1-deficient satellite cells, activated by sporadically damaged myofibers, in the 
presence of an intact stem cell niche.  
 
7.3 The controlled transition between quiescence and activation of 
satellite cells requires both mTORC1 and mTORC2 
Quiescent satellite cells reside in their niche tightly associated to myofibers underneath the 
basal lamina. Satellite cell quiescence is regulated by cell intrinsic signaling pathways, but 
it is also controlled by external stimuli in the close environment of the satellite cell, called 
the niche. Whether satellite cell quiescence and the maintenance of the pool are regulated 
by mTORC1 or mTORC2 signaling has not yet been investigated. During my PhD work, I 
unraveled that RImyfKO muscle lose satellite cells following repeated injuries and during 
physiological aging, indicating that mTORC2 contributes to the maintenance and 
homeostasis of satellite cells (Figure 4). Results obtained so far in RAscKO mice indicated 
that the satellite cell pool is maintained in mutant muscle three months after mTORC1 
inactivation, which suggests that mTORC1 signaling is dispensable for satellite cell 
quiescence. However, to confirm this hypothesis, the analysis of the stem cell pool in 
RAscKO muscle at later time points, e.g. one year after tamoxifen-induced mTORC1 
inactivation in satellite cells, is required.  
 
The decline of the stem cell pool in RImyfKO muscle was not caused by an 
impairment in satellite cell self-renewal, as verified with single isolated muscle fibers. 
Notably, I observed that already at young age, fewer Pax7-positive cells remained 
associated to freshly isolated RImyfKO myofibers. Concomitantly, an increased proportion 
of satellite cells failed to maintain their typical anatomical localization underneath the basal 
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lamina, and relocated to the interstitial space in RImyfKO muscle. In light of these 
observations, it could be that loss of mTORC2 in satellite cells affects their interaction and 
adhesion to the niche. Previously, it was demonstrated that deregulation of Notch 
components in satellite cells causes instable adhesive interactions between the satellite cell 
and the myofiber, resulting in an interstitial localization of the stem cell and in the loss of its 
quiescent features (Brohl et al., 2012). Similarly, satellite cells deficient for syndecan-3, a 
transmembrane heparan sulfate proteoglycan acting as a co-receptor for Notch signaling, 
were prone to migrate away from their niche and showed defective ability to replenish the 
pool following injury-induced muscle regeneration (Pisconti et al., 2016; Pisconti et al., 
2010). Interestingly, syndecan-3 depletion in satellite cells still allowed efficient fiber 
restoration in conditions of chronic degeneration and regeneration due to an enlarged 
number of activated stem cells remaining in the interstitial space (Pisconti et al., 2016). In 
line with this, it will be interesting to investigate whether the loss of mTORC2 in satellite 
cells affects their interaction with their niche. To do so, satellite cell homing should be 
analyzed in RImyfKO embryos during late fetal development, paying special attention to 
adhesion molecules, such as M-cadherin, Mcam, Megf10 and integrin α4β1 (Brohl et al., 
2012). In adult RImyfKO mice, it will also be interesting to analyze the activation state of 
satellite cells, especially those located in the interstitial space, in uninjured muscle, to 
confirm that they prematurely lose their quiescent properties upon migration. Lastly, the 
satellite cell niche is also involved in the homeostasis of the stem cell pool by controlling 
the occurrence of asymmetric and symmetric cell divisions, the latter mainly ensuring the 
maintenance of cells with stemness characteristics (Le Grand et al., 2009). Symmetric cell 
division is controlled by the non-canonical Wnt pathway, which induces the cytoplasmic 
scaffolding protein Dishevelled to activate Rac/JNK and Rho/ROCK pathways, 
subsequently leading to cytoskeletal remodeling and changes in gene expression (Dumont 
et al., 2015). In light of the role of mTORC2 in cytoskeleton organization (Jacinto et al., 
2004; Sarbassov et al., 2004), it will be relevant to study whether deregulation of mTORC2 
affects cytoskeleton organization in satellite cells, which could impact on symmetric cell 
division and the replenishment of the stem cell pool. To distinguish between a satellite cell-
autonomous effect and changes upon mTORC2-deficiency in myofibers, the phenotype of 
RImyfKO mice, depleted for rictor in satellite cells and myofibers, and RImKO mice, in which 
only myofibers are targeted for mTORC2 inactivation, should be compared. Overall, my 
results pave the way for additional experiments, which may unravel the mechanisms 
underlying the function of mTORC2 in satellite cell maintenance. 
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Loss of mTORC1 in adult muscle progenitors delays their activation 
Quiescent satellite cells quickly respond to external stimuli and enter activation by boosting 
their metabolism and changing gene expression. In particular, upon activation, satellite cells 
induce translation of sequestered Myf5 mRNA and promote MyoD transcription, both 
processes being hallmarks of an activated state (Crist et al., 2012). In my PhD work, I 
determined that RImyfKO satellite cells showed no impairments in the transition from 
quiescence to activation upon stimulation / injury, thus confirming that mTORC2 is 
dispensable for their myogenic function. Inversely, MyoD expression in RAscKO satellite 
cells was delayed upon external, activating stimuli. Nevertheless, RAscKO satellite cells still 
entered the myogenic program at later time points, suggesting that mTORC1 signaling is 
important, but not absolutely required, for satellite cell activation. Consistently, it was 
demonstrated that mTORC1 activity is low in quiescent satellite cells, but that the signaling 
is induced in the GAlert and activated states (Rodgers et al., 2014). Interestingly, Rodgers et 
al. showed that upon a systemic injury, satellite cells enter the GAlert state, mainly 
characterized by a faster cell cycle entry and an increase in energy levels (Rodgers et al., 
2014). As it was claimed that the GAlert state is dependent on mTORC1, the analysis of the 
uninjured, contralateral muscle in regenerating RAscKO mice will be of particular interest, 
to confirm or invalidate this hypothesis, and to get further insights on the characteristics of 
the GAlert state. In particular, the mechanisms linking mTORC1 to satellite cell activation are 
not yet known. As I observed that mTORC1-deficient myoblasts exhibit reduced rates of 
protein synthesis in culture, delayed expression of determination factors, such as MyoD, 
during satellite cell activation, may be caused by limited translation initiation in the absence 
of mTORC1. Previously, it was described that a general boost in mRNA translation, 
controlled by eIF2α dephosphorylation, accompanies satellite cell activation (Zismanov et 
al., 2016). In light of these results, the function of mTORC1 in promoting protein synthesis 
may underlie the decisive role of the signaling in the control of the transition between 
quiescence and activation of satellite cells. Hence, in the long-term, analysis of the proteins, 
which are specifically translated under the control of mTORC1 during the different phases 
of the myogenic process, will be of interest.  
 
Does deregulation of mTOR signaling drive quiescent satellite cells to enter 
senescence? 
During aging, satellite cells undergo geroconversion, which corresponds to the transition 
from quiescence into senescence, a process that has been related to impaired autophagy, 
increased mitochondrial dysfunction and oxidative stress (Garcia-Prat et al., 2016; Sousa-
Victor et al., 2014). Interestingly, in skeletal muscle of RAmKO mice autophagy is constantly 
induced and the flux with subsequent degradation steps are reduced (Castets et al., 2013). 
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Concomitantly, protein synthesis is expected to be decreased in RAmKO muscle, hence 
resulting in imbalanced proteostasis. Since proteostasis seems to play a role in satellite cell 
maintenance, by controlling geroconversion, I hypothesized that the loss of mTORC1 and 
consequently the perturbed proteostasis in satellite cells may affect their quiescent state 
and their transition to senescence. In line with this hypothesis, mTORC1-deficient satellite 
cells showed an impaired myogenic potential during muscle regeneration. Therefore, it will 
be important, as mentioned above, to study the long-term effects of mTORC1 inactivation 
in satellite cells by analyzing mutant mice one year after tamoxifen treatment. At the same 
time, analysis of senescent markers, such as p21, p16INK4a and pH2AX, may unravel 
premature, or alternatively delayed, geroconversion of RAscKO satellite cells. On the other 
hand, mTORC2 has not been linked to autophagy dysfunction or cellular senescence, but 
considering the decline of the satellite cell pool in aged RImyfKO muscle, it could be that 
inactivation of mTORC2 prematurely converts satellite cells into a senescent state by cell 
intrinsic or extrinsic changes. As for RAscKO cells, it will be of particular interest to analyze 
senescence markers in satellite cells from RImyfKO mice at different ages, to identify 
potential anticipated geroconversion, in the absence of mTORC2. In the future, single cell 
RNA sequencing and proteomic studies on isolated, quiescent satellite cells from RAscKO 
and RImyfKO muscles should also give further insights on the consequences of mTOR 
deregulation in the maintenance of satellite cell quiescence.  
 
7.4 Concluding remarks 
My PhD thesis establishes that mTORC1 signaling is predominantly active in proliferating 
muscle progenitors and precursors, while decreasing upon differentiation and fusion of 
myocytes during the embryonic wave of myogenesis. In line with this, I demonstrated that 
mTORC1, but not mTORC2, is crucial for proliferation, differentiation and fusion of muscle 
cells in vitro and in vivo. Consequently, mice deficient for mTORC1 in developing muscle 
die perinatally, while mTORC2 inactivation in muscle progenitors does not affect survival of 
the mice. The limited capacity of mTORC1-deficient myoblasts to enter the myogenic 
process may be caused by the reduced rates of protein synthesis. Similarly, mTORC1 is 
crucial for the activation of adult muscle progenitors, and essential for the regeneration of 
the adult muscle tissue. Although mTORC2 is dispensable for the myogenic function of 
myoblasts, I unraveled that the signaling is necessary for the maintenance of the satellite 
cell pool after repeated injuries and during aging. 
 
In light of my observations, it will be of major importance to further understand the 
distinct roles and to identify the molecular functions of mTORC1 and mTORC2 signaling in 
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the myogenic process, since mTOR signaling is often deregulated in pathological 
conditions. Chronic muscle degeneration is a major hallmark of dystrophic muscle, such as 
in Duchenne muscular dystrophy or in merosin-deficient congenital muscular dystrophy, in 
which the limited regenerative capacity of the diseased muscle ultimately leads to the 
deterioration of the tissue. Therefore, understanding the mechanisms involved in muscle 
regeneration, and controlling the maintenance and renewal of satellite cells, is crucial to 
limit muscle alterations and improve muscle homeostasis in pathological context. 
Furthermore, myogenesis not only occurs during development and regeneration of the 
tissue, but is also involved in the spontaneous activation, differentiation and fusion of 
satellite cells to myofibers naturally occurring over time. Even though it has been suggested 
that the decline in satellite cell content is not the main driver of sarcopenia, analysis of the 
mechanisms controlling the balance between quiescence, activation and senescence, is 
essential to understand the exact relationship between age-dependent muscle dysfunction 
and satellite cell decline, and thereby to identify potential strategies to limit alterations of 
skeletal muscle with age. 
  References 
Page | 126 
 
8. References 
Agrogiannis, G.D., S. Sifakis, E.S. Patsouris, and A.E. Konstantinidou. 2014. Insulin-like growth 
factors in embryonic and fetal growth and skeletal development (Review). Mol Med Rep. 
10:579-584. 
Alessi, D.R., S.R. James, C.P. Downes, A.B. Holmes, P.R. Gaffney, C.B. Reese, and P. Cohen. 
1997. Characterization of a 3-phosphoinositide-dependent protein kinase which 
phosphorylates and activates protein kinase Balpha. Curr Biol. 7:261-269. 
Ben-Yair, R., and C. Kalcheim. 2005. Lineage analysis of the avian dermomyotome sheet reveals 
the existence of single cells with both dermal and muscle progenitor fates. Development. 
132:689-701. 
Bentzinger, C.F., K. Romanino, D. Cloetta, S. Lin, J.B. Mascarenhas, F. Oliveri, J. Xia, E. Casanova, 
C.F. Costa, M. Brink, F. Zorzato, M.N. Hall, and M.A. Ruegg. 2008. Skeletal muscle-specific 
ablation of raptor, but not of rictor, causes metabolic changes and results in muscle 
dystrophy. Cell Metab. 8:411-424. 
Bentzinger, C.F., Y.X. Wang, and M.A. Rudnicki. 2012. Building muscle: molecular regulation of 
myogenesis. Cold Spring Harb Perspect Biol. 4. 
Bernet, J.D., J.D. Doles, J.K. Hall, K. Kelly Tanaka, T.A. Carter, and B.B. Olwin. 2014. p38 MAPK 
signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of 
aged mice. Nat Med. 20:265-271. 
Biressi, S., M. Molinaro, and G. Cossu. 2007. Cellular heterogeneity during vertebrate skeletal 
muscle development. Dev Biol. 308:281-293. 
Bjornson, C.R., T.H. Cheung, L. Liu, P.V. Tripathi, K.M. Steeper, and T.A. Rando. 2012. Notch 
signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells. 
30:232-242. 
Blandino-Rosano, M., R. Barbaresso, M. Jimenez-Palomares, N. Bozadjieva, J.P. Werneck-de-
Castro, M. Hatanaka, R.G. Mirmira, N. Sonenberg, M. Liu, M.A. Ruegg, M.N. Hall, and E. 
Bernal-Mizrachi. 2017. Loss of mTORC1 signalling impairs beta-cell homeostasis and insulin 
processing. Nat Commun. 8:16014. 
Bodine, S.C., T.N. Stitt, M. Gonzalez, W.O. Kline, G.L. Stover, R. Bauerlein, E. Zlotchenko, A. 
Scrimgeour, J.C. Lawrence, D.J. Glass, and G.D. Yancopoulos. 2001. Akt/mTOR pathway 
is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. 
Nat Cell Biol. 3:1014-1019. 
Brack, A.S., and P. Munoz-Canoves. 2016. The ins and outs of muscle stem cell aging. Skelet 
Muscle. 6:1. 
Braun, T., E. Bober, B. Winter, N. Rosenthal, and H.H. Arnold. 1990. Myf-6, a new member of the 
human gene family of myogenic determination factors: evidence for a gene cluster on 
chromosome 12. Embo J. 9:821-831. 
Braun, T., G. Buschhausen-Denker, E. Bober, E. Tannich, and H.H. Arnold. 1989. A novel human 
muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 
fibroblasts. Embo J. 8:701-709. 
Braun, T., M.A. Rudnicki, H.H. Arnold, and R. Jaenisch. 1992. Targeted inactivation of the muscle 
regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell. 71:369-
382. 
Brohl, D., E. Vasyutina, M.T. Czajkowski, J. Griger, C. Rassek, H.P. Rahn, B. Purfurst, H. Wende, 
and C. Birchmeier. 2012. Colonization of the satellite cell niche by skeletal muscle progenitor 
cells depends on Notch signals. Dev Cell. 23:469-481. 
Brown, E.J., M.W. Albers, T.B. Shin, K. Ichikawa, C.T. Keith, W.S. Lane, and S.L. Schreiber. 1994. 
A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 
369:756-758. 
Brunn, G.J., C.C. Hudson, A. Sekulic, J.M. Williams, H. Hosoi, P.J. Houghton, J.C. Lawrence, Jr., 
and R.T. Abraham. 1997. Phosphorylation of the translational repressor PHAS-I by the 
mammalian target of rapamycin. Science. 277:99-101. 
Buckingham, M., L. Bajard, T. Chang, P. Daubas, J. Hadchouel, S. Meilhac, D. Montarras, D. 
Rocancourt, and F. Relaix. 2003. The formation of skeletal muscle: from somite to limb. J 
Anat. 202:59-68. 
Buckingham, M., and F. Relaix. 2007. The role of Pax genes in the development of tissues and 
organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu Rev Cell Dev Biol. 
23:645-673. 
Cafferkey, R., P.R. Young, M.M. McLaughlin, D.J. Bergsma, Y. Koltin, G.M. Sathe, L. Faucette, W.K. 
Eng, R.K. Johnson, and G.P. Livi. 1993. Dominant missense mutations in a novel yeast 
  References 
Page | 127 
 
protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin 
cytotoxicity. Mol Cell Biol. 13:6012-6023. 
Castets, P., S. Lin, N. Rion, S. Di Fulvio, K. Romanino, M. Guridi, S. Frank, L.A. Tintignac, M. 
Sinnreich, and M.A. Ruegg. 2013. Sustained activation of mTORC1 in skeletal muscle 
inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset 
myopathy. Cell Metab. 17:731-744. 
Chakkalakal, J.V., K.M. Jones, M.A. Basson, and A.S. Brack. 2012. The aged niche disrupts muscle 
stem cell quiescence. Nature. 490:355-360. 
Chal, J., and O. Pourquie. 2017. Making muscle: skeletal myogenesis in vivo and in vitro. 
Development. 144:2104-2122. 
Charge, S.B., and M.A. Rudnicki. 2004. Cellular and molecular regulation of muscle regeneration. 
Physiol Rev. 84:209-238. 
Chen, S.E., B. Jin, and Y.P. Li. 2007. TNF-alpha regulates myogenesis and muscle regeneration by 
activating p38 MAPK. Am J Physiol Cell Physiol. 292:C1660-1671. 
Chen, W.Y., C.L. Lin, J.H. Chuang, F.Y. Chiu, Y.Y. Sun, M.C. Liang, and Y. Lin. 2017. 
Heterogeneous nuclear ribonucleoprotein M associates with mTORC2 and regulates muscle 
differentiation. Sci Rep. 7:41159. 
Cheung, T.H., N.L. Quach, G.W. Charville, L. Liu, L. Park, A. Edalati, B. Yoo, P. Hoang, and T.A. 
Rando. 2012. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature. 
482:524-528. 
Cheung, T.H., and T.A. Rando. 2013. Molecular regulation of stem cell quiescence. Nat Rev Mol Cell 
Biol. 14:329-340. 
Comai, G., R. Sambasivan, S. Gopalakrishnan, and S. Tajbakhsh. 2014. Variations in the Efficiency 
of Lineage Marking and Ablation Confound Distinctions between Myogenic Cell Populations. 
Dev Cell. 31:654-667. 
Comai, G., and S. Tajbakhsh. 2014. Molecular and cellular regulation of skeletal myogenesis. Curr 
Top Dev Biol. 110:1-73. 
Conejo, R., A.M. Valverde, M. Benito, and M. Lorenzo. 2001. Insulin produces myogenesis in C2C12 
myoblasts by induction of NF-kappaB and downregulation of AP-1 activities. J Cell Physiol. 
186:82-94. 
Conerly, M.L., Z. Yao, J.W. Zhong, M. Groudine, and S.J. Tapscott. 2016. Distinct Activities of Myf5 
and MyoD Indicate Separate Roles in Skeletal Muscle Lineage Specification and 
Differentiation. Dev Cell. 36:375-385. 
Coolican, S.A., D.S. Samuel, D.Z. Ewton, F.J. McWade, and J.R. Florini. 1997. The mitogenic and 
myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol 
Chem. 272:6653-6662. 
Cordani, N., V. Pisa, L. Pozzi, C. Sciorati, and E. Clementi. 2014. Nitric oxide controls fat deposition 
in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem 
Cells. 32:874-885. 
Cornelison, D.D., B.B. Olwin, M.A. Rudnicki, and B.J. Wold. 2000. MyoD(-/-) satellite cells in single-
fiber culture are differentiation defective and MRF4 deficient. Dev Biol. 224:122-137. 
Crist, C.G., D. Montarras, and M. Buckingham. 2012. Muscle satellite cells are primed for 
myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by 
microRNA-31 in mRNP granules. Cell Stem Cell. 11:118-126. 
Cuenda, A., and P. Cohen. 1999. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive 
pathway are required for C2C12 myogenesis. J Biol Chem. 274:4341-4346. 
Dai, N., J. Christiansen, F.C. Nielsen, and J. Avruch. 2013. mTOR complex 2 phosphorylates IMP1 
cotranslationally to promote IGF2 production and the proliferation of mouse embryonic 
fibroblasts. Genes Dev. 27:301-312. 
DeChiara, T.M., A. Efstratiadis, and E.J. Robertson. 1990. A growth-deficiency phenotype in 
heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. 
Nature. 345:78-80. 
Deries, M., and S. Thorsteinsdottir. 2016. Axial and limb muscle development: dialogue with the 
neighbourhood. Cell Mol Life Sci. 73:4415-4431. 
Dorrello, N.V., A. Peschiaroli, D. Guardavaccaro, N.H. Colburn, N.E. Sherman, and M. Pagano. 
2006. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation 
and cell growth. Science. 314:467-471. 
Dowling, R.J., I. Topisirovic, T. Alain, M. Bidinosti, B.D. Fonseca, E. Petroulakis, X. Wang, O. 
Larsson, A. Selvaraj, Y. Liu, S.C. Kozma, G. Thomas, and N. Sonenberg. 2010. mTORC1-
mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science. 328:1172-
1176. 
  References 
Page | 128 
 
Duchesne, E., M.H. Tremblay, and C.H. Cote. 2011. Mast cell tryptase stimulates myoblast 
proliferation; a mechanism relying on protease-activated receptor-2 and cyclooxygenase-2. 
BMC Musculoskelet Disord. 12:235. 
Dumont, N.A., C.F. Bentzinger, M.C. Sincennes, and M.A. Rudnicki. 2015. Satellite Cells and 
Skeletal Muscle Regeneration. Compr Physiol. 5:1027-1059. 
Duvel, K., J.L. Yecies, S. Menon, P. Raman, A.I. Lipovsky, A.L. Souza, E. Triantafellow, Q.C. Ma, R. 
Gorski, S. Cleaver, M.G.V. Heiden, J.P. MacKeigan, P.M. Finan, C.B. Clish, L.O. Murphy, 
and B.D. Manning. 2010. Activation of a Metabolic Gene Regulatory Network Downstream 
of mTOR Complex 1. Mol Cell. 39:171-183. 
Edmondson, D.G., and E.N. Olson. 1989. A gene with homology to the myc similarity region of 
MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation 
program. Genes Dev. 3:628-640. 
Esner, M., S.M. Meilhac, F. Relaix, J.F. Nicolas, G. Cossu, and M.E. Buckingham. 2006. Smooth 
muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of the 
myotome. Development. 133:737-749. 
Evans, D., H. Baillie, A. Caswell, and P. Wigmore. 1994. During fetal muscle development, clones of 
cells contribute to both primary and secondary fibers. Dev Biol. 162:348-353. 
Evans, W.J., and W.W. Campbell. 1993. Sarcopenia and Age-Related-Changes in Body-
Composition and Functional-Capacity. J Nutr. 123:465-468. 
Fry, C.S., J.D. Lee, J. Mula, T.J. Kirby, J.R. Jackson, F. Liu, L. Yang, C.L. Mendias, E.E. Dupont-
Versteegden, J.J. McCarthy, and C.A. Peterson. 2015. Inducible depletion of satellite cells 
in adult, sedentary mice impairs muscle regenerative capacity without affecting sarcopenia. 
Nat Med. 21:76-80. 
Gangloff, Y.G., M. Mueller, S.G. Dann, P. Svoboda, M. Sticker, J.F. Spetz, S.H. Um, E.J. Brown, S. 
Cereghini, G. Thomas, and S.C. Kozma. 2004. Disruption of the mouse mTOR gene leads 
to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell 
Biol. 24:9508-9516. 
Ganley, I.G., H. Lam du, J. Wang, X. Ding, S. Chen, and X. Jiang. 2009. ULK1.ATG13.FIP200 
complex mediates mTOR signaling and is essential for autophagy. J Biol Chem. 284:12297-
12305. 
Garcia-Martinez, J.M., and D.R. Alessi. 2008. mTOR complex 2 (mTORC2) controls hydrophobic 
motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 
(SGK1). Biochem J. 416:375-385. 
Garcia-Prat, L., M. Martinez-Vicente, E. Perdiguero, L. Ortet, J. Rodriguez-Ubreva, E. Rebollo, V. 
Ruiz-Bonilla, S. Gutarra, E. Ballestar, A.L. Serrano, M. Sandri, and P. Munoz-Canoves. 
2016. Autophagy maintains stemness by preventing senescence. Nature. 529:37-42. 
Ge, Y., A.L. Wu, C. Warnes, J. Liu, C. Zhang, H. Kawasome, N. Terada, M.D. Boppart, C.J. 
Schoenherr, and J. Chen. 2009. mTOR regulates skeletal muscle regeneration in vivo 
through kinase-dependent and kinase-independent mechanisms. Am J Physiol Cell Physiol. 
297:C1434-1444. 
Ge, Y., M.S. Yoon, and J. Chen. 2011. Raptor and Rheb negatively regulate skeletal myogenesis 
through suppression of insulin receptor substrate 1 (IRS1). J Biol Chem. 286:35675-35682. 
Gensch, N., T. Borchardt, A. Schneider, D. Riethmacher, and T. Braun. 2008. Different autonomous 
myogenic cell populations revealed by ablation of Myf5-expressing cells during mouse 
embryogenesis. Development. 135:1597-1604. 
Gingras, A.C., B. Raught, and N. Sonenberg. 1999. eIF4 initiation factors: effectors of mRNA 
recruitment to ribosomes and regulators of translation. Annu Rev Biochem. 68:913-963. 
Glass, D.J. 2005. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell 
Biol. 37:1974-1984. 
Guertin, D.A., D.M. Stevens, C.C. Thoreen, A.A. Burds, N.Y. Kalaany, J. Moffat, M. Brown, K.J. 
Fitzgerald, and D.M. Sabatini. 2006. Ablation in mice of the mTORC components raptor, 
rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, 
but not S6K1. Dev Cell. 11:859-871. 
Guridi, M., B. Kupr, K. Romanino, S. Lin, D. Falcetta, L. Tintignac, and M.A. Ruegg. 2016. Alterations 
to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism. 
Skelet Muscle. 6:13. 
Guridi, M., L.A. Tintignac, S. Lin, B. Kupr, P. Castets, and M.A. Ruegg. 2015. Activation of mTORC1 
in skeletal muscle regulates whole-body metabolism through FGF21. Science signaling. 
8:ra113. 
  References 
Page | 129 
 
Gwinn, D.M., D.B. Shackelford, D.F. Egan, M.M. Mihaylova, A. Mery, D.S. Vasquez, B.E. Turk, and 
R.J. Shaw. 2008. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol 
Cell. 30:214-226. 
Hagiwara, A., M. Cornu, N. Cybulski, P. Polak, C. Betz, F. Trapani, L. Terracciano, M.H. Heim, M.A. 
Ruegg, and M.N. Hall. 2012. Hepatic mTORC2 Activates Glycolysis and Lipogenesis 
through Akt, Glucokinase, and SREBP1c. Cell Metab. 15:725-738. 
Haldar, M., G. Karan, P. Tvrdik, and M.R. Capecchi. 2008. Two cell lineages, myf5 and myf5-
independent, participate in mouse skeletal myogenesis. Dev Cell. 14:437-445. 
Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. 
Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 
by MyoD. Science. 267:1018-1021. 
Hara, T., A. Takamura, C. Kishi, S. Iemura, T. Natsume, J.L. Guan, and N. Mizushima. 2008. FIP200, 
a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J 
Cell Biol. 181:497-510. 
Harrington, L.S., G.M. Findlay, A. Gray, T. Tolkacheva, S. Wigfield, H. Rebholz, J. Barnett, N.R. 
Leslie, S. Cheng, P.R. Shepherd, I. Gout, C.P. Downes, and R.F. Lamb. 2004. The TSC1-2 
tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol. 
166:213-223. 
Hasty, P., A. Bradley, J.H. Morris, D.G. Edmondson, J.M. Venuti, E.N. Olson, and W.H. Klein. 1993. 
Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. 
Nature. 364:501-506. 
Hinterberger, T.J., D.A. Sassoon, S.J. Rhodes, and S.F. Konieczny. 1991. Expression of the muscle 
regulatory factor MRF4 during somite and skeletal myofiber development. Dev Biol. 147:144-
156. 
Hollenberg, S.M., P.F. Cheng, and H. Weintraub. 1993. Use of a conditional MyoD transcription 
factor in studies of MyoD trans-activation and muscle determination. Proc Natl Acad Sci U S 
A. 90:8028-8032. 
Holz, M.K., B.A. Ballif, S.P. Gygi, and J. Blenis. 2005. mTOR and S6K1 mediate assembly of the 
translation preinitiation complex through dynamic protein interchange and ordered 
phosphorylation events. Cell. 123:569-580. 
Hosokawa, N., T. Sasaki, S. Iemura, T. Natsume, T. Hara, and N. Mizushima. 2009. Atg101, a novel 
mammalian autophagy protein interacting with Atg13. Autophagy. 5:973-979. 
Hsu, P.P., S.A. Kang, J. Rameseder, Y. Zhang, K.A. Ottina, D. Lim, T.R. Peterson, Y. Choi, N.S. 
Gray, M.B. Yaffe, J.A. Marto, and D.M. Sabatini. 2011. The mTOR-regulated 
phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor 
signaling. Science. 332:1317-1322. 
Hung, C.M., C.M. Calejman, J. Sanchez-Gurmaches, H. Li, C.B. Clish, S. Hettmer, A.J. Wagers, and 
D.A. Guertin. 2014. Rictor/mTORC2 loss in the Myf5 lineage reprograms brown fat 
metabolism and protects mice against obesity and metabolic disease. Cell Rep. 8:256-271. 
Hutcheson, D.A., J. Zhao, A. Merrell, M. Haldar, and G. Kardon. 2009. Embryonic and fetal limb 
myogenic cells are derived from developmentally distinct progenitors and have different 
requirements for beta-catenin. Genes Dev. 23:997-1013. 
Inoki, K., Y. Li, T. Xu, and K.L. Guan. 2003a. Rheb GTPase is a direct target of TSC2 GAP activity 
and regulates mTOR signaling. Genes Dev. 17:1829-1834. 
Inoki, K., Y. Li, T. Zhu, J. Wu, and K.L. Guan. 2002. TSC2 is phosphorylated and inhibited by Akt 
and suppresses mTOR signalling. Nat Cell Biol. 4:648-657. 
Inoki, K., T. Zhu, and K.L. Guan. 2003b. TSC2 mediates cellular energy response to control cell 
growth and survival. Cell. 115:577-590. 
Izumiya, Y., T. Hopkins, C. Morris, K. Sato, L. Zeng, J. Viereck, J.A. Hamilton, N. Ouchi, N.K. 
LeBrasseur, and K. Walsh. 2008. Fast/Glycolytic muscle fiber growth reduces fat mass and 
improves metabolic parameters in obese mice. Cell Metab. 7:159-172. 
Jacinto, E., R. Loewith, A. Schmidt, S. Lin, M.A. Ruegg, A. Hall, and M.N. Hall. 2004. Mammalian 
TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol. 
6:1122-1128. 
Joe, A.W., L. Yi, A. Natarajan, F. Le Grand, L. So, J. Wang, M.A. Rudnicki, and F.M. Rossi. 2010. 
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat 
Cell Biol. 12:153-163. 
Jones, D.L., and A.J. Wagers. 2008. No place like home: anatomy and function of the stem cell niche. 
Nat Rev Mol Cell Biol. 9:11-21. 
  References 
Page | 130 
 
Jones, N.C., Y.V. Fedorov, R.S. Rosenthal, and B.B. Olwin. 2001. ERK1/2 is required for myoblast 
proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol. 
186:104-115. 
Jung, J., H.M. Genau, and C. Behrends. 2015. Amino Acid-Dependent mTORC1 Regulation by the 
Lysosomal Membrane Protein SLC38A9. Mol Cell Biol. 35:2479-2494. 
Kanisicak, O., J.J. Mendez, S. Yamamoto, M. Yamamoto, and D.J. Goldhamer. 2009. Progenitors of 
skeletal muscle satellite cells express the muscle determination gene, MyoD. Dev Biol. 
332:131-141. 
Kassar-Duchossoy, L., B. Gayraud-Morel, D. Gomes, D. Rocancourt, M. Buckingham, V. Shinin, and 
S. Tajbakhsh. 2004. Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant 
mice. Nature. 431:466-471. 
Kassar-Duchossoy, L., E. Giacone, B. Gayraud-Morel, A. Jory, D. Gomes, and S. Tajbakhsh. 2005. 
Pax3/Pax7 mark a novel population of primitive myogenic cells during development. Genes 
Dev. 19:1426-1431. 
Kaul, A., M. Koster, H. Neuhaus, and T. Braun. 2000. Myf-5 revisited: loss of early myotome 
formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice. Cell. 102:17-
19. 
Kawabe, Y., Y.X. Wang, I.W. McKinnell, M.T. Bedford, and M.A. Rudnicki. 2012. Carm1 regulates 
Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem 
cell divisions. Cell Stem Cell. 11:333-345. 
Keefe, A.C., J.A. Lawson, S.D. Flygare, Z.D. Fox, M.P. Colasanto, S.J. Mathew, M. Yandell, and G. 
Kardon. 2015. Muscle stem cells contribute to myofibres in sedentary adult mice. Nat 
Commun. 6:7087. 
Kim, J., M. Kundu, B. Viollet, and K.L. Guan. 2011. AMPK and mTOR regulate autophagy through 
direct phosphorylation of Ulk1. Nat Cell Biol. 13:132-141. 
Kleinert, M., B.L. Parker, R. Chaudhuri, D.J. Fazakerley, A. Serup, K.C. Thomas, J.R. Krycer, L. 
Sylow, A.M. Fritzen, N.J. Hoffman, J. Jeppesen, P. Schjerling, M.A. Ruegg, B. Kiens, D.E. 
James, and E.A. Richter. 2016. mTORC2 and AMPK differentially regulate muscle 
triglyceride content via Perilipin 3. Mol Metab. 5:646-655. 
Kuang, S., K. Kuroda, F. Le Grand, and M.A. Rudnicki. 2007. Asymmetric self-renewal and 
commitment of satellite stem cells in muscle. Cell. 129:999-1010. 
Kumar, A., T.E. Harris, S.R. Keller, K.M. Choi, M.A. Magnuson, and J.C. Lawrence, Jr. 2008. Muscle-
specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal 
glycogen synthase activity. Mol Cell Biol. 28:61-70. 
Kunz, J., R. Henriquez, U. Schneider, M. Deuter-Reinhard, N.R. Movva, and M.N. Hall. 1993. Target 
of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required 
for G1 progression. Cell. 73:585-596. 
Lamming, D.W., L. Ye, P. Katajisto, M.D. Goncalves, M. Saitoh, D.M. Stevens, J.G. Davis, A.B. 
Salmon, A. Richardson, R.S. Ahima, D.A. Guertin, D.M. Sabatini, and J.A. Baur. 2012. 
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from 
longevity. Science. 335:1638-1643. 
Laplante, M., and D.M. Sabatini. 2009. mTOR signaling at a glance. J Cell Sci. 122:3589-3594. 
Laplante, M., and D.M. Sabatini. 2012. mTOR signaling in growth control and disease. Cell. 149:274-
293. 
Le Grand, F., A.E. Jones, V. Seale, A. Scime, and M.A. Rudnicki. 2009. Wnt7a activates the planar 
cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell. 
4:535-547. 
Leu, M., E. Bellmunt, M. Schwander, I. Farinas, H.R. Brenner, and U. Muller. 2003. Erbb2 regulates 
neuromuscular synapse formation and is essential for muscle spindle development. 
Development. 130:2291-2301. 
Liu, J.P., J. Baker, A.S. Perkins, E.J. Robertson, and A. Efstratiadis. 1993. Mice carrying null 
mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor 
(Igf1r). Cell. 75:59-72. 
Long, X., Y. Lin, S. Ortiz-Vega, K. Yonezawa, and J. Avruch. 2005. Rheb binds and regulates the 
mTOR kinase. Curr Biol. 15:702-713. 
Manning, B.D., A.R. Tee, M.N. Logsdon, J. Blenis, and L.C. Cantley. 2002. Identification of the 
tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the 
phosphoinositide 3-kinase/akt pathway. Mol Cell. 10:151-162. 
Massari, M.E., and C. Murre. 2000. Helix-loop-helix proteins: regulators of transcription in eucaryotic 
organisms. Mol Cell Biol. 20:429-440. 
  References 
Page | 131 
 
Matsumoto, A., A. Pasut, M. Matsumoto, R. Yamashita, J. Fung, E. Monteleone, A. Saghatelian, K.I. 
Nakayama, J.G. Clohessy, and P.P. Pandolfi. 2017. mTORC1 and muscle regeneration are 
regulated by the LINC00961-encoded SPAR polypeptide. Nature. 541:228-232. 
McKinnell, I.W., J. Ishibashi, F. Le Grand, V.G. Punch, G.C. Addicks, J.F. Greenblatt, F.J. Dilworth, 
and M.A. Rudnicki. 2008. Pax7 activates myogenic genes by recruitment of a histone 
methyltransferase complex. Nat Cell Biol. 10:77-84. 
Menon, S., C.C. Dibble, G. Talbott, G. Hoxhaj, A.J. Valvezan, H. Takahashi, L.C. Cantley, and B.D. 
Manning. 2014. Spatial control of the TSC complex integrates insulin and nutrient regulation 
of mTORC1 at the lysosome. Cell. 156:771-785. 
Messina, G., S. Biressi, S. Monteverde, A. Magli, M. Cassano, L. Perani, E. Roncaglia, E. Tagliafico, 
L. Starnes, C.E. Campbell, M. Grossi, D.J. Goldhamer, R.M. Gronostajski, and G. Cossu. 
2010. Nfix regulates fetal-specific transcription in developing skeletal muscle. Cell. 140:554-
566. 
Miner, J.H., and B. Wold. 1990. Herculin, a fourth member of the MyoD family of myogenic regulatory 
genes. Proc Natl Acad Sci U S A. 87:1089-1093. 
Miyabara, E.H., T.C. Conte, M.T. Silva, I.L. Baptista, C. Bueno, Jr., J. Fiamoncini, R.H. Lambertucci, 
C.S. Serra, P.C. Brum, T. Pithon-Curi, R. Curi, M.S. Aoki, A.C. Oliveira, and A.S. Moriscot. 
2010. Mammalian target of rapamycin complex 1 is involved in differentiation of regenerating 
myofibers in vivo. Muscle Nerve. 42:778-787. 
Mourikis, P., R. Sambasivan, D. Castel, P. Rocheteau, V. Bizzarro, and S. Tajbakhsh. 2012. A critical 
requirement for notch signaling in maintenance of the quiescent skeletal muscle stem cell 
state. Stem Cells. 30:243-252. 
Mozzetta, C., S. Consalvi, V. Saccone, M. Tierney, A. Diamantini, K.J. Mitchell, G. Marazzi, G. 
Borsellino, L. Battistini, D. Sassoon, A. Sacco, and P.L. Puri. 2013. Fibroadipogenic 
progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic 
muscles of young, but not old Mdx mice. EMBO Mol Med. 5:626-639. 
Murakami, M., T. Ichisaka, M. Maeda, N. Oshiro, K. Hara, F. Edenhofer, H. Kiyama, K. Yonezawa, 
and S. Yamanaka. 2004. mTOR is essential for growth and proliferation in early mouse 
embryos and embryonic stem cells. Mol Cell Biol. 24:6710-6718. 
Murphy, M., and G. Kardon. 2011. Origin of vertebrate limb muscle: the role of progenitor and 
myoblast populations. Curr Top Dev Biol. 96:1-32. 
Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, I. Nonaka, and Y. Nabeshima. 1993. 
Myogenin gene disruption results in perinatal lethality because of severe muscle defect. 
Nature. 364:532-535. 
Nishiyama, T., I. Kii, and A. Kudo. 2004. Inactivation of Rho/ROCK signaling is crucial for the nuclear 
accumulation of FKHR and myoblast fusion. J Biol Chem. 279:47311-47319. 
Ohanna, M., A.K. Sobering, T. Lapointe, L. Lorenzo, C. Praud, E. Petroulakis, N. Sonenberg, P.A. 
Kelly, A. Sotiropoulos, and M. Pende. 2005. Atrophy of S6K1(-/-) skeletal muscle cells 
reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol. 7:286-294. 
Pallafacchina, G., E. Calabria, A.L. Serrano, J.M. Kalhovde, and S. Schiaffino. 2002. A protein kinase 
B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber 
type specification. Proc Natl Acad Sci U S A. 99:9213-9218. 
Pisconti, A., G.B. Banks, F. Babaeijandaghi, N.D. Betta, F.M. Rossi, J.S. Chamberlain, and B.B. 
Olwin. 2016. Loss of niche-satellite cell interactions in syndecan-3 null mice alters muscle 
progenitor cell homeostasis improving muscle regeneration. Skelet Muscle. 6:34. 
Pisconti, A., D.D. Cornelison, H.C. Olguin, T.L. Antwine, and B.B. Olwin. 2010. Syndecan-3 and 
Notch cooperate in regulating adult myogenesis. J Cell Biol. 190:427-441. 
Potter, C.J., L.G. Pedraza, and T. Xu. 2002. Akt regulates growth by directly phosphorylating Tsc2. 
Nat Cell Biol. 4:658-665. 
Rebsamen, M., L. Pochini, T. Stasyk, M.E. de Araujo, M. Galluccio, R.K. Kandasamy, B. Snijder, A. 
Fauster, E.L. Rudashevskaya, M. Bruckner, S. Scorzoni, P.A. Filipek, K.V. Huber, J.W. 
Bigenzahn, L.X. Heinz, C. Kraft, K.L. Bennett, C. Indiveri, L.A. Huber, and G. Superti-Furga. 
2015. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls 
mTORC1. Nature. 519:477-481. 
Relaix, F., D. Rocancourt, A. Mansouri, and M. Buckingham. 2004. Divergent functions of murine 
Pax3 and Pax7 in limb muscle development. Genes Dev. 18:1088-1105. 
Relaix, F., D. Rocancourt, A. Mansouri, and M. Buckingham. 2005. A Pax3/Pax7-dependent 
population of skeletal muscle progenitor cells. Nature. 435:948-953. 
Rhodes, S.J., and S.F. Konieczny. 1989. Identification of MRF4: a new member of the muscle 
regulatory factor gene family. Genes Dev. 3:2050-2061. 
  References 
Page | 132 
 
Rodgers, J.T., K.Y. King, J.O. Brett, M.J. Cromie, G.W. Charville, K.K. Maguire, C. Brunson, N. 
Mastey, L. Liu, C.R. Tsai, M.A. Goodell, and T.A. Rando. 2014. mTORC1 controls the 
adaptive transition of quiescent stem cells from G0 to G(Alert). Nature. 510:393-396. 
Romanino, K., L. Mazelin, V. Albert, A. Conjard-Duplany, S. Lin, C.F. Bentzinger, C. Handschin, P. 
Puigserver, F. Zorzato, L. Schaeffer, Y.G. Gangloff, and M.A. Ruegg. 2011. Myopathy 
caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed 
by restoring mitochondrial function. Proc Natl Acad Sci U S A. 108:20808-20813. 
Rommel, C., S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, T.N. Stitt, G.D. Yancopoulos, and 
D.J. Glass. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by 
PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 3:1009-1013. 
Rudnicki, M.A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to 
up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle 
development. Cell. 71:383-390. 
Rudnicki, M.A., P.N. Schnegelsberg, R.H. Stead, T. Braun, H.H. Arnold, and R. Jaenisch. 1993. 
MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 75:1351-1359. 
Ryall, J.G., S. Dell'Orso, A. Derfoul, A. Juan, H. Zare, X. Feng, D. Clermont, M. Koulnis, G. Gutierrez-
Cruz, M. Fulco, and V. Sartorelli. 2015. The NAD(+)-dependent SIRT1 deacetylase 
translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell 
Stem Cell. 16:171-183. 
Sabatini, D.M., H. Erdjument-Bromage, M. Lui, P. Tempst, and S.H. Snyder. 1994. RAFT1: a 
mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is 
homologous to yeast TORs. Cell. 78:35-43. 
Sabers, C.J., M.M. Martin, G.J. Brunn, J.M. Williams, F.J. Dumont, G. Wiederrecht, and R.T. 
Abraham. 1995. Isolation of a protein target of the FKBP12-rapamycin complex in 
mammalian cells. J Biol Chem. 270:815-822. 
Sancak, Y., T.R. Peterson, Y.D. Shaul, R.A. Lindquist, C.C. Thoreen, L. Bar-Peled, and D.M. 
Sabatini. 2008. The Rag GTPases bind raptor and mediate amino acid signaling to 
mTORC1. Science. 320:1496-1501. 
Sancak, Y., C.C. Thoreen, T.R. Peterson, R.A. Lindquist, S.A. Kang, E. Spooner, S.A. Carr, and 
D.M. Sabatini. 2007. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. 
Mol Cell. 25:903-915. 
Sarbassov, D.D., S.M. Ali, D.H. Kim, D.A. Guertin, R.R. Latek, H. Erdjument-Bromage, P. Tempst, 
and D.M. Sabatini. 2004. Rictor, a novel binding partner of mTOR, defines a rapamycin-
insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 
14:1296-1302. 
Sarbassov, D.D., D.A. Guertin, S.M. Ali, and D.M. Sabatini. 2005. Phosphorylation and regulation of 
Akt/PKB by the rictor-mTOR complex. Science. 307:1098-1101. 
Saxton, R.A., and D.M. Sabatini. 2017. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 
168:960-976. 
Scadden, D.T. 2006. The stem-cell niche as an entity of action. Nature. 441:1075-1079. 
Schwander, M., M. Leu, M. Stumm, O.M. Dorchies, U.T. Ruegg, J. Schittny, and U. Muller. 2003. 
Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev Cell. 4:673-685. 
Seale, P., L.A. Sabourin, A. Girgis-Gabardo, A. Mansouri, P. Gruss, and M.A. Rudnicki. 2000. Pax7 
is required for the specification of myogenic satellite cells. Cell. 102:777-786. 
Serrano, A.L., B. Baeza-Raja, E. Perdiguero, M. Jardi, and P. Munoz-Canoves. 2008. Interleukin-6 
is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 
7:33-44. 
Shah, O.J., Z. Wang, and T. Hunter. 2004. Inappropriate activation of the TSC/Rheb/mTOR/S6K 
cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr 
Biol. 14:1650-1656. 
Shaw, R.J., N. Bardeesy, B.D. Manning, L. Lopez, M. Kosmatka, R.A. DePinho, and L.C. Cantley. 
2004. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell. 6:91-
99. 
Shea, K.L., W. Xiang, V.S. LaPorta, J.D. Licht, C. Keller, M.A. Basson, and A.S. Brack. 2010. 
Sprouty1 regulates reversible quiescence of a self-renewing adult muscle stem cell pool 
during regeneration. Cell Stem Cell. 6:117-129. 
Sheehan, S.M., and R.E. Allen. 1999. Skeletal muscle satellite cell proliferation in response to 
members of the fibroblast growth factor family and hepatocyte growth factor. J Cell Physiol. 
181:499-506. 
  References 
Page | 133 
 
Shefer, G., D.P. Van de Mark, J.B. Richardson, and Z. Yablonka-Reuveni. 2006. Satellite-cell pool 
size does matter: defining the myogenic potency of aging skeletal muscle. Dev Biol. 294:50-
66. 
Shimobayashi, M., and M.N. Hall. 2016. Multiple amino acid sensing inputs to mTORC1. Cell Res. 
26:7-20. 
Shiota, C., J.T. Woo, J. Lindner, K.D. Shelton, and M.A. Magnuson. 2006. Multiallelic disruption of 
the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. 
Dev Cell. 11:583-589. 
Shu, L., and P.J. Houghton. 2009. The mTORC2 complex regulates terminal differentiation of C2C12 
myoblasts. Mol Cell Biol. 29:4691-4700. 
Sousa-Victor, P., and P. Munoz-Canoves. 2016. Regenerative decline of stem cells in sarcopenia. 
Molecular aspects of medicine. 50:109-117. 
Sousa-Victor, P., E. Perdiguero, and P. Munoz-Canoves. 2014. Geroconversion of aged muscle 
stem cells under regenerative pressure. Cell Cycle. 13:3183-3190. 
Stokoe, D., L.R. Stephens, T. Copeland, P.R. Gaffney, C.B. Reese, G.F. Painter, A.B. Holmes, F. 
McCormick, and P.T. Hawkins. 1997. Dual role of phosphatidylinositol-3,4,5-trisphosphate 
in the activation of protein kinase B. Science. 277:567-570. 
Tee, A.R., B.D. Manning, P.P. Roux, L.C. Cantley, and J. Blenis. 2003. Tuberous sclerosis complex 
gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-
activating protein complex toward Rheb. Curr Biol. 13:1259-1268. 
Thedieck, K., P. Polak, M.L. Kim, K.D. Molle, A. Cohen, P. Jeno, C. Arrieumerlou, and M.N. Hall. 
2007. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. 
PLoS One. 2:e1217. 
Troy, A., A.B. Cadwallader, Y. Fedorov, K. Tyner, K.K. Tanaka, and B.B. Olwin. 2012. Coordination 
of satellite cell activation and self-renewal by Par-complex-dependent asymmetric activation 
of p38alpha/beta MAPK. Cell Stem Cell. 11:541-553. 
Truitt, M.L., C.S. Conn, Z. Shi, X. Pang, T. Tokuyasu, A.M. Coady, Y. Seo, M. Barna, and D. Ruggero. 
2015. Differential Requirements for eIF4E Dose in Normal Development and Cancer. Cell. 
162:59-71. 
Uezumi, A., S. Fukada, N. Yamamoto, S. Takeda, and K. Tsuchida. 2010. Mesenchymal progenitors 
distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell 
Biol. 12:143-152. 
Vander Haar, E., S.I. Lee, S. Bandhakavi, T.J. Griffin, and D.H. Kim. 2007. Insulin signalling to mTOR 
mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol. 9:316-323. 
Vinagre, T., N. Moncaut, M. Carapuco, A. Novoa, J. Bom, and M. Mallo. 2010. Evidence for a 
myotomal Hox/Myf cascade governing nonautonomous control of rib specification within 
global vertebral domains. Dev Cell. 18:655-661. 
Wan, M., X. Wu, K.L. Guan, M. Han, Y. Zhuang, and T. Xu. 2006. Muscle atrophy in transgenic mice 
expressing a human TSC1 transgene. FEBS Lett. 580:5621-5627. 
Wang, L., T.E. Harris, R.A. Roth, and J.C. Lawrence, Jr. 2007. PRAS40 regulates mTORC1 kinase 
activity by functioning as a direct inhibitor of substrate binding. J Biol Chem. 282:20036-
20044. 
Wang, S., Z.Y. Tsun, R.L. Wolfson, K. Shen, G.A. Wyant, M.E. Plovanich, E.D. Yuan, T.D. Jones, L. 
Chantranupong, W. Comb, T. Wang, L. Bar-Peled, R. Zoncu, C. Straub, C. Kim, J. Park, B.L. 
Sabatini, and D.M. Sabatini. 2015. Metabolism. Lysosomal amino acid transporter SLC38A9 
signals arginine sufficiency to mTORC1. Science. 347:188-194. 
Weintraub, H., R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T.K. Blackwell, D. Turner, 
R. Rupp, S. Hollenberg, and et al. 1991. The myoD gene family: nodal point during 
specification of the muscle cell lineage. Science. 251:761-766. 
Wick, M.J., L.Q. Dong, R.A. Riojas, F.J. Ramos, and F. Liu. 2000. Mechanism of phosphorylation of 
protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-
1. J Biol Chem. 275:40400-40406. 
Wood, W.M., S. Etemad, M. Yamamoto, and D.J. Goldhamer. 2013. MyoD-expressing progenitors 
are essential for skeletal myogenesis and satellite cell development. Dev Biol. 384:114-127. 
Yablonka-Reuveni, Z., R. Seger, and A.J. Rivera. 1999. Fibroblast growth factor promotes 
recruitment of skeletal muscle satellite cells in young and old rats. J Histochem Cytochem. 
47:23-42. 
Yang, G., D.S. Murashige, S.J. Humphrey, and D.E. James. 2015. A Positive Feedback Loop 
between Akt and mTORC2 via SIN1 Phosphorylation. Cell Rep. 12:937-943. 
  References 
Page | 134 
 
Yennek, S., M. Burute, M. Thery, and S. Tajbakhsh. 2014. Cell adhesion geometry regulates non-
random DNA segregation and asymmetric cell fates in mouse skeletal muscle stem cells. 
Cell Rep. 7:961-970. 
Yu, Y., S.O. Yoon, G. Poulogiannis, Q. Yang, X.M. Ma, J. Villen, N. Kubica, G.R. Hoffman, L.C. 
Cantley, S.P. Gygi, and J. Blenis. 2011. Phosphoproteomic analysis identifies Grb10 as an 
mTORC1 substrate that negatively regulates insulin signaling. Science. 332:1322-1326. 
Yuan, M., E. Pino, L. Wu, M. Kacergis, and A.A. Soukas. 2012. Identification of Akt-independent 
regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J 
Biol Chem. 287:29579-29588. 
Zhang, W., R.R. Behringer, and E.N. Olson. 1995. Inactivation of the myogenic bHLH gene MRF4 
results in up-regulation of myogenin and rib anomalies. Genes Dev. 9:1388-1399. 
Zinzalla, V., D. Stracka, W. Oppliger, and M.N. Hall. 2011. Activation of mTORC2 by association with 
the ribosome. Cell. 144:757-768. 
Zismanov, V., V. Chichkov, V. Colangelo, S. Jamet, S. Wang, A. Syme, A.E. Koromilas, and C. Crist. 
2016. Phosphorylation of eIF2alpha Is a Translational Control Mechanism Regulating 
Muscle Stem Cell Quiescence and Self-Renewal. Cell Stem Cell. 18:79-90. 
Zoncu, R., L. Bar-Peled, A. Efeyan, S. Wang, Y. Sancak, and D.M. Sabatini. 2011. mTORC1 senses 
lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-
ATPase. Science. 334:678-683. 
  Appendix – Research highlight 
Page | 135 
 
9. Appendix 
9.1 Research highlight: “LncRNA-encoded peptides: More than 
translational noise?” 
  Appendix – Research highlight 
Page | 136 
 
 
 
 
 
  Appendix – Publication 3 
Page | 137 
 
9.2 Publication 3: “Targeting deregulated AMPK/mTORC1 pathways 
improves muscle function in myotonic dystrophy type I” 
 
 
  Appendix – Publication 3 
Page | 138 
 
 
 
 
 
  Appendix – Publication 3 
Page | 139 
 
 
 
 
 
  Appendix – Publication 3 
Page | 140 
 
 
 
 
 
  Appendix – Publication 3 
Page | 141 
 
 
 
 
 
  Appendix – Publication 3 
Page | 142 
 
 
 
 
 
  Appendix – Publication 3 
Page | 143 
 
 
 
 
 
  Appendix – Publication 3 
Page | 144 
 
 
 
 
 
  Appendix – Publication 3 
Page | 145 
 
 
 
 
 
  Appendix – Publication 3 
Page | 146 
 
 
 
 
 
  Appendix – Publication 3 
Page | 147 
 
 
 
 
 
  Appendix – Publication 3 
Page | 148 
 
 
 
 
 
  Appendix – Publication 3 
Page | 149 
 
 
 
 
 
  Appendix – Publication 3 
Page | 150 
 
 
 
 
 
  Appendix – Publication 3 
Page | 151 
 
 
 
